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Summary      Seidu-Larry, Salifu; M. Sc. Chem. 
 
Title: Studies on the chemical biology of natural and chemical ribonucleotide 
modifications 
 
1. Examiner: Prof. Dr. Andres Jäschke 
2. Examiner: PD. Dr. Mark Helm 
 
This work is centered on the synthesis and chemical recognition of modified RNA. 
Phosphoramidites of m5U, Ψ, m1G, m2G and m22G were synthesized and were incorporated into 
RNA oligomers by standard SPS. The synthesized oligomers were used for two purposes: (i) the 
total construction of tRNA via enzyme catalyzed ligation, and (ii) investigations of modifications 
in siRNAs.  
The construction of human mitochondrial tRNAIle (i) with and without modification was 
achieved in a one-pot 3 fragments ligation using T4-DNA-ligase with a DNA-splint. The yield 
for the ligation was 20-30 % and the products were further investigated for the stability of the 
tertiary structure via UV-melting curve analysis. The unmodified tRNA was found to be 
significantly less stable than the fully modified tRNA.  
In the second case (ii) RNAi efficiency and the immunostimulation in cells were investigated 
with 22 nucleotide long double-stranded siRNAs that were synthesized containing the 
modifications m1G, m2G, m22G, rT and Ψ in varying stochiometry. The investigations showed 
differential effects in knock-down as well as immunostimulation. 
In a related perspective, compounds for the chemical recognition of modifications in RNA were 
synthesized. Since the recognition of pseudouridine by 4-bromomethyl-coumarin derivates is of 
particular interest, 7-azido-4-bromomethyl-coumarin was obtained with an overall yield of 44 % 
in a 5-step synthesis. Another derivative, the biotinylated 4-bromomethyl-coumarin spaced with 
jeffamine-148 was obtained in a 6-step synthesis with an overall yield of 17 %, to allow the use 
of strepavidin for affinity separation. 
In the course of further investigations of coumarine conjugates, mild and bio-compatible 
conditions for the syntheses of rhodols and rhodamines were discovered. The conversion of 
fluorescein into the 3’-mesylated or 3’-6’-dimesylated derivate and the subsequent displacement 
of the mesylate with a nitrogenous nucleophile gave rise to rhodols or rhodamines, respectively. 
As these reaction conditions are compatible with biomolecular labeling, the tagging of 
polypeptides was investigated. Tri-and pentapeptides were synthesized, and dye-labeled via 
3’/6’-xanthene substitution, and the product identity confirmed by MALDI-TOF-MS. Further 
syntheses via 3’/6’-xanthene substitution lead to moderate yields of 3',6'-bis(dimethylamino)-3H-
spiro[isobenzofuran-1,9'-xanthen]-3-one, 3',6'-di(piperidin-1-yl)-3H-spiro[isobenzofuran-1,9'-
xanthen]-3-one and the 3',6'-bis(2-(2-(2-aminoethoxy)ethoxy)ethyl amino)-3H-
spiro[isobenzofuran-1,9'-xanthen]-3-one.  
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Zusammenfassung    Seidu-Larry, Salifu; M. Sc. Chem. 
 
Title: Untersuchungen zur Chemischen Biologie von natürlichen und chemischen 
Ribonukleotidmodifikationen 
 
1. Gutachter: Prof. Dr. Andres Jäschke 
2. Gutachter: PD. Dr. Mark Helm 
 
Im Mittelpunkt dieser Arbeit stehen die Synthese und chemische Erkennung von modifizierter 
RNA. Die Phosphoramidite von m5U, Ψ, m1G, m2G und m22G wurden synthetisiert und mittels 
Standard-Festphasensynthese in RNA-Oligonukleotide inkorporiert. Die synthetisierten RNA 
Oligomere wurden für zwei Zwecke verwendet: (i) die Totalsynthese von tRNA mittels 
enzymkatalysierter Ligation und (ii) Untersuchungen zu Modifikationen in siRNAs.  
Die Synthese von humaner mitochondrialer tRNAIle (i) mit und ohne Modifikationen wurde in 
einer Eintopfligation von drei Fragmenten durch T4-DNA-Ligase mit einem DNA-Splint erzielt. 
Die Ausbeuten lagen zwischen 20-30 %. Die Produkte wurden durch UV-Schmelzkurvenanalyse 
auf Stabilität der Tertiärstrukturen untersucht. Hierbei zeigte sich, dass modifizierte tRNA 
signifikant stabiler als die unveränderte tRNA war. 
Im zweiten Fall, (ii) wurden RNAi Effizienz und zelluläre Immunstimulation von, 
doppelsträngigen siRNAs (22 Nukleotide) untersucht, welche mit den Modifikationen m5U, Ψ, 
m1G, m2G und m22G in unterschiedlicher Stöchiometrie synthetisiert worden waren. Die 
Untersuchungen zeigten differenzierte Effekte in Knock-Down und Immunostimulation. 
Vor diesem Hintergrund wurden Verbindungen zur chemischen Erkennung von Modifikationen 
in RNA synthetisiert. Weil der Erkennung von Pseudouridin durch Derivate von 4-
Brommethylcumarin eine besondere Bedeutung zukommt, wurde 7-Azid-4-brommethyl-
coumarin mit einer Gesamtausbeute von 44 % in einer fünfstufigen Synthese erhalten. Ein 
weiteres Derivat wurde in einer sechsstufigen Synthese mit einer Gesamtausbeute von 17 % 
erhalten. Dieses biotinylierte 4-Brommethylcumarin, welches ein Jeffamine-148 als 
Abstandshalter enthält, ist für den Gebrauch in der Affinitätsreinigung mittels Streptavidin 
einsatzbereit.   
Während weiterer Untersuchungen zu Konjugaten von Cumarinen wurden schonende und bio-
kompatible Bedingungen für die Synthesen von Rhodolen und Rhodaminen entdeckt. Die 
Umwandlung von Fluorescein in 3’-mesylierte beziehungsweise 3’-6’-dimesylierte Derivate, 
gefolgt von einer nukleophilen Substitution der Mesylate durch Stickstoffnukleophile führte zu 
Rhodolen beziehungsweise Rhodaminen. Da sich diese Bedingungen als kompatibel mit der 
Markierung von Biomolekülen erwiesen, wurden Konjugationsreaktionen mit Peptiden 
untersucht. Tri- und die Pentapeptide wurden synthetisiert, per 3’/6’-Xanthen-Substitution 
markiert, und die Identität der Produkte wurde durch MALDI-TOF-MS bestätigt. Weitere 
Untersuchungen zur 3’/6’-Xanthen-Substitution führten zu Synthesen von 3',6'-
Bis(dimethylamino)-3H-spiro[isobenzofuran-1,9'-xanthen]-3-on, 3',6'-Di(piperidin-1-yl)-3H-
spiro[isobenzofuran-1,9'-xanthen]-3-on und 3',6'-Bis(2-(2-(2-aminoethoxy)ethoxy)ethyl amino)-
3H-spiro[isobenzofuran-1,9'-xanthen]-3-on in moderaten Ausbeuten. 
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1 Introduction 
 
1.1 Modification of RNA by Enzymes. 
 
1.1.1 RNA  
 
Ribonucleic acid (RNA) is a type of chain polymeric molecule that consists of nucleotides as 
monomeric units. They were discovered by Friedrich Miescher in 1868 in the nucleus and were 
called ‘nuclein’ 1. Each nucleotide consists of a purine or pyrimidine base, a ribose sugar and a 
phosphate. RNA is very similar to DNA, but differs in a few important structural details: in the 
cell RNA is usually single-stranded whilst DNA is double stranded. On the chemical level RNA 
nucleotides contain the ribose whilst the DNA contains deoxyribose, also in RNA the base uracil 
is replaced with thymine in DNA as shown in Figure 1. The bases in nucleic acids do pair by H-
bond formation resulting in structural rigidity through folding.  
 
 
Figure 1 Schematic representation of nucleic acids 
 
The H-bonds in nucleic acids do follow Watson-Crick rule where the bases may form H-bonds 
between cytosine and guanine, and that between adenine and uracil/thymine. There is also the 
case of the wobble H-bonding between guanine and uracil which mainly occurs in RNA as 
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shown in Figure 2 2. It is known that for equivalent complementary sequences, the RNA duplex is 
more stable than the DNA duplex under most laboratory and physiological conditions. 
Traditionally, this has been explained by a variety of factors, including differential stacking, 
sugar puckering, and solvation 3-5.  
 
 
Figure 2 Base pairing in RNA and DNA 
 
Recently, it was shown in non-base-paired mononucleotides that the difference in pKa values of 
rA and rU is less than that for dA and dT, from which it was inferred that RNA hydrogen bonds 
can be stronger than those of DNA 6. In the cell the synthesis of RNA is performed on a DNA 
template via a process called transcription by enzymes called RNA polymerases. The transcribed 
RNA is further processed by other enzymes where several other activities are involved such as 5′-
capping, poly(A) tailing and removal of introns by spliceosomes. There is messenger RNA which 
carries the code responsible for protein synthesis. Those RNAs that however do not code for 
proteins are called non-coding RNAs. Prominent examples of the non-coding RNAs are the 
transfer RNA (tRNA) and the ribosomal RNA (rRNA), both of which are involved in the process 
of translation. There are other non-coding RNAs that are implicated in the regulation of gene 
expression, RNA processing and other roles. Certain RNAs are able to catalyze chemical 
reactions such as the scissoring and joining of other RNA molecules 7, peptide bond formation in 
ribosomes 8 and that of the Diels-Alder reaction 9, 10, these are known as ribozymes. In general 
the role of RNA could be translational, regulatory, genomic, processing and in some cases 
transcriptional.  
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1.1.2 Natural Modification of RNA by Enzymes 
 
Natural modification of RNAs was first reported in the works of Cohn et al. 11. In 1951, a 
modified nucleoside differing from the four canonical nucleosides was isolated. This identified 
modification was later characterized as pseudouridine, a 5-ribosyl isomer of uridine 12. This 
modification was found to be widely distributed in most types of RNAs (1-2 % of total RNA), 
with the noticeable exception of mRNA (although its absence remains to be definitively proven 
13. Other modified nucleosides such as m1G, m2G, m22G and m5U are present in much smaller 
quantities, but they represent a large diversity of original structures and or functions and are 
mainly found in tRNAs with 66 % of the known modifications in RNA 13, 14. There are about 32 
known uridine modifications including Ψ. The known modified uridines include the following 
variations: Ψ m, m1Ψ, m3Ψ, and m1acp3Ψ. These modifications are found in rRNA, mRNA and 
mainly tRNA. There are about 13 different types of modifications in cytidine, about 23 in 
adenosine and over 30 of varying degrees of modifications in guanosine. A recent list of natural 
modifications in nucleic acids can be found in book chapter 15. The structural and functional 
effects of these modifications are investigated using chemical and biological procedures. The 
chemical synthesis of RNA oligomers including base modifications via phosphoramidite 
chemistry, the specific reagents for recognition of such modifications, and the incorporation of 
fluorescence tagging moieties such as coumarin, rhodamine, cy3 etc which would allow the use 
of FRET for their investigation e. g. 16.  
These are the four main areas that will be treated thoroughly, however, from the diverse nature of 
this topic; there is a general introduction to each of the four specific areas mentioned. 
 
1.2 Phosphoramidite Synthesis including Modified Bases 
 
1.2.1 Chemical Synthesis of Oligonucleotides 
 
This technology, first developed for the preparation of DNA oligonucleotides and then adapted, 
taking into consideration the 2′-OH, to the synthesis of RNA oligonucleotides, is similar to other 
solid-phase methods, such as the solid-phase peptide synthesis (SPPS). A controlled pore-glass 
(CPG) solid support, with a long chain alkyl spacer functionalized with an amine is bonded with 
the first nucleoside via the terminal 3′-OH. The solid-phase synthesis is a stepwise coupling of 
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single building blocks, which are suitably orthogonally protected and functionalized. The product 
of the synthesis is then cleaved from the solid support, deprotected and then purified. As shown 
in Figure 3, such a single reaction cycle is schematically illustrated; the number (n) of repetition 
of this cycle leads to the desired oligonucleotide (n+1). 
 
 
Figure 3 Schematic representation of SPOS. 
 
The phosphoramidite building blocks are 5′-O-protected with a trityl moiety; usually the 4,4′-
dimethoxytrityl (5′-O-DMT) protecting group, which is removed under acidic conditions Figure 
3. This cleavage reaction, which constitutes the first step of the cycle, liberates the 5′-OH 
functionality. After washing to get rid of the cleaved trityl cation, a mixture of an appropriate 
phosphoramidite and 1H-benzylthio tetrazole (BTT) is added, which in situ react with each other 
under the formation of the activated form of the nucleotide; phosphorotetrazolide 3 shown in 
Figure 4. This reactive intermediate is then allowed to react with the previously liberated 5′-OH 
group of the growing chain. 
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Figure 4 Activation and coupling during the SPS. 
 
Although quite efficient, with usually 90-99 % yield per a cycle, this coupling step leaves a few 
unreacted 5′-OH groups, which later could lead to the formation of (shorter fragments) sequences 
that contaminate the full-length product. In order to prevent an accumulation of these undesired 
sequences, the unreacted nucleosides are blocked in a process called ‘capping’ by acetylation 
with acetic anhydride in the presence of N-methylimidazole and 2,6-lutidine. The phosphate 
triester obtained after coupling is prevented from degradation by oxidation with a mixture of 
iodine, lutidine and water. The considerations required to achieve a high-speed synthesis of RNA 
oligomer were described by Marshall et al. 17. 
 
1.2.2 General Syntheses of Modified Phosphoramidites 
 
The general considerations in phosphoramidite synthesis will be discussed bearing in mind the 
following three considerations:  
1. Protection of exo-cyclic amines and/or other reactive functionalities on the nucleobase. 
In this respect base modification to achieve a desired goal is done under the protection of 
the 2′, 3′ and 5′-OHs after which they are cleaved.  
1 Introduction  6 
 
2. The orthogonal protection of the 5′-OH and the 2′-OH groups taking into consideration 
the compatibility with the SPS.  
3. Finally, the phosphitylation at the 3′-OH position allowing chain elongation.  
 
For the complete list of available modifications synthesized or commercially available see the 
publication book chapter 15. The detailed protocol for the synthesis of a particularly modified 
phosphoramidite will be discussed taking into consideration the type of modification, 
orthogonality of protection groups and introduction of the phosphitylation moiety as shown in 
Figure 5. 
 
 
Figure 5 General scheme of phosphoramidite synthesis from nucleoside. 
 
The differences in procedure for the synthesis of phosphoramidite depend on it being either  
(i) a non base-protected phosphoramidite or  
(ii) a base protected or modified phosphoramidite. 
To illustrate examples of published syntheses of the two cases given will be discussed below i.e. 
synthesis of (i) m5U and pseudouridine and (ii) m1G, m2G and m22G respectively. 
 
1.2.3 Synthesis of m5U Modified Phosphoramidite 
 
In 1995 Soell et al. reported that 5-methyluridine (ribothymidine, rT), one of the most conserved 
modified nucleosides found in tRNAs is located at position 54 in the TψC loop 18. This 
modification has been implicated to be introduced by methylation of uridine with the (m5U54) 
methyltransferase. The mechanism of modification has simply been an extrapolated one 19 since 
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the sequence of the enzyme is similar to the enzyme thymidylate synthase, which generates 
(d)TMP from (d)UMP. A mechanism that involves a cysteine residue attacking the C6, 
generating an enolate and a nucleophilic C5, which subsequently allows reaction with an 
electrophilic methyl group has been implicated.  
Alluringly, the nature of the methylating reagent depends on the organism. It is often SAM but 
can also be 5,10-methylenetetrahydrofolate which was reported by Delk et al.20. Furthermore, 
although the identification elements involved in the process depend on the organism, same 
dependence is observed for the nature of identity elements involved in the editing process. 
Whereas in yeast some specific nucleobases have been identified, in E.coli no such sequence 
specificity has been observed and the interaction depends on the structure of the T arm as was 
reported by Becker et al. 21. 
 
The m5U nucleoside is readily available commercially and as such the synthesis of the 
phosphoramidite involves standard procedures. The reported synthesis of the m5U 
phosphoramidite involves the protection of the 2′-OH with TOM. The formation of the 2′-O-
TOM protected 5-methyluridine 8 from the parent nucleoside is done in two steps, by first 
introducing the trityl-group with (MeO)2Tr-Cl in pyr according to Gasparutto et al. 22, and Pitsch 
et al. 23, followed by alkylation of the product 7 with TOM-Cl under standard conditions as 
shown in Figure 6. Finally the 3′-OH unprotected product was converted to the final 
phosphoramidite 9 by CEP-Cl 23. For the synthesis of similar and other natural phosphoramidites 
one could refer to the book chapter 15. 
 
 
Figure 6 Synthesis of the m5U phosphoramidite 
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1.2.4 Synthesis of Pseudouridine Phosphoramidite 
 
Pseudouridine; a chemically simple modification 24, present in all variety of RNAs (rRNA, 
snRNA, snoRNA, tRNA) is mainly obtained by isolation from natural sources resulting in a 
prohibitive price. Pseudouridine is highly conserved at position 55 in most of the tRNAs in the 
TψC loop and is also found at other positions where it appears to influence the three-dimensional 
structure, cell viability and or aminoacylation 25, 26. This 5-ribosyl isomer of uridine is unique by 
having a C-C, rather than the usual N-C glycosyl bond that links base and sugar 27. This feature 
confers different hydrogen bonding capacities to it and influences the conformational 
preferences. Whereas the free nucleotide shows no real preferential conformation 28,29, NMR and 
X-ray experiments have demonstrated that it exhibits an extraordinary conformational rigidity in 
RNA sequences due to the coordination of a water molecule between N1-H and the 5′-phosphate 
group 25, 30. This feature improves base stacking interactions and contributes significantly to the 
structural stability of RNAs 28, 29, 31, 32. Among the modified nucleosides of tRNA, pseudouridine 
possesses the unique feature to be also present in the middle of the anticodon (position 35) where 
it is supposed to reinforce the base pairing strength 33. One can describe its presence to be 
vaguely universal and as such its role extensive. 
Consequently, some attention was given to its chemical preparation in milligram scale, but the 
stereoselective formation of C-nucleosides is still and remains a challenging task. The first of 
these syntheses was reported in 1961 by the work of Shapiro et al. 34. The synthetic strategy 
makes use of an ether-protected 2,4-dimethoxy-bromopyrimidine which was bromo-substituted 
into a lithiated analogue and used as a nucleophile in an SN2 type reaction with tri-benzoyl-
protected D-ribofuranosyl chloride. The β-anomer of the pseudouridine was synthesized in a 5-
step reaction with an overall yield of 2 %. 
The work of Brown et al. in 1981 uses the benzyl protected ribofuranose instead of the benzoyl 
analogue. Even though the yield of the final steps of the reactions was not given, the 6-step 
reaction was described as successful 35. 
A process, involving the coupling of an iodinated pyrimidine with a suitably protected 
ribonolactone was presented by Grohar et al. 36, 37. In their approach, a protected 5′-O-TBDMS-
2,3-O-isopropylidene-D-ribolactone was used instead of the protected ribose used in the first two 
cases. The pyrimidine surrogate used in this work was 2,4-dimethoxy-1-iodopyrimidine, whose 
methyl-ether deprotection could be challenging. There was however a moderate improvement in 
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the ratio of the α to β in the mixture after coupling. An inproportionate decrease in the yield of 
the final purified product was observed and attributed probably to the difficulty in the cleavage of 
the methoxy groups. The most current synthetic reported work on the synthesis of pseudouridine 
was by Hanessian et al in 2003 38. The synthetic strategy was not different from that of Grohar et 
al. except for the use of the very easily deprotectible tert-butyl group. The reducing agent used in 
the step before the cyclization reaction leading to the formation of the ribofuranose was also 
investigated. The overall reported yield showed 10 % increase in the deprotection step. This 
indicates an advantage when the methyl-ether was substituted for with the easily cleavable 
tertbutyoxy group. 
The conversion of pseudouridine to its phosphoramidite as reported by Chui et al. involves the 
formation of the cyclic bridging of the 5′-OH and the 3′-OH by the use of TIPDSCl. The 
protection of the 2′-OH with TMS and the successive deprotection of the 3′,5′-O-TIPDS afforded 
the 2′-O-TMS-pseudouridine which was converted to the 5′-O-BzH-2′-O-ACE pseudouridine and 
finally to the phosphoramidite by action of MEP-Cl 37, 39. Gasparutto et al. reported the synthesis 
of the pseudouridine phosphoramidite. The synthetic strategy made use of protected 5′-O-DMT-
2′-O-TBDMS-ribonucleoside which was finally phosphitylated using 2-Cyanoethyl-N-ethyl-N-
methyl-chlorophosphoramidite 22, 40. 
 
1.2.5 Synthesis of m1G, m2G and m22G Modified Phosphoramidites 
 
The m2G and m22G nucleosides have been already incorporated into RNA sequences as 2′-O-
TOM/O-C(6) nitrophenylethyl protected phosphoramidite building blocks. They have been 
prepared by nucleophilic aromatic substitution reaction of a protected 2-fluoroinosine derivative 
with the appropriate amine, MeNH2 for m
2G and Me2NH for m
2
2G, respectively. The conversion 
to the 5′-O-DMT and the protection of the 2′-OH with the fluoride labile silyl moiety and the 
final conversion to the phosphoramidite using CEP-Cl could be achieved as was reported by 
Hoebartner et al 41. There was also the reported work of Beier et al. where they employed an 
azomethane, to a protected 2′-O-mthp guanosine (Gnpe, npeoc), as the alkylating reagent. The 5′-OH 
protection and the phosphitylation follow similar procedure as reported by Beier et al. 42. 
In contrary, a route proposed by Sekine and Satoh was adopted giving mixed products. The 
introduction of the methyl group into the protected guanosine derivative in a one-pot synthesis 
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was chosen. First, the treatment of nucleoside in pyr with Me3SiCl (silylation of O-C(6) and O-
C(3′)), and then subsequently with 1,3-benzodithiozolium tetrafluoroborate 43, 44. The resulting 
N2-benzodithiol-2-yl derivative was filtered on silica gel and treated with (Me3Si)3SiH (Ballestri 
et al. 1991) and AIBN in refluxing benzene. Finally, cleaving the Me3Si-group off with NH3 in 
MeOH resulted in the formation of the modified nucleoside with an overall yield of 38 %. The 
protected N2,N2-dimethylguanosine nucleoside could be prepared from the crude N2-
monomethylated intermediate by repeating the sequential treatment above. After cleavage of the 
Me3Si-group with HF-pyridine as was reported on a similar system by Iwase et al., the fully 
modified nucleoside could be obtained 45. 
 
1.3 Reagents for Specific Recognition of RNA Modifications 
 
1.3.1 Specific Recognition of Modified RNA 
 
The specific reactions of certain electrophiles with nucleophiles e.g the exo-cyclic amines in 
nucleic acids have been known for some time and have been subjected to research for decades 
with several applications.  
 
Reagent(s) Nucleophile Comment(s) 
Dimethyl sulfate (DMS) 
chloroethylamine 
G(N-7), A(N-3), 
C(N-3) 
Order of reactivity G(N-7)> 
A(N-3)> C(N-3) 
Ethyl nitrosourea (ENU),  
methyl nitrosourea (MNU) 
phosphates Other nucleophiles are also 
affected 
β-ethoxy-α-ketobutyraldehyde 
(Ketoxal) 
G (N1 and N2) 
in ssRNA 
N-1 and N-2 involved in ring 
Diethyl pyrocarbonate (DEPC) A(N-7) N-7 of adenine, N-7 and C-8 
opening of ring upon aniline 
treatment 
1-cyclohexyl-3-(2-morpholino-4-
ethyl)carbodiimide 
methoptosylate (CMCT) 
Ψ(N-3), G(N-1), 
D(N-3) 
Reacts with Ψ, G and U but Ψ-
adduct is resistant to alkaline 
treatment 
BenzN2+ and derivatives/hυ phosphates Statistical modification 
Tritiated water HC-8Py Complete modification 
1-Fluoro-2,4-dinitrobenzene 2′-OH ss A Complete modification 
Table 1 Probing reagents and reacting nucleophile. 
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These applications include site-specific modification of RNAs leading for structural probing. 
Table 1 shows some of these reagents used in these modification recognition reactions. These 
reagents are specific to recognition of modified bases, and as such some are being used in 
combination with mass spectrometry which has become an increasingly powerful tool in the 
identification of modified nucleotides. The combination of site specific modification and mass 
spectrometry has taken an important place in the detection and mapping of post-transcriptionally 
modified nucleosides 46. 
The mass spectrometry of pseudouridine is not straightforward because: (1) pseudouridine has 
the same elemental composition and hence is isobaric with uridine, which is present in excess in 
RNA from natural sources, (2) pseudouridine does not readily fragment at the glycosidic bond of 
the base and (3) pseudouridine is poorly retained on reversed phase columns 47 and tends to elute 
in the solvent front making it difficult to spot. Several methods have been proposed for the 
specific sequence placement of pseudouridine. A method based on the reaction of pseudouridine 
with CMCT was described by Bakin and Ofengand 48, and later applied with matrix assisted laser 
desorption ionization (MALDI) mass spectrometry as the detection method by Patteson et al. 49. 
More recently, Mengel-Jorgensen et al. reported a different approach based on the Michael type 
addition of acrylonitrile in weakly alkaline conditions followed by MALDI mass spectrometry 50.  
It is conceivable that, because the addition reaction proceeds through a deprotonated nucleobase, 
the acidity of the base protons determines largely the reactivity of pseudouridine and its 
unmodified counterpart, uridine. Both these methods allow specific sequence placement of 
pseudouridine in the RNA strand, but so far no data is provided about any increase in detection 
sensitivity of pseudouridine in nucleoside mixtures. The most recent report was a derivatization 
reagent for pseudouridine, methyl vinyl sulfone (MVS). The derivatization reaction is also a 
Michael type addition and the reaction product has a higher electrospray ionization efficiency 
compared to non-derivatized pseudouridine, allowing lower detection limits. The moderate 
specificity (more than 4:1 of Ψ to U) makes this reagent useful for sensitive and specific 
detection of pseudouridine in presence of high amounts of uridine 51. 
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1.3.2 Coumarins and Derivatives 
 
The specific recognition of 4-thiouridine in pure E. coli tRNA fMet using 4-bromomethyl-7-
methoxycoumarin (BMB) as the reacting counterpart was reported first by Yang et al. about 35 
years ago 52. In a follow-up publication, Yang et al. reported that in the presence of pseudouridine 
and thiouridine containing mixture of nucleotides, the reaction of BMB was evident with 2-thio-
5-(N-methylaminomethy1)uridine as well as with pseudouridine and thus this could be extended 
to a total tRNA containing pseudouridine 53. The attractive part of this choice of reagent is that 
the covalent attachment of pseudouridine is multi-purposeful. The multifunctional role of 
coumarin both for specific labeling of pseudouridine and also for spectrofluorometric detection 
might be extended by further tailor-functionalizing the coumarin without changing the reactivity 
of the bromide. In this direction one could envisage an azido-functionalized coumarin that could 
be employed in a ‘click’ chemistry with a counterpart functionalized with a terminal alkyne 54, 55. 
A biotin-functionalized coumarin that could be used as a separation tool taking advantage of the 
high affinity between biotin and strepavidin (avidin) is illustrated in Figure 7 56. For the synthesis 
of these multi-functionalized or derivatized coumarins, one might look to the established and 
published protocols.  
ψBiotin linked 
bromomethyl coumarin
+
Strepavidin coated 
magnetic beads
+
+
Isolation of Ψ conataining RNA
RNA  containing no Ψ
Ψ
Ψ
Ψ containing RNA
Ψ
ψ
ψ
ψ
 
Figure 7 Using strepavidin to capture biotin linked RNA 
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Coumarins and their derivatives form a class of compounds, occupying an important place in the 
realm of natural products and synthetic organic chemistry. Their application runs a broad 
spectrum; ranging from additives in food, perfumes, cosmetics, pharmaceuticals, and in the 
preparation of insecticides 57, optical brightness 58, 59, and dispersed fluorescent and tuner laser 
dyes. It shows a variety of bioactivities including its application in the inhibition of platelet 
aggregation, as an anticancer agent with inhibitory properties against the 5α-reductases, 
anthelmintic and hypnotic properties. These properties have made coumarins interesting targets 
for organic chemists. The last decade witnessed a series of publications on the development of a 
synthetic methodology for this important heterocyclic scaffold. A typical example of the 
synthesis of 7- functionalized coumarin is shown in Figure 8. Thus, it is evidently required to be 
circumspective, when one needs to accommodate important functionalities which are broad in 
scope, and therefore the need for development of new and flexible protocols are required. The 
synthesis of coumarin has been performed following one of the following routes; Pechmann 60, 
Perkin 61, Knoevenagel 62-65, Reformatsky 66 and Wittig reactions 67, 68 among others including 
flash vacuum pyrolysis 69. Among these, the Pechmann reaction is the most widely used method 
as it involves the use of simple starting materials in the presence of acidic condensing agents. The 
use of Lewis acids in the Pechmann condensation reaction has been reported in several 
publications including that of Bose et al. 70, Smitha et al. 71, Kimura et al. 72 and that of 
Varughese et al. 73 The use of Lewis acids such as AlCl3, FeCl3, ZnCl2, POCl3, P2O3, ZrCl4 and 
that of Bismuth (III) derivatives has been reported in the catalysis of the Pechmann condensation 
of phenols with β-ketoesters. There is also the use of Brønsted acids as catalyst in the 
condensation reaction leading to the formation of coumarin as shown in Figure 8. 
 
 
Figure 8 Synthesis of coumarin. 
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1.4 Synthesis of Xanthene and Related Derivatives 
 
1.4.1 General Introduction to Xanthenes 
 
Xanthene (9H-xanthene, 10H-9-oxaanthracene) is a yellow heterocyclic compound with the 
chemical formula C13H10O. It is soluble in ether. Its melting point is 101-102 °C and its boiling 
point is 310-312 °C. Xanthene is used as a fungicide and it is also a useful intermediate in 
organic synthesis. Xanthene is relatively easy to synthesize; heating of phenyl salicylate 23 in the 
presence of a lewis acid affords the xanthone which is then reduced to the xanthene 24 under 
standard reduction condition using LAlH4 as illustrated in Figure 9 74. 
 
 
Figure 9 Synthesis of the core xanthene moiety 
 
Xanthene and derivatives among others are the basis of a class of dyes which includes 
fluorescein, eosins, rhodols and rhodamines. Xanthene dyes tend to be fluorescent, yellow to pink 
to bluish red, brilliant dyes. Many xanthene dyes can be prepared by condensation of derivates of 
phthalic anhydride 16 with derivates of resorcinol 15 or 3-aminophenol 12. A typical example of 
the synthesis of xanthene is shown in Figure 10. Mixture of phthalic anhydride 16 and 2 
equivalent of resorcinol 15 is heated usually in a solvent free Lewis acid catalyzed reaction. The 
resulting mixture is purified by re-crystallization from di-ethylether; however flash 
chromatography is frequently required for purification of xanthene dye and derivatives. 
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Figure 10 Synthesis of fluorescein 
 
1.4.2 Synthesis of Rhodols 
 
Rhodols are highly fluorescent dyes that form a structural hybrid of fluorescein 17 and rhodamine 
18, as shown in Figure 11. They are useful for oligonucleotide, antibody and protein labeling 
studies and for the preparation of peptidase and esterase substrates. Rhodols retain the pH-
sensitive properties conferred by a phenolic hydroxyl group, whereas the amine substituent 
reduces the pKa values. Rhodols exhibit high extinction coefficient (usually >70,000 cm-1M-1) 
and high quantum yield (~0.80–0.99) in aqueous solution, with absorption maxima at 
approximately 490 nm and emission maxima between 520 and 545 nm. As with fluorescein-
based dyes, the fluorescence excitation profiles of rhodol-based dyes are pH dependent, which 
can be useful for ratiometric pH determinations intracellularly. The dyes, however, show less 
spectral sensitivity to pH in the physiological range than does fluorescein. Rhodols have higher 
solubility in non-polar solvents and have improved photostability. 
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Figure 11 Rhodol, a hybridized product of fluorescein and rhodamine 
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Rhodols are synthesized chemically by a stepwise condensation reaction. This usually involves a 
sequential condensation of phthalic anhydride 16 with resorcinol 15 followed by addition of 3-
aminophenol 12, as shown in Figure 12. The reaction is catalyzed by a Lewis acid and the 
product is purified by re-crystallization or chromatography 75. Even though rhodols could be 
described as hybridized products of fluorescein and rhodamines, there is no reported data that 
show the conversion of fluorescein to rhodol or vice versa under mild conditions.  
 
 
Figure 12 Synthesis of rhodol via a stepwise condensation 
 
1.4.3 Synthesis of Rhodamines 
 
Rhodamines are a family of related chemical compounds, fluorone dyes. Just like fluorescein and 
rhodols they contain the xanthene core moiety with two aminyl moieties at the 3′ and 6′-position 
of the xanthene. Examples include among others the well known Rhodamine 6G and Rhodamine 
B. They are used for labeling and also as dye laser gain media. They are also often used as a 
tracer dye within water to determine the rate and direction of flow and transport. Rhodamine 
dyes, just like fluorescein, fluoresce and can thus be easily detected with fluorometers. 
Rhodamine dyes are used extensively in biotechnology applications such as fluorescence 
microscopy, flow cytometry, fluorescence correlation spectroscopy and ELISA. Rhodamine dyes 
are generally toxic, and are soluble in water, methanol and ethanol. They are usually synthesized 
in a condensation reaction of phthalic anhydride 16 and the particular 3-alkyl aminophenol 21, as 
shown in Figure 13 76. This reaction however is conducted at high temperature > 150 °C which is 
not compatible with most biochemical investigations. 
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Figure 13 The synthesis of rhodamine by Obata et al. 76. 
 
Kim et al. reported the use of a new rhodamine-derived boronic acid as derivatization agent for 
the detection of a variety of sugars and related biomolecules. This dye is formed from reaction 
between rhodamine and formylphenylboronic acid after which the product is reduced with 
NaBH4. The detection of sugars by forming reversible fluorescent complexes has been implicated 
in mixtures containing the dye and sugars 77. Chang et al. reported the synthesis and use of 
xanthene core peroxyfluor-1 (PF1), a new type of optical probe for intracellular imaging of 
hydrogen peroxide in living biological samples. The PF1 Utilizes a boronate deprotection 
mechanism to provide unprecedented selectivity and optical dynamic range for detecting H2O2 in 
aqueous solution. Also in imaging changes in [H2O2] in living mammalian cells 78. Dickinson et 
al. reported the synthesis, via derivatization of 3′,6′-diiodofluorescein, of a boronic acid 
functionalized xanthene core-moiety for an in vitro hydrolysis assay to monitor the H2O2 
production in the mitochondria of living cells, in a case of rendering a non-fluorescent boronic 
acid fluorescent 79. Miller et al. reported the synthesis and application of Peroxy Green (PG) and 
Peroxy Crimson (PC), two new fluorescent probes that show high selectivity for H2O2 and are 
capable of visualizing endogenous H2O2 produced in living cells by growth factor stimulation, 
including the first direct imaging of peroxide produced for brain cell signaling 80. Li et al. 
reported the use of ‘Singapore Green’ a peptide coupled rhodol-like molecule that allows the 
indirect measurement of peptidase activity as an increase of the fluorescence intensity in a 
microarray-based protease substrate profiling and living-cell experiments as illustrated in Figure 
14 130. 
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Figure 14 ‘Singapore Green’ for cell-profiling by Li et al. 
 
The conversion of 3′, 6′-dichloro- or difluorofluorescein to rhodamine has been reported as patent 
data. The reaction involves heating of the respective amine with the 3′,6′-dihalofluorescein at 
elevated temperature in high boiling solvent such as sulfolane 81. Similarly, a patented report of 
the reaction between fluorescein and thionyl chloride followed by the refluxing of the crude 
mixture in high boiling solvents with an amine results in the formation of the desired rhodamine. 
The use of high boiling solvents coupled with the high temperature of reaction in the synthesis of 
rhodamines do not allow the use of similar procedure where biomolecular investigation of 
proteins, nucleic acids and RNA in particular are of concern. There is therefore the need for a 
mild and compatible approach that allows the incorporation of rhodamines into RNA, peptides 
etc. 
  19 
2 Aims and Scope 
 
The objective of this thesis is the use of chemical biology as a tool to investigate modifications in 
RNA including the synthesis of particular nucleotide modifications and its conversion into 
phosphoramidites for later incorporation into RNA oligonucleotides. The synthesis of the 
following phosphoramidite and their incorporation into RNA were pursued; m5U, Ψ, m1G, m2G 
and m22G. The synthesized modified phosphoramidites were then to be fused into RNA 
oligonucleotides via the SPOS which will then be utilized for the construction of full length 
tRNA and for siRNA studies. 
One particular project was to investigate the recognition of these modifications and in particular 
the chemical recognition of pseudouridine by various multifunctional derivatives of 4-
bromomethyl-coumarin.  
In investigating different approaches to modify the detection sensitivity of the presumably 
pseudouridine selective bromomethyl-coumarin reaction, there was a serendipitous discovery of 
the possibility to directly transform fluorescein into rhodols and rhodamines. This found method 
occurs under mild reaction condition which could allow for biomolecular labeling which are 
usually difficult to be performed under harsh conditions. In addition the novelty of the reaction 
prompted us to further investigate it into more detail. 
  20 
3 Results and Discussions 
 
3.1 2′-Hydroxy Protection in Phosphoramidite Synthesis 
 
The protection of the 2′-hydroxy functionality could either be done by either of the fluoride labile 
silyl protecting groups widely used in RNA phosphoramidite synthesis: TBDMS-Cl or TOM-Cl. 
The latter was chosen due to the 2′-3′ non migration character of silyl moiety in basic condition 
as shown in Figure 15. TOM-Cl was synthesized according to the published protocol by Pitsch et 
al. 23. 
 
 
Figure 15 1,2-Silyl Migration in basic medium. 
 
The 2′-OH protection with TOM-Cl as was introduced by Pitsch et al. went successful with 
yields in the range 30-45 %. However, the formation of a foamy suspension which makes the 
work-up very difficult needs to be mentioned. The suspension is conceived to be as a result of the 
coordination of water molecules to ditertbutyltin dichloride which then gets distributed between 
the phases. DIEA catalyzed SN2 reaction between TOM-Cl and the 2′-OH group proceeded via 
the formation of the tin mediated complex. The sterically less hindered side which is usually the 
2′-OH section allows selectivity of the 2′-OH over the 3′-OH. In our case the selectivity 
enhancement was not pronounced, yielding a mixture of 2′-O- and the 3′-O- isomers which were 
separated by fCC. The extraction of the organic layer with DCM resulted into formation of an 
inseparable scum which made the whole work-up difficult to handle. This problem was 
circumvented by the filtration of the scum and re-suspending the mixture in the separating funnel 
for separation. 
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3.2 Synthesis of m5U Phosphoramidite 
 
This Section describes the synthesis of 5-methyluridine (m5U) phosphoramidite starting with 
commercially available 5-methyluridine. These synthesized phosphoramidite was finally used in 
the SPOS of which detailed procedure is described in chapter 3.6. 
 
The synthesis of the m5U phosphoramidite was achieved in a 3-step synthetic strategy starting 
from the commercially available 5-methyluridine which is schematically represented in Figure 
16. The 5′-OH was protected with the acid labile DMT-Cl in pyridine at rt for 5 h reaction time 
after which the dried crude was purified by fCC giving a yield of 85 %.  
 
 
Figure 16 Synthesis of m5U phosphoramidite. 
 
The 5′-O-DMT protected m5U was subjected to the fluoride labile protection of the 2′-hydroxy 
group in pyridine basified with imidazole at rt. The reaction mixture was quenched after 
overnight reaction when no starting material was detected by TLC. The reaction products were 
purified by fCC resulting in the desired 2′-O-TOM isomer, and the undesired 3′ isomer in equal 
ratio. There was also very little amount of the 2′,3′-di-O-TOM which was not quantified. The 
attachment of the phosphoryl group to the 3′-OH was finally achieved in a 2 h reaction in DCM 
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using DIEA as base for the reaction at rt. The product of this final step was 86 % after fCC 
purification on silica gel with a gradient eluent system of Hex:EtOAc; (20:1, 5:1). This 
phosphoramidite was used in the SPS of the RNA Oligonucleotides which is described in chapter 
3.6. 
 
3.3 Synthesis of Pseudouridine 
 
This section describes the synthesis of Pseudouridine starting with the commercially available 5-
bromouracil. Subsequently the obtained Pseudouridine is converted into the required 
phosphoramidite which was finally used in the SPOS described in detail in chapter 3.6. 
 
3.3.1 Known Synthetic Approaches to the Synthesis of Pseudouridine  
 
At the onset of this work, there were four reported total syntheses of pseudouridine. The first of 
these syntheses was reported in 1961 by the work of Shapiro and Chambers 34. The synthetic 
strategy makes use of an ether-protected 2,4-dimethoxy bromopyrimidine which was bromo-
substituted into a lithiated analogue and used as a nucleophile in an SN2 type reaction with tri-
benzoyl protected D-ribofuranosyl chloride, as represented schematically in Figure 17.  
 
 
Figure 17 Synthesis of Pseudouridine by Chambers et al. 1961. 
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The pseudouridine surrogate product which was finally cleaved off its protection groups afforded 
the undesired 6-membered heterocyclic hexose n together with the desired α and β anomers in a 
total overall synthesis of 5 steps with a yield of 3.6 % for all the various isomers Figure 17. The 
side product may have been formed as a result of protonation of the ribofuranose bridge oxygen 
leading to ring expansion. The difficulty in this strategy was in the coupling and the deprotection 
steps. The coupling makes use of the very short-lived intermediate; the lithiated pyrimidine, 
which often gets reduced by protonation within a short time of formation. It is therefore an 
important decision exactly when should the two coupling parts be put together in order to achieve 
maximum yield, forming less of the undesired 2,4-dimethoxyuracil. The second problem in this 
synthesis involves the difficulty in the cleavage of the methoxy group. There was incomplete 
cleavage after refluxing in 20 % (v/v) of dichloroacetic acid for 4 h. A lower pH condition could 
effect fast deprotection but this could as well speed up the isomerisation of the product. The final 
pure product was obtained after two times re-crystallization of the obtained crude from the 
deprotection using 95 % refluxing ethanol. The β-anomer of the pseudouridine was synthesized 
in a 5-step reaction with an overall yield of 2 %.  
The second total synthesis of pseudouridine was reported by Brown and Ogden in 1981. Their 
synthetic strategy uses the benzyl protected ribofuranose instead of the benzoyl moiety as was 
reported separately in the works of Buchanan et al. and Moffat et al. in C-C nucleoside synthesis. 
Also the very acid labile moiety tertbutoxy group was use for protection instead of the very 
difficult to cleave methyl ether analogue. The reaction proceeded in THF at -78 °C giving rise to 
the two D-allo and D-altro isomers shown in Figure 18. 
 
 
Figure 18 The chemical synthesis of Pseudouridine by Brown & Odgen (1981). 
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The two epimeric mixtures were cyclisized under the condition of ethanolic hydrochloric acid 
giving rise to the respective α and β forms of the nucleoside in the same ratio as the starting 
material suggestion stereospecificity in reaction as shown schematically in Figure 19. The non-
isomerization and stereospecificity of the reaction makes this condition superior compared to the 
SN2 mechanism shown in the method executed by Shapiro et al. 34. The benzyl groups were later 
cleaved from the surrogate pseudouridine by boron trichloride in DCM at -78 °C without any 
isomerisation as shown in Figure 19, after several failed attempts using catalytic hydrogenation 
procedure resulting in mainly 5-ribityluracil. 
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Figure 19 Cyclization and deprotection leading to α and β pseudouridine 
 
The application of the above discussed synthetic strategy using the methyl-protected ribose 
analogue lead to an increase in the D-altro anomer. The incomplete deprotection; a problem with 
the cleavage of the methyl-group, after the acidic cyclization condition, using the boron 
trichloride was observed. The use of the harsher boron tribromide led to the isomerisation of the 
product formed after a prolonged deprotection time of 2 days. The reaction of 2,3-O-
isopropylidene-D-ribose with lithiated ditert-butoxyuracil was also investigated. There was 
however no formation of any of the polyol derivatives. The unusual product which was the 
lithiated reagent with acetone as could be confirmed by high resolution mass spectrometry and 1H 
NMR as is being depicted in Figure 20. This was further confirmed when acetone was solely 
used as the electrophilic carbonyl component in the reaction instead of the 5′-O-trityl-2,3-O-
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isopropylidene-D-ribose. In summary the use of the benzyl ribose was successful in forming the 
desired β-pseudouridine in very good yield even though the percentage is not given. 
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Figure 20 Using 2,3-O-isopropylidene-D-ribose as the electrophile. 
 
The third synthetic work of pseudouridine was published by Grohar et al. in 1999 36. This 
synthetic work used a protected 5′-O-TBDMS-2, 3-O-isopropylidene-D-ribolactone instead of the 
protected ribose used in the first two cases. The pyrimidine surrogate used in this work was rather 
the difficult to cleave methyl ether; 2,4-dimethoxy-1-iodopyrimidine. Surprisingly, there was an 
improvement in the ratio of the α to β anomers in the mixture after coupling which was 1:8 as 
compared to 2:5 in the previous synthesis by Chambers et al. shown in Figure 21. 
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Figure 21 Synthesis of pseudouridine by Chow et al. 
 
There was however the isomerisation of the product during the reduction process leading to a 1:1 
mixture of both the α and β forms. The successful deprotection of the methyl ether using NaI in a 
refluxing acetic acid without any isomerisation within 25 min reaction time was an important step 
in the synthetic strategy. The final deprotection of the TBDMS was achieved using methanolic 
HCl with yield greater than 95 %. The final β-pseudouridine was obtained in 10-20 % after 7 
steps. 
The most current reported work on the synthesis of pseudouridine was published by Hanessian et 
al. in 2003 38. The synthetic strategy was very similar to that reported by Chow et al. except in 
the fact that the very acid labile non-cyclic acetal protection of the 5′-OH functionality was 
achieved as a one-port protection during the formation of the stable isopropylidene moiety. The 2 
and 4 positions of the pyrimidine were also protected as tertbutyl ether in order to achieve easy 
and complete deprotection as and when it was needed. The reported α to β ratio in the synthesis 
was same (1:8) as reported in the work of Chow et al. confirming the proposed stereochemical 
environment of the reaction and the reproducibility of the synthetic condition. The reduction of 
the diasteromeric lactols was achieved with the aid of L-selectride in the presence of ZnCl2 
giving the final acyclic-D-altro-hexitol as a single isomer in 85 % yield. The absence of ZnCl2 
results in the formation of the single D-allo-hexitol isomer suggesting the Si-face attack as 
illustrated by the scheme in Figure 22. 
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Figure 22 Possible pathways of stereoselective reduction. 
 
The synthesis of the allo form of this hexitol could follow the pathway where there is no ZnCl2-
complex formation due to the absence of ZnCl2. The resulting Re-face attack leads to the product 
as illustrated schematically in Figure 22 (B). The cycloetherification reaction was achieved under 
the Mitsunobu reaction conditions using DIAD and triphenylphosphine in THF with yield greater 
than 70 %. The final deprotection using 70 % acetic acid gave no isomerized product but rather 
more than 93 % of β-pseudouridine. It is however very important to note that the non-
isomerizable reduction condition, using the L-selectride, reported in this work failed in our case. 
There was therefore the need to re-strategize in order to circumvent the problems. 
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Figure 23 Total synthesis of pseudouridine in the present work. 
 
3.3.2 Own Synthetic Approach to the Synthesis of Pseudouridine 
 
Considering the synthetic strategies used in the syntheses of β-pseudouridine described in the 
four cases above, we endeavored to incorporate the advantages as well as minimized the 
disadvantages in order to synthesize β-pseudouridine in as few steps as possible. By considering 
the most current work by Hanessian et al. in 2003, we envisaged a similarly plausible route due 
to the improved yield in the number of steps as shown in Figure 23. The synthesis of 
pseudouridine started from the commercially available material 5-bromouracil. The conversion of 
this substance to the 2,4-dichloro-5-bromouracil was achieved in excellent yield, using 
diethylaniline and phosphorous oxychloride under reflux, and the subsequent conversion of the 
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2,4-dichloro-5-bromouracil to the ditert-butoxy analogue was also achieved without much 
difficulty using potassium ditert-butoxide in hexane under reflux for 5 h. The schematic 
representation for these reactions is shown in Figure 24. Phosphorus oxychloride has been used 
as a phosphorylating agent in the nucleotide chemistry 82. In the contrary, we employed it as a 
chlorinating agent. Based on the reported work of Zhang et al., Bobosik et al. and Szulc et al. the 
use of phosphorus oxychloride for reductive chlorination results in yields of not less than 70 % 83-
85. 
 
 
Figure 24 Synthesis of 2,4-ditert-butoxy-5-bromouracil. 
 
The conversion of the 2,4-di-tertbutoxy-5-bromouracil reagent into the lithiated derivative 
resulting into a charge inverted center usually termed ‘Umpolung’ was very quick. The 
subsequent reaction of this intermediate with the protected lactone gave variable yields 
depending on the time at which the lactone is added to the organo-lithiated intermediate. 
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Figure 25 Coupling of 2,4-ditert-butoxy-5-bromouracil to the protected lactone  
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The lithiated intermediate which is bright yellow in color can survive within 30 min of the 
reaction time. The amount then decreases very quickly forming the proton substituted analogue. 
The optimal condition for the coupling is within 20 min when the brightest yellow is first 
observed. The isolated yield of the coupling reaction is between 60-90 %, shown in Figure 25. As 
was reported by the work of Gazivoda et al., the organolithiated-mediated coupling of uracils 
usually gives lower yields due to the fast protonation reaction in the absence of a nucleophile 86-
88. The reduction of the pseudouridine surrogate, formed by the coupling reaction, needs to be 
done under conditions compatible with the stability of the acetal-protected hydroxy group. The 
ether functionality is known to cleave off under acidic conditions.For this reason pHs lower than 
7 need to be avoided. There are quite a number of reducing agents that could be used for this 
purpose including Et3SiH-BF3.OEt2 89, 90, LiAlH4 91, H-DIBAL 92, DIBAL 93, ReDAL 94, 95, and 
L-Selectride 96.  
However the stability of the final reduced product will be compromised if available options are 
not carefully considered. 
 
 
Figure 26 Reduction of pseudouridine surrogate with RedAL. 
 
The use of RedAL was reported separately by Satoh et al. 94 and Eland et al. 95. Other reported 
alternatives include H-DiBaL, L-selectride and LiAlH4. Red-Al (sodium bis(2-
methoxyethoxy)aluminum hydride) is primarily use as a reducing agent or a source of hydride 
very similar to LiAlH4. 
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The reduction of the equilibrium deprived form of the coupling product was achieved after 
several failed attempts. The use of H-DIBAL 92 in THF failed and so also was the use of L-
Selectride. Strangely the use of Et3SiH-BF3.OEt2 89 gave several spots from the TLC and so the 
reaction mixture was discarded. The solvent dependency of this reaction needs to be mentioned; 
in THF the reaction worked very slowly and was usually finished after 3 days without allowing 
the reaction to warm up above 0 °C. There were unidentified side-products though. The reaction 
was successful using DCM as solvent after an over-night reaction at 0 °C as shown schematically 
in Figure 26. Subsequently, the cyclization of this product under the Mitsunobu conditions using 
Ph3P and DIAD 97 resulted in the formation of the diastereomeric mixtures which were not 
separated during fCC purification and were used in the next step of the reaction as shown in 
Figure 27. The cleavage of the acetal and ethereal protection groups was achieved in one step 
using refluxing acetic acid for 6.5 h. The crude product which precipitated was not further 
purified. It was used in the next reaction after extensive drying under vacuo. 
 
 
Figure 27 Cyclization leading to pseudouridine surrogate. 
 
The α and β forms of the pseudouridine were produced after cleavage of the protection groups. 
They have very similar Rf-value and were therefore difficult to separate after several failed 
attempts with various solvent combinations. We therefore proceeded with the mixture to form the 
5′-O-protected DMT-product which eventually allowed us to separate α and β pseudouridine 
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(ratio 1:8 respectively) by fCC as shown in Figure 27. The β-5′-O-DMT-pseudouridine was 
synthesized in an 8–steps reaction with an overall yield of 18 %. The 8:1 ratio of the β to α  
anomers reported separately by Grohar et al. 36 and Hanessian et al. 38 was confirmed. 
 
3.4 Synthesis of Pseudouridine Phosphoramidite 
 
 
Figure 28 Synthesis of pseudouridine phosphoramidite. 
 
The synthesis of the pseudouridine phosphoramidite started with the conversion of the 
diastereomeric mixture of α and β pseudouridine to the α− and β-5′-O-DMT-pseudouridine 
allowing us to separate the diastereomeric mixtures by fCC. The β-5′-O-DMT-Pseudouridine was 
used in the synthesis of the desired phosphoramidite whilst the undesired 3′-product was cleaved 
off its 3′-protection by the action of TBAF and was further re-used for synthesis. 
The 2′-OH protection of the β-5′-O-DMT-pseudouridine was achieved using TOM-Cl in DCE 
shown in Figure 28. The reaction proceeded forming both the 2′-O- and 3′-O-TOM products in 
equal amounts, together with some of the 2′,3′-di-O-TOM, which were separated and the 2′-O-
TOM-5′-O-DMT-pseudouridine dried under vacuum overnight giving a yield of 48 %. The final 
reaction that involves the attachment of the phosphitylation moiety to the 3′-OH functionality was 
achieved in a very successful 95 % yield reaction. The addition of the 2-day vacuum-dried 2′-O-
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TOM-5′-O-DMT-pseudouridine in dry DCM at 0 °C pre-equipped with DIEA and the subsequent 
addition of the CEP-Cl as a solution in THF resulted in the diastereomeric products which were 
purified by fCC and subsequently used in the SPOS which is described in-depth in chapter 3.6. 
 
3.5 Synthesis of m1G, m2G and m22G Phosphoramidites 
 
This Section describes the synthesis of N1-methylguanosine (m1G), N2-methylguanosine (m2G) 
and N2,N2-dimethyguanosine (m22G) phosphoramidites starting with commercially available 
guanosine. These synthesized phosphoramidites were finally used in the SPOS of which the 
detailed procedure is described in Chapter 3.6. 
 
3.5.1 Synthesis of m1G Phosphoramidite 
 
 
Figure 29 Synthesis of the m1G phosphoramidite. 
 
3 Results and Discussions  34 
 
The synthesis of the phosphoramidite m1G was achieved from commercially available guanosine 
40 according to an already established method described by Hörbartner et al. with a few changes 
leading to improved yields as shown in Figure 29. 
 
40 41
NH
N
N
O
NH2N
O
OHOH
HO
N
N
N
O
NHN
O
OO
O
O
OO
O
CH3
Chemical Formula: C19H23N5O9
Exact Mass: 465.15
Chemical Formula: C10H13N5O5
Molecular Weight: 283.24
Methylation
Peracetylation
 
Figure 30 Synthesis of 2′, 3′, 5′-O-triacetyl-N2-acetyl-N1-methylguanosine. 
 
The methylation of the N1-postion of the purine base was achieved using NaH in anhydrous 
DMSO at rt to which the methylating reagent, MeI, was added. This product was not purified and 
was used in the next step after 5 h reaction time when the mixture was evaporated under vacuo at 
80 °C. The peracetylation of the N1-methylguanosine was achieved using refluxing mixture 
containing DMSO, Ac2O and pyr in the ratio 1:1:1 (40 equivalents) in 14 h reaction time. The 
variation of the ratio of the DMSO, pyr and the acetic anhydride could lead mainly to the tri-
esterified product. The resulting product 41 was very sticky and very difficult to purify. The 
dissolution of the crude in MeOH, addition of coarse silica and evaporation in vacuo finally 
ensured the successful packing onto an already prepared column which was eluted with a mixture 
of DCM and MeOH to give the product with yield for both steps being greater than 60 %. The 
scheme of these reactions is shown in the Figure 30. 
The ester functionalities of the peracetylated product were cleaved off selectively in the presence 
of the amide functionality by careful addition of a 2 M solution of NaOH to a vigorously stirring 
mixture of the peracetylated product in a mixture of THF/MeOH/ H2O in ratio 5:4:2. The 
saponification reaction was usually finished within 15 min and the reaction mixture was brought 
to pH 6.5-7 and kept at 4 °C overnight to precipitate. The precipitate was filtered and washed 
with a cold mixture of THF/MeOH/ H2O in ratio 5:4:2 and dried under vacuo. The product 42, a 
fluffy yellow solid, was obtained in a yield of 72 %. 
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Figure 31 Attaching the trityl moiety to the 5′-O-position of m1G. 
 
The synthesis of the 5′-O-DMT-1-methylguanosine was achieved using the already established 
procedure used by Micura et al. 41. The N2-acetyl-1-methylguanosine 42 was dissolved in 
pyridine and the pyridine evaporated under reduced pressure, this was repeated three times to 
make the reaction mixture H2O-free. To the finally dried mixture, molecular-sieve dried-pyridine 
was added and stirred at rt for 30 min. To this stirring mixture DMT-Cl as a solution in pyridine 
was then added slowly within 1 h. The reaction mixture was stirred and monitored by the aid of 
TLC. The reaction was finished within 8 h and was quenched with MeOH. The solvent was 
removed under vacuo and the crude product purified by fCC to yield the 5′-O-DMT–N2-acetyl-
N1-methylguanosine in a yield of 85 % as shown in Figure 31. The product was allowed to dry 
under vacuum for 3 days and was used in the next reaction. 
 
N
N
N
O
NHN
O
OOH
O
O
CH3
Ph
MeO
OMe
O
Si
Chemical Formula: C44H57N5O9Si
Molecular Weight: 828.04
N
N
N
O
NHN
O
OHOH
O
O
CH3
Ph
MeO
OMe
Chemical Formula: C34H35N5O8
Molecular Weight: 641.67
TOM-Cl
DCE, DIEA
46 %
43 44
. 
Figure 32 Attaching the TOM-group to the 2′-O position of m1G. 
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The 2′-OH protection of the β-5′-O-DMT-N2-acetyl-1-methylguanosine was achieved using 
TOM-Cl in dichloroethane in a similar reaction condition as described in the case of 
pseudouridine above. The reaction proceeded forming both the 2′-O and 3′-O-TOM protected 
products in non-equal amounts, but in this case no detectable amount of the 2′,3′-di-TOM 
product. The crude mixture was separated and the 2′-O-TOM-5′-O-DMT-N2-acetyl-1-
methylguanosine dried under vacuum overnight, giving a fluffy white solid with a yield of 46 % 
illustrated in Figure 32. The 3′-diastereomer was also formed with a yield of 36 %. This minor 
preference of the 2′-O- over the 3′-O-diastereomer was however not reproducible. 
 
 
Figure 33 Ultimate step in the formation of the phosphoramidite m1G. 
 
The ultimate step which is the conversion of the 2′-O-TOM-5′-O-DMT-N2-acetyl-1-
methylguanosine into the phosphoramidite reagent that could be used in the SP-RNA-S was 
executed based on similar conditions used in the synthesis of the pseudouridine phosphoramidite 
using DCM and CEP-Cl at 0 °C to rt. The yield of this final step after fCC purification and 
subsequent drying under vacuo, was 85 %. The reaction scheme is illustrated in Figure 33. Care 
must be taken in order not to cleave off the DMT protection of the 5′-OH. An addition of 1-3 % 
Et3N in the elution solvent mixture was therefore used in the fCC. 
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3.5.2 Synthesis of Precursor for m2G and m22G Phosphoramidite 
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N
N
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O
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Molecular Weight: 409.35
93 %Acetic anhydride
DMF, pyr, 75 °C, 4 h.40
46
 
Figure 34 Synthesis of 2′,3′,5′-O-triacetylguanosine. 
 
The 2′,3′,5′-tri-O-acetyl-O6-npe-guanosine is a common precursor for both m2G and m22G 
synthesis. The synthesis of this precursor follows a procedure reported by Robins et al. in which 
the esterification reaction occurs selectively in the presence of the free exo-cyclic amino 
functionality of the purine 98. A reaction mixture containing acetic anhydride, pyridine and DMF 
in the ratio 6:3:8 was heated together with guanosine at 75 °C for 4 h giving rise to only the tri-
ester with no detectable amount of the N2-acetyl side product, as shown in Figure 34. The 
purification involves hot filtering and allowing the warm solution to cool to rt. The precipitate 
formed is filtered and re-crystallized in hot isopropanol. The yield for this reaction was in the 
range of 90-95 %. 
 
Figure 35 Protection of O6-carbonyl using npe under Mitsunobu reaction condition. 
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3.5.3 Synthesis of m2G Phosphoramidite 
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Figure 36 Synthesis of the m2G phosphoramidite. 
 
The general scheme for the synthesis of the m2G phosphoramidite is illustrated in Figure 36. 
Using the 2′,3′,5′-tri-O-acetylguanosine, the protection of the O6-hydroxy functionality was 
achieved using Mitsunobu reaction conditions as shown in Figure 35. The two reaction parts are 
2-(4-nitrophenyl)ethanol and the 2′,3′,5′-tri-O-acetylguanosine in the presence of PPh3 and 
DEAD as promoters for the etherification reaction. The reaction was carried out in dioxane at 80 
°C and allowed to cool down to 60 °C within 1 h, after which the clear solution was reduced 
under vacuo when TLC shows no starting nitrophenyl alcohol left. The product of this 
etherification reaction was purified by fCC using Et2O and DCM mixture to yield of 80 % as a 
semi-solid. 
The methylation of the N2-exo-cyclic amine functionality was achieved through the indirect 
convertible nucleotide strategy. The addition of HBF4 first and subsequent addition of NaNO2 
resulted in the exchange reaction between the formed nitroso and the fluoride functionality. The 
fluoride solution formed was neutralized with NaOH. Afterwards it was extracted into DCM and 
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dried further with anhydrous Na2SO4 after which it was evaporated under vacuo. The crude 
product was not further purified but used in the next step. The crude material was dissolved in 8 
M CH3NH2 in ethanol and stirred overnight after which it was evaporated to dryness under 
reduced pressure. During the fluoride methylamine exchange reaction, the acetyl group of the 
ester was cleaved off in a one-pot reaction giving the product 48 with a yield of 51 %. 
The 5′-O-DMT protection was achieved using the general procedure applied in the synthesis of 
the m1G phosphoramidite. There was in this case the addition of the base DMAP due to the very 
slow rate of reaction.  
 
 
Figure 37 Selective protection of 5′-OH of the m2G with DMT-Cl. 
 
Typically, 5′-O-DMT protection reaction was completed within 8 h. However, we had to consider 
an overnight reaction due to the difficulty in the dissolution of the modified G and the resulting 
decrease in the reaction rate. The yield for this reaction was 70 %, a fluffy pale yellow product 
49. Typical yield for the 5′-O-DMT protection was 85 % or greater. 
The 2′-OH protection was achieved using the fluoride labile non-migrating TOM-Cl. This 
reaction just like the 5′-O-DMT protection gave rather low yields compared to other 2′-OH 
protections. Longer reaction time was not resulting into an appreciable increase in the amount of 
product formed.  
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Figure 38 Protection of the 2′-O- with TOM. 
 
The reason for this low yield will be attributed to the low dissolution of the starting material in 
DCE or DCM. The regioselectivity of the 2′-O-alkylated over 3′-O-alkylated product was not 
different. The product 50, a foamy white solid was obtained after fCC with 3 % Et3N, giving a 
yield of 30 %. The scheme of the reaction is as shown in Figure 38. 
 
 
Figure 39 The phosphitylation reaction of m2G. 
 
The conversion of the 5′-O-DMT-2′-O-TOM-m2G 50 to the m2G-phosphoramidite 51 was 
achieved using DCM to which DIEA was pre-dissolved at rt. The addition of the starting material 
during cooling after which the mixture was brought to rt and then the successive addition of 
CEP-Cl as a solution in THF within 15 min resulted in the formation of the m2G-
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phosphoramidite 51 shown in Figure 39. This phosphoramidite was purified by fCC giving a 
yield of 65 % and used in the SPOS which is described in detail in chapter 3.6. 
 
3.5.4 Synthesis of m22G Phosphoramidite 
 
Using the 2′,3′,5′-tri-O-acetylguanosine, the protection of the O6-hydroxy functionality after 
tautomerization from the keto form was achieved using the Mitsunobu reaction condition. The 
reaction condition was similar to the one used in the synthesis of the m2G. The resulting yield 
was 82 % as a semi-solid. The di-methylation of the N2-exo-cyclic amine functionality was 
achieved through the indirect convertible nucleotide strategy. 
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Figure 40 Synthesis of m22G phosphoramidite. 
 
The successive addition of HBF4 and NaNO2 resulted in the exchange reaction between the 
nitroso and the fluoride functionality. The mixture was neutralized with NaOH after which it was 
extracted into DCM and dried furthermore with Na2SO4, evaporated under vacuo. The crude 
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product was used in the next step without further purification as shown in Figure 40. The crude 
material was dissolved in ~12M (CH3)2NH in ethanol and stirred overnight after which water was 
added to speed up the saponification of the product and then evaporated to dryness under reduced 
pressure. During the fluoride-dimethylamine exchange reaction, the acetyl groups of the ester 
were cleaved off in the one-pot reaction giving the product with yield of 51 % shown in Figure 
40. 
 
 
Figure 41 Protection of the 5′-OH for the synthesis of the m22G phosphoramidite. 
 
The 5′-O-DMT protection was achieved using the general procedure applied in the synthesis of 
the m2G phosphoramidite. As described earlier, an overnight reaction was considered due to the 
difficulty in the dissolution of the modified G and the resulting decrease in the reaction rate 
which is similar to the case of the m2G. The yield for this reaction, a fluffy pale yellow product 
53, was 68 % as shown in Figure 41. 
 
 
Figure 42 Fluoride labile protection of the 2′-OH for the synthesis of m22G phosphoramidite. 
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The 2′-hydroxy protection was achieved using the fluoride labile non-migrating TOM-Cl. This 
reaction just like the case in the m2G gave rather low yields compared to other 2′-protections. 
Similarly, longer reaction time was not resulting into an appreciable increase in the amount of 
product formed. The reason for this low yield may be attributed to the low dissolution of the 
starting material in DCE or DCM. The regioselectivity of the 2′-O-alkylated over 3′-O-alkylated 
product was 5:3. The product, a foamy off-white solid was obtained after fCC with 3 % Et3N in 
an Hexane-EtOAc mixture with a yield of 32 %. The scheme of the reaction is as shown in Figure 
42. 
 
 
Figure 43 The ultimate step in the synthesis of m22G phosphoramidite. 
 
The ultimate step, which was the conversion of the 5′-O-DMT-2′-O-TOM-m22G to its 
phosphoramidite, was achieved using DIEA activation of the 3′-OH functionality in DCM prior 
to the addition of the CEP-Cl as a solution in THF at rt. The finally formed diastereomeric crude 
phosphoramidite was purified by fCC giving a yield of 69 %, illustrated in Figure 43, which was 
used in the SPOS described in detail in chapter 3.6. 
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3.6 RNA Oligonucleotide Syntheses 
 
This Section describes the Solid-Phase RNA Oligomeric Synthesis (SPOS) of the various RNA 
fragments that were used for both tRNA fragments for the ligation construction kit and those for 
the siRNA investigations. The synthesis employs the use of both modified synthesized and 
commercially available phosphoramidites. 
 
3.6.1 Construction Kit to Investigate Effects of Modification on tRNA 
 
The Solid phase RNA synthesis was performed using both the purchased and the self-synthesized 
modified phosphoramidites. The incorporation of the modified m5U and Ψ phosphoramidites was 
equally efficient as that of the unmodified counterparts A, C, G and U used in the SPS. There was 
however low coupling efficiency from the modified guanosine phosphoramidite. This reduction 
of coupling efficiency might be due to the difficulty in the dissolution of the modified guanosine 
phosphoramidite in the solvent (AN) used for the synthesis and hence the low reactivity. The 
synthesis failed for the cases where more than one modified guanosine was to be incorporated. 
This problem was finally solved by making a dilute solution of the modified phosphoramidite 
(0.1 M instead of the 0.25 M in AN) and repeating each step in the cycle of the protocol for the 
modified guanosine phosphoramidites. 
The RNA oligonucleotides were synthesized for two main research purposes. In the first instance, 
our idea of a construction kit shown in Figure 44, that allows the total chemical synthesis of full 
length tRNA fragments which are themselves products of finally ligated shorter fragments was 
envisaged 99.  
Formation of cloverleaf 
Structure after DNase
digestion of template in 
the presence of Mg2+ ions
OHOHOHOH
5’
3’
3’
5’DNA template
 
Figure 44 Concept of the ligation kit. 
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In this respect, the synthesis was strategized to achieve RNA fragments as long as possible but as 
well without compromising on the practicability of the process. Typically, oligomeric units of up 
to 40 nucleotides length could be synthesized but for a very efficient synthesis, nucleotide lengths 
of 20 to 30 are optimal. The construction kit was designed to synthesize tRNAs using fragments 
of oligonucleotides with varying degree of bases modifications. The construction of the tRNAIle 
with total modification and without any modification was achieved in a 3-fragment T4 DNA 
ligase catalyzed synthesis with yields between 20-30 %. 
 
3.6.2 Ligation Experiment 
 
The ligation reaction was conducted overnight at 16 °C and the crude mixture was purified by 
GEL electrophoresis after digestion of the DNA splint using a DNase. The digestion was 
monitored by analyzing the result of 1 μL on using PAGE. The result of the PAGE is displayed 
in the experimental section. The following scheme was used for synthesis of tRNAIle Table 2. 
 
 oligo1  oligo2  oligo3  Splint  L-premix  ligase  H2O  T. vol  
MH  272  274  276  329  4x      
Conc  100  100  100  100      Ile1  
μL  20  20  20  20  62.5 40  67.5  250   
MH  273 275 276 329      
Conc  100  100  100  100      Ile4  
μL  20  20  20  20  62.5  40  67.5  250   
 
Table 2 The ligation scheme for the synthesis of tRNAIle. 
 
3.6.3 Analysis of tRNAIle by Thermal Melting Curves  
 
The stability of a tertiary structure of the RNA was measured by thermal denaturation 
experiments on a UV-visible spectrophotometer, by recording the absorbance at 260 nm as a 
function of temperature. Heating a RNA sample results in a change in absorbance properties, 
which reflects a conformational change of the molecule in solution, and allows the determination 
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of RNA secondary structure stability. Denaturation leads to a hyperchromism of 15-20%. 
Cooling the sample leads to a renaturation of the structure.  
A thermal denaturation experiment of RNA yields the melting temperature value Tm, which 
corresponds to the temperature at which half of the sample is base-paired and half is unwinded. 
Tm deteremination implies the measurement of the absorbance properties of the folded and 
unfolded forms as a function of temperature. 
 
 
Figure 45 The first derivative of the UV melts of tRNA Ile with (purple) and without (blue) 
modifications.  
 
The results of the melting curve analysis show that the unmodified tRNA (Tm ~ 77.1 °C) were (~ 
4.5 °C) less stable as compared to the fully modified tRNA (Tm ~ 81.6 °C) as shown in Figure 45. 
This was however not surprising since the modification will result into more stable tertiary 
structure hence the stability. 
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3.6.4 Effects of Base Modifications on siRNA Studies 
 
Table 3 Synthesized siRNAs for knock-down and immunostimulation studies. 
Synthesized Oligomers Code 
r(GAACUψCAGGGUCAGCUUGCCG) MH278 
r(GAACUψCAGGGψCAGCUUGCCG) MH279 
r(GAACUψCAGGGψCAGCUψGCCG) MH280 
r(GAACUUCAGGGUCAGCUTGCCG) MH281 
r(GAACUUCAGGGTCAGCUTGCCG) MH282 
r(GAACUTCAGGGTCAGCUTGCCG) MH283 
r(GAACUUCAGGGUCAGCUUm1GCCG) MH284 
r(GAACUUCAGGm1GUCAGCUUm1GCCG) MH285 
r(m1GAACUUCAGGm1GUCAGCUUm1GCCG) MH286 
r(GAACUUCAGGGUCAGCUUm2GCCG) MH287 
r(GAACUUCAGGm2GUCAGCUUm2GCCG) MH288 
r(m2GAACUUCAGGm2GUCAGCUUm2GCCG) MH290 
GCAAGCUGACCCUGAAGUUCAU MH294 
GCAAGCψGACCCUGAAGUUCAU MH295 
GCAAGCUGACCCUGAAGUψCAU MH296 
GCAAGCUGACCCψGAAGUUCAU MH297 
GCAAGCUGACCCUGAAGψψCAU MH298 
GCAAGCψGACCCψGAAGUψCAU MH299 
 
In the second case we endeavored to investigate the effect of modified bases in siRNA. The 
synthesis of the following RNAs with the modifications shown were achieved, (see Table 3), 
using the modified phosphoramidites that were synthesized and purified as described in Chapter 
3. 
The synthesized RNA oligomeric units were used for the investigation of the knock-down effects 
and also tested for immunostimulation efficiency. This was done in a collaborative work with 
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Dalpke et al. (Florian Eberle). The results of the knock-down and the immunostimulation 
efficiency are shown in the following. 
In a series where the antisense strand of the GFP siRNA has been made to contain 1, 2 or 3 
pseudouridines or no pseudouridine, the influence of these pseudouridine moieties on 
immunostimulation was negligible. From the bar graph shown in Figure 46, the extent of 
immunostimulation was highest with the strand containing no modification. However there was 
no significant decrease in immune stimulation in the number of introduced pseudouridines in the 
strand.  
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Figure 46 Immunostimulation of IL8 in the presence pseudouridine: Effect of varying 
concentration of siRNA on sensitivity of IL8 induction as a measure of varying the position and 
the number of Ψ in siRNA. Increasing concentration results in increase in immune response. 
 
R-848 an immune response modifier, which is a known immunostimulator was used as a positive 
control for the experiment. Also for the negative control DOTAP which has no 
immunostimulation effect was used. There was also the blank which contains only the cell line 
shown in Figure 46. 
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Figure 47 TNF-alpha stimulation using single strand siRNA with modifications: Effect of 
varying concentration of siRNA on sensitivity of mTNF-α induction as a measure of fixed 
position and the number of Ψ in siRNA. 
 
In another series where the antisense strand with a sequence complementary of the GFP 
containing either no pseudouridine or 1, 2 or 3 pseudouridines moieties were tested for the 
expression of mTNF-alpha induction on a cell line as shown in the bar graph in Figure 47. There 
was an inexplicably high immunostimulation with the MH294 and MH295 containing no 
modification and 1 modification at position 7 respectively. There was however no such 
expression with similar siRNA containing 1 modification at position 19 (MH296) and position 13 
(MH297). The results of the test of the expression of interleukins by the induction of the cells 
with the siRNAs containing various modifications of pseudouridine did not give very clear 
results.  
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Figure 48 IFN-alpha expressions in the presence of modified siRNA: Sensitivity and effect of 
modification types on the stimulation of INF-alpha using siRNA containing 1, 2 or 3 Ψ, rΤ, m2G, 
m22G and m1G. The results show a proportionate responds with respect to incressing 
concentration of modified siRNA. 
 
 
 
We therefore decided to consider various modifications using one, two or three modifications of 
pseudouridine, ribothymidine (T), m1G, m2G and m22G. The synthesized siRNAs were tested for 
their immunostimulation in concentrations of 0.3, 1.0 and 3 μg/mL. The amount of interferon 
alpha expressed was measured in each case. The result of this investigation is shown in Figure 
48. There was a proportionate increase in the amount of expressed IFN-alpha in the case of the 
m1G and the ribothymidine introduced modifications. That could however not be stated for the 
others. Based on this finding, the m1G and the ribothymidine modified siRNAs were re-
investigated. 
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Figure 49 IFN-alpha expression in the presence of modified siRNA containing rT and m1G: 
Effects of varying concentration of modified siRNA as anti sense strand on IFN-alpha 
stimulation showing inexplicable high induction in the presence of m1G.  
 
 
In a series of experiments where the antisense strand has been made to contain one, two or three 
ribothymidine and m1G, the immunostimulation was measured as the amount of secreted 
interferon-alpha. There was a higher expression of interferon by the siRNA containing the m1G 
as compared to the others shown in Figure 49.  
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Figure 50 Knockdown of GFP protein in the presence of modified siRNA: GFP knockdowns vs. 
type and number of modification using siRNA containing 1, 2 or 3 rT, m2G, m1G and m22G. 
Results show efficient knock down with rT, m2G and m1G but very poor knock down with m22G. 
 
 
The knock-downs of GFP by the siRNA with modifications introduced were measured by the 
amount of fluorescence emitted by the cells. The m1G, m2G and the rT modified siRNAs showed 
very high knock-down efficiency and the results were proportionate with the amounts used in the 
investigation as shown in Figure 50. The m22G containing siRNA as expected showed a poor 
knock-down of the GFP and hence a high mean fluorescence. 
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3.7 Syntheses of Bromocoumarins and Derivatives  
 
This Section describes the synthesis of the various bromomethylcoumarins and their derivatives 
to be used for the qualitative and quantitative investigations of pseudouridine containing 
oligonucleotides. 
 
3.7.1 Synthesis of 7-azido-4-bromomethylcoumarin 
 
In our bid to synthesize the 4-bromomethyl-coumarin compound, we performed the following 
trial reactions in order to ascertain the feasibility and ease of reaction taking into consideration 
the susceptibility to hydrolysis of the benzylic-like bromide functionality. The reactions are 
usually performed under solventless condition. However reported work of the synthesis of 7-
acetamide-4-bromomethylcoumarin was employed using 75 % H2SO4 with the dual role of 
catalyst and solvent. This alternative allows the uniform mixing of reagents and therefore was 
considered superior even though an additional step was required for the removal of the sulfuric 
acid.  
 
 
Figure 51 Scheme of 7-azido-4-bromomethylcoumarin. 
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The protection of the amino functionality of the 3-aminophenol was achieved following the 
already established protocol published by Maly et al 100. The mixture was filtered whilst hot and 
the hot filtrate cooled to rt and then evaporated to dryness. The isopropanol recrystallized product 
was obtained in a yield greater than 95 % shown in Figure 51. This did not differ from the 
reported yield of the published work. The product of this reaction was analyzed after thorough 
drying under reduced pressure and used in the next step. A critical step in this synthesis was the 
formation of the coumarin moiety by the Pechmann condensation reaction. This critical reaction, 
was conducted using the ethyl 3-hydroxyphenylcarbamate formed and the heat sensitive 
cyclization partner diethyl 3-oxopentane-1,5-dioate in an acid catalyzed reaction. The reaction 
was typically finished after 10 h and was therefore left overnight after which it was checked for 
the formation of the product by TCL. The product formed was dissolved in water and extracted 
into EtOAc, the H2O dried with anhydrous Na2SO4 evaporated to dryness and used in the next 
step without further purification. The yield of this important step shown in Figure 51 was 90 %.  
 
 
Figure 52 Hydrolysis and cabarmoyl deprotection. 
 
The deprotection of the amino-functionality was achieved in a one pot reaction that also removes 
the ethyl ester protection on the exo-cyclic carboxylic acid. A 16 h reflux of the carbamate-ethyl 
protected product in a 4 M solution of NaOH resulted in the formation of the product; 2-(7-
amino-2-oxo-2H-chromen-4-yl)acetic acid shown in Figure 52. The formation of the azido-
functionality was executable at this stage. Consecutively, the addition of 2-(7-amino-2-oxo-2H-
chromen-4-yl) acetic acid, conc. H2SO4 and ice slurry, and the temperature of the mixture was 
maintained at 0 °C for 15 min. Furthermore, NaNO2 was added portion-wise as a solution in ice-
water whilst stirring vigorously and subsequently NaN3 was added in one portion (as a solution in 
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ice-water). The reaction mixture was stirred overnight after which it was extracted with EtOAc. 
The organic layer was washed with brine and then dried with anhydrous sodium sulfate, filtered 
and concentrated under vacuo.  
 
 
Figure 53 Formation of 7-azido-4-methylcarbamoylcoumarin. 
 
The product was pure enough (from NMR) and was therefore used in the next step without 
further purification, as shown in Figure 53. Part of this crude mixture was purified by fCC with a 
yield of 86 %. 
The ultimate step involves the decarboxylic bromination reaction under acidic condition. It was 
reported by Secrist et al. that under refluxing acetic acid the methylcarbamoyl-coumarin was 
converted into its bromo product as shown in Figure 54 101. The reported yield of the reaction 
using equal equivalents of bromine and 7-methoxycoumarin-4-methylcarboxylic acid was 51 %. 
 
O
OH
O OH3CO
Br
O OH3CO
Br2
Acetic acid
reflux
+ CO2
Chemical Formula: C11H9BrO3
Molecular Weight: 269.09
Chemical Formula: C12H10O5
Molecular Weight: 234.20
 
Figure 54 Decarboxylative bromination reaction by Secrist et al. (1971). 
 
We endeavored to achieve the decarboxylative bromination reaction following the reported 
protocol by Secrist et al. with very minor modification in order to increase the yield. A refluxing 
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solution containing 2-(7-azido-2-oxo-2H-chromen-4-yl)acetic acid in acetic acid was stirred for 
10 min. Br2 was added as a solution in acetic acid and the reaction mixture was refluxed for 1 h 
after which TLC reveals large amount of starting material. Additionally, Br2 (1 equiv) was added 
and the refluxing was continued for 1 h after which TCL still showed starting material. Br2 was 
then added again and the mixture refluxed overnight. The mixture was concentrated under 
reduced pressure and with the aid of a short fCC, the product was eluted with ethyl acetate. The 
total amount of bromine used was 3 equivalents and the yield after purification was 93 %. The 
reaction scheme is shown in Figure 55. The product 61 was analyzed for the integrity of the 
azido-functionality by IR-spectroscopy 
 
O
OH
O ON3
Br
O ON3
Br2
Acetic acid
reflux
Chemical Formula: C10H6BrN3O2
Molecular Weight: 280.08
Chemical Formula: C11H7N3O4
Molecular Weight: 245.19
+ CO2
60 61
 
Figure 55 Decarboxylative bromination of 7-azidocoumarin-4-methylcarboxylic acid. 
 
The product, a yellowish-brown solid, is light sensitive and decomposes upon exposure to light. 
It is stored under argon in a light-opaque flask at -20 °C. The 7-azido-4-bromomethylcoumarin 
61 is currently used in the studies of specific recognition of pseudouridine in the Helm group 
{unpublished results}. 
 
3.7.2 Synthesis of 7-(biotinyl-jeffamine-succinyl-4-bromomethylcoumarin 
 
The retrosynthetic scheme of the synthesis of biotinylated bromomethyl coumarin spaced with 
jeffamine succinate is shown in Figure 56. The reported work of the Hong et al. 102 where the 
coupling of the 7-hydroxy-4-bromomethycoumarin and the activated carboxylic acid 
functionality as reported was carefully studied for its applicability to our case. The easily 
hydrolizable bromide functionality need to be preserved during the reaction and purification of 
the crude product. In the reported work of Hong et al., the polydispersed and high molecular 
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weight of the carboxylic acid functionalized moiety allows the product of the reaction to be 
separated by radial chromatography. 
 
 
Figure 56 Retrosynthetic scheme of 7-(biotin-jeffaminyl-succinoyl)-4-bromomethyl coumarin. 
 
3.7.3 Synthesis of Biotin–NHS Ester 
 
The conversion of biotin to the biotin-NHS ester was performed according to published result 
from the work of Charvet et al 103. The synthetic strategy involves the use of DCC to activate the 
carboxylic acid functionality of biotin after which the NHS is added to form the semi-stable 
biotin-NHS ester intermediate 63; shown in Figure 57. The reaction durations are typically very 
long, 2-3 days at rt. There is often an increase in yield of the side product when the temperature is 
increased due to re-arrangement of the very stable DCC activated product. The filtration of the 
DCU formed and the subsequent dissolution of the mixture in water and extracting with 
DCM/MeOH (1:1) mixture, drying the organic phase with anhydrous Na2SO4 and evaporation 
under reduced pressure gave the crude.  
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Chemical Formula: C14H19N3O5S
Molecular Weight: 341.38
Chemical Formula: C10H16N2O3S
Molecular Weight: 244.31
62 63
 
Figure 57 Synthesis of biotin–NHS ester. 
 
Re-crystallization of the crude from hot isopropanol and allowing the mixture to cool to rt results 
in the prism-like product with a yield of 92 %. 
 
3.7.4 Synthesis of 3-(2-(2-(2-aminoethoxy)ethoxy)ethylcarbamoyl)propanoic acid 
 
 
Figure 58 Synthesis of jeffaminylsuccinylate. 
 
In order to maintain the water solubility of the final molecule, the desired linker should be as 
short as possible and hydrophilic in nature. We started with oxalic acid, attempting to protect one 
of the two carboxylic acid functionalies with tert-butanol, as had been described for malonic acid 
by Gao et al. 104. This reaction failed, probably due to the instability of such oxalic acid 
derivatives in general. It was proceeded with analogous protection of malonic acid and 
subsequent formation of a succinimide at the free acid functionality. However, this was 
accompanied by side product formations which led to low yields. Succinic acid was then chosen 
as dicarboxylic acid linker, as the amide bond formation with jeffamine 148 could easily be 
achieved by simply adding succinic anhydride to the latter diamine without an additional 
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protection step. The mono-protection of the diamine functionalized water soluble compound, 
Jeffamine-148 64, was achieved without much difficulty. The drop-wise addition of 1 equivalent 
of succinic anhydride, as a solution in THF, to a refluxing mixture of containing 4 equivalent of 
2,2′-(ethane-1,2-diylbis (oxy)) diethanamine in THF. The refluxing was stopped and the mixture 
was allowed to cool to rt after which the formed precipitates were filtered and washed several 
times with EtOAc and allowed to dry in air. This crude product 65 was pure enough and was 
used in the next stage of the reaction without further purification. The yield of this reaction was 
estimated as quantitative as no succinic anhydride was observed; the scheme of the reaction is as 
shown in Figure 58. The product, an amino-acid like compound, could act as a water soluble 
linker for most syntheses that require a hetero-bifunctional group for orthogonal coupling. 
 
3.7.5 Synthesis of Biotinylated-jeffaminylsuccinylate 
 
The attachment of the hydrophilic spacer-linker to biotin was achieved using the NHS-activated 
strategy. The biotin-NHS ester was dissolved in DCM to which the amino-like acid was added as 
a solution in MeOH and the reaction mixture stirred and monitored by the aid of TLC. The 
reaction was finished within 1 h after which it was evaporated to dryness and purified by fCC. 
The yield of this penultimate step was greater than 80 %. The scheme of this reaction is shown in 
Figure 59. 
 
 
Figure 59 Synthesis of biotin-jeffaminylsuccinylate. 
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The ultimate step of the reaction involves the attachment of the coumarin moiety bearing the 
easily hydrolysable bromine functionality to the water soluble spacer-linked biotin. The 7-
hydroxy-4-bromomethyl coumarin 56 was synthesized from the 7-acetoxy-4-bromomethyl 
coumarin 57 by selectively saponifying the acetyl moiety with sodium perborate in MeOH 
without hydrolyzing the bromide. This final step in our synthetic strategy was successful after 
several failed attempts. Ester bond formation between 66 and 56 was attempted with 
dicyclohexylcarbodiimide and DMAP according to Neises et al. 105and Besheer et al. 106 as well 
as by using a large excess (10 equiv) of DCC without further additives 102. Both reactions failed; 
instead of ester formation only hydrolysis of the bromide could be observed as confirmed by 
TLC. The Steglich reaction condition which is usually employed in the synthesis of amides 
usually works for the synthesis of esters too. The use of the combination of EDC-HCl and DMAP 
as activator in dioxane for this coupling also failed. Most of the conditions that allow the readily 
formation of an ester functionality e.g. the use of inorganic base or acid catalyzed aqueous media 
reaction was not a matter of choice since this will as equally lead to the hydrolysis of the bromide 
functionality. The use of pentafluorophenol in combination with DCC was also investigated but 
there was basically no product formation after an overnight reaction time. In our bid to adopting 
an alternative strategy that would lead to the formation of same compound or with little 
modification in structure, we decided to try the combination of DCC and HOBt, which is also 
used in the activation of sterically hindered carboxylic acid functionalities. This trial investigation 
finally gave the product 67 in a yield of around 30 % as shown in Figure 60.  
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Figure 60 Scheme of the ultimate reaction leading to the final product. 
 
This result was not very different from the work of Delmotte et al. where they reported 45 % 
yield, using the DCC/HOBt combination as compared to the case of TBTU/HOBt combination 
with a yield of 90 %, on a very similar system 107. There was therefore the need for testing the use 
of TBTU/HOBt combination for the activation of the carboxylic acid functionality. The test 
experiment showed the formation of product within 6 h. We would however not hesitate to say 
that the possibility of the hydrolysis of the benzylic-like bromide of the coumarin as was 
observed with the DCC/DMAP combination occurred for longer reaction times. 
The concept of the applicability of the finally synthesized multi-functionalized compound 66 is 
illustrated in Figure 61. Functionalization of 4-bromomethyl coumarin with a biotin handle 
(fishable end in blue), via a water soluble linker, could allow easy detection and isolation 
respectively. 
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Figure 61 Concept of using biotinylated coumarin for ‘fishing out’ pseudouridine. 
 
The biotin will allow isolation via immobilization of the coupled product onto a strepavidin resin 
whilst the fluorescence nature of the coumarin moiety will allow for easy detection. 
 
3.8 Syntheses of Xanthenes and its Multi-Functionalization for Bio-
conjugation 
 
This Section describes the syntheses of xanthenes and its multi-functionalization for bio-
conjugation. The serendipitous discovery of the synthetic route for the syntheses of 
multifunctional xanthenes and related dyes including the classes: rhodols and rhodamines. 
3.8.1 Synthetic Route to the Rhodols 
 
 
Figure 62 Synthesis of mono- and di-mesylfluorescein. 
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The discovery of the synthetic route to this compound was serendipitous. During the process in 
the investigation of the successive protection and attachment of fluorescein to bromo-coumarin in 
order to enhance sensitivity and hence the quantum yield this discovery was made. The synthesis 
of the 3,6-di-mesylfluorescein was made under general conditions using pyr and MsCl yielding 
both the disubstituted and the undesired mono-substituted products as shown in Figure 62.  
 
 
Figure 63 Synthesis of rhodols. 
 
In the investigations for the deprotection conditions of these mesylated products using different 
bases, as shown in Figure 63, the formation of either the hydrolyzed and or the amine substituted 
products were observed. The results of the reaction of the bases with the 3-mesylfluorescein at rt 
is summarized in Table 4. 
 
Base Product Hydrolysis(%) 
Piperidine Mono-substituted product ~10  
Methylamine Mono-substituted product ~15 
dimethylamine Mono-substituted product ~10+ 
Table 4 Results of reaction of 3-mesylfluoran with bases. 
 
There was also a similar trend of results when the dimesyl-protected fluorescein was investigated 
for hydrolysis. Based on these preliminary findings we decided to investigate the synthetic 
plausibility that might lead to the formation of the asymmetric rhodols with variations in the type 
of the amine functionality used in the synthesis. 
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Figure 64 Synthesis of rhodol. 
 
The mono-mesylation of fluorescein was carried out under the condition of pyridine and 0.9 
equivalent of the mesylating reagent: MsCl. The yield for this reaction is usually between 80-90 
% with the remainder being recovered starting material. The reaction mixture was then 
evaporated in vacuo to effect the removal of unreacted MsCl after which the mixture was re-
suspended in pyridine and cooled to 0 °C. Subsequently the addition of the nucleophyllic bases 
result in the production of the following rhodols as shown in Table 5.  
 
R Name 
jeffamine 3’-jeffaminyl-fluorescein 
methylamine 3’-methylaminyl-fluorescein 
dimethylamine 3’-dimethylaminyl-fluorescein 
Table 5 Reaction of bases with 3-monomesyl-fluorescein 
 
The synthesized Rhodols; 3-dimethylaminyl-fluorescein, 3-methylaminyl-fluorescein and 3-
jeffaminyl-fluorescein were then quantified and characterized by HPLC, MS and NMR. Typical 
UV spectra are as shown below. 
 
3 Results and Discussions  65 
 
 3'-piperidinyl fluorescen in Basic 
medium
0
0.1
0.2
0.3
0.4
0.5
0.6
250 350 450 550 650
wavelength in nm
A
bs
3'-jeffaminyl fluorescein in basic 
medium
0
0.5
1
250 350 450 550 650
wavelength in nm
A
bs
 
Graph showing the typical absorption spectra from Rhodols: 3’-piperidinyl and 3’-jeffaminyl 
fluorescein respectively. 
 
3.8.2 Synthetic Route to the Rhodamines 
 
Rhodamines are a family of related chemical compounds, fluorone dyes. Just like fluorescein and 
rhodols they contain the Xanthene core moiety with two aminyl moieties at the 3 and 6-postion of 
the Xanthene. Examples include among others: Rhodamine 6G and Rhodamine B. They are used 
as dyes and also as dye laser gain media. They are also often used as a tracer dye within water to 
determine the rate and direction of flow and transport. Rhodamine dyes, like fluorescein, 
fluoresce and can thus be detected easily and inexpensively with fluorometers. Rhodamine dyes 
are used extensively in biotechnology applications such as fluorescence microscopy, flow 
cytometry, fluorescence correlation spectroscopy and ELISA. Rhodamine dyes are generally 
toxic, and are soluble in water, methanol and ethanol. 
 
OEt
O
N+ON
H
Rhodamine G H
Cl-
Rhodamine B
OH
O
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Cl-
 
Figure 65 Typical examples of rhodamine. 
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The rhodamine dyes are relatively expensive and there is basically not very much literature freely 
accessible on their synthesis. Most of the published data and of the synthesis of this class of 
compounds are patented 81. The rhodamine dyes are usually sold as salts of HCl (as shown in the 
Figure 65) possibly due to the fact that their free base might be less stable. 
 
 
Figure 66 Synthetic pathways to rhodamines. 
 
The di-mesylation of fluorescein was successfully carried out under the condition of molecular-
sieved dried pyridine and 4 equivalents of the mesylating reagent MsCl at 0 °C. The yield for this 
reaction is usually above 90 %. After the removal of unreacted MsCl by evaporation of mixture 
in vacuo, the formed di-mesylfluorescein was re-suspended in pyr and cooled to 0 °C. 
Subsequently, the addition in excess (4-6 equivalents) of the nucleophyllic bases piperidine, 
dimethylamine and Jeffamine-148 resulted in the formation of the following rhodamines as 
shown in Figure 67. The conversion rates for these reactions are usually in the range of 40-60 %. 
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Figure 67 Some of the synthesized rhodamines. 
 
The yields of these reactions are between 35-45 % as were characterized and quantified by NMR 
and HPLC respectively. The absorption, emission and excitation spectra are shown in the Table 
6. 
 
Table 6 Characterisation of dyes by Abs, Excitation and Emission spectra. 
3,6-dipiperidinyl 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation/ nm Emission/ nm 
Acidic condition 519, 492, 448 456, 504 546 
Neutral condition 512 516 545 
Basic condition 500 510 537 
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UV-Visible spectra of 3’,6’-dipiperidinyl fluorescein showing absorption on right hand side and 
excitation and emission spectra on the left hand side in basic, neutral and acidic media 
respectively. 
 
Basic Abs
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wavelength in nm 
Neutral Abs
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wavelength in nm 
Acidic Abs
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3,6-bis(dimethylamino) 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation / nm Emission / nm 
Acidic condition 508  318 508 
Neutral condition 507 512 537 
Basic condition 502 507 533 
Table showing the absorption excitation and emission maxima for 3’,6’-bis(dimethylamino) 
fluorescein 
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UV-Visible spectra of 3’,6’-bis(dimethylamino) fluorescein showing absorbtion on righthand 
side and excitation and emission spectra in left hand side in the basic, neutral and acidic media 
respectively. 
 
 
3’,6’-bisjeffaminyl 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation / nm Emission / nm 
Acidic condition 514, 492, 455 - 525 
Neutral condition 508 515 538 
Basic condition 500 550 573 
Table showing the absorption excitation and emission maxima for 3’,6’-bisjeffaminyl fluorescein 
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UV-Visible spectra of 3’,6’-bisjeffaminyl fluorescein showing absorbtion on righthand side and 
excitation and emission spectra in left hand side in the basic and neutral media respectively. 
 
3’-jeffaminyl 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation / nm Emission / nm 
Acidic condition - 440 512, 548 
Neutral condition - 500 525 
Table showing the absorption excitation and emission maxima for 3’-jeffaminyl fluorescein 
 
3’-Piperidinyl 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation / nm Emission / nm 
Acidic condition 492,  461, 502 506 
Neutral condition 512 506 515 
Basic condition 490 502 525 
Table showing the absorption excitation and emission maxima for 3’-Piperidinylfluorescein 
 
3’-Glycinyl-6’-
jeffaminyl 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation / nm Emission / nm 
Acidic condition 514, 492, 446 456, 504 516 
Neutral condition 508 512 515 
Basic condition 494 508 517 
Table showing the absorption excitation and emission maxima for 3’-Glycinyl-6’-jeffaminyl 
fluorescein. 
 
 
(NH4Ac) Neutral Abs
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3’-Piperidinyl-6’-
Sulfonyl 
fluorescein 
Abs. max 
wavelength(s)/ nm 
Excitation / nm Emission / nm 
Acidic condition 508  504 506 
Neutral condition 502 496 501 
Basic condition 500 510 517 
Table showing the absorption excitation and emission maxima for 3’-Piperidinyl-6’-Sulfonyl 
fluorescein 
 
3.8.3 Peptide Labeling using Fluorescein Surrogates 
 
The monitoring of most biological reactions requires the use of a ‘moiety’ that allows sensitive 
detection and measurable changes in both concentration and in certain cases its physical 
environment like pH and or temperature. Frequently used moieties include radio-labeling, 
fluorophore labeling or the use of an affinity tag like biotin. Labeling peptides with fluorophore 
reporters has always been fraught with limitations: poor dye selection, dye isomer contamination, 
inefficient dye incorporation and poor sensitivity. Labeling and detection allows the preparation 
of custom peptide conjugates utilizing conventional fluorescent dyes, quenchers. The exact 
specifications and purity are usually a challenge in some cases whilst, the expertise to conjugate a 
peptide to other molecules including labeled antibodies remains not that trivial. In addition to the 
common fluorophores like fluorescein and rhodamine the increasing list includes also; Atto, 
Alexa Fluor, BODIPY, Cyanine, Oregon Green and Texas Red dyes, QSY quenchers, Biotin, 
desthiobiotin (DSB) and Qdots nanocrystals. 
Based on the success of the syntheses of the rhodols and the rhodamines, we endeavored to seek 
for a simple and pragmatic use to which the mono- and the dimesylfluorescein could be put to. 
The usual methods by which peptides are labeled with a fluorophore apply one of the following 
chemistries: amide, isocyanate, thiol, epoxide or phosphine etc. There is therefore the need for 
one to include a tailored-reactive group which is compatible with the choice one makes with the 
chemistry. The free amino functionality of the amino acid units within the peptide could be 
employed in our case as an anchor to which the fluorophore could be attached directly in a one-
pot synthesis. In principle there is also the possibility to pre-attach the fluorophore to a resin 
before attaching the peptide via the mesyl-elimination as shown in Figure 68B or alternatively 
attaching the fluorophore as the ultimate step in the synthesis as shown in Figure 68A. 
3 Results and Discussions  73 
 
 
 
Figure 68 Labeling of peptides via rhodamine formation. 
 
We investigated both labeling either before or after the synthesis of the peptide. The penta- and 
tri-peptides shown in Figure 69 were synthesized according to standard solid phase peptide 
synthesis on a Rink AM resin 108. After cleavage of the final fmoc from the amino functionality 
the resin was dried after which dimesylfluorescein was added as a solid in excess (> 4 equiv.) to 
which pyridine was then aspirated and shaken overnight at rt. The resulting purplish-orange 
beads were washed several times with DMSO and then swirled with DCM after which it was 
dried under vacuum overnight awaiting cleavage. The addition of 95 % TFA in DCM to the dried 
resin, swirling for 15 minutes and filtering resulted in the formation of the product after 3 
repetitions. Care must be taken since an irreversible coupling of the resin and the product has 
been reported in such similar cleavage condition 109, 110. The collected filtrate was cooled and 
dried overnight by freeze drying. Purity and also the level of incorporation of the fluorophore was 
assessed using HPLC and MALDI–TOF-MS 
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Figure 69 Synthesis of Rhodamine labeled peptide. 
 
The results of an analytical HPLC using isocratic mixture of water/acetonitrile (4:1)containing 3 
% TFA at 45 °C with a flow rate of 1 mL/min resulted in the separation of all the various 
components which was detected with the aid of both the DAD and FLD. The purified product 
from the HPLC was then analysed by MALDI-TOF-MS. The measured mass was 882.9 amu 
which was not different from the expected mass as shown in Figure 71.  
 
 
Figure 70 Post labeling of peptide on a resin. 
 
The structure of the tri- and pentapeptide is shown in Figure 69. Polypeptides with sterically free 
amino functionality can be synthesized on a resin and be allowed to react with a 
dimesylfluorescein. The fluorescence product could be use as a means of monitoring the 
diffusion of the peptide in cells. Fluorophore labeling of the polypeptide as we have done with tri 
and pentapeptide could be extended to other amine containing biomolecules. 
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Figure 71 MALDI-TOF-MS of pentapeptide coupled with diMsFl. 
 
The pre-labeling of the amino functionalized resin (AM Resin) with dimesylfluorescein was 
achieved using overnight reaction time following the procedure discussed in the post synthetic 
method Figure 68B. The product of the reaction which is mesylated at one end, after extensive 
drying and weighing, was used in the next step as it was still coupled to the resin without further 
purification. To this dried mixture was added a tripeptide which has both the amino and 
carboxylic acid functionality free to react. An overnight reaction time resulted after several 
washing steps with DMF and DCM and then drying under reduced pressure a mass gain 
corresponding to 40 % coupling.  
 
 
Figure 72 Possible decomposition route of coupled product. 
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In the first instance, the cleavage of the product from the resin and analysis of the crude product 
by MALDI-TOF-MS shows higher masses which do not correspond to the expected calculated 
masses. Upon purification by HPLC and analysis, there were masses corresponding to the intra-
molecular cyclization, as well as some decomposed product, as one could envisage through the 
scheme in Figure 72.  
 
 
  77 
4 Conclusions & Outlook 
 
4.1 Synthesis, incorporation and effects of nucleotide modifications  
 
In order to investigate the effects of modifications in RNA, the syntheses of the modified RNA 
phosphoramidites m5U, Ψ, m1G m2G and m22G were successfully executed. They were then 
incorporated into RNA oligomers using standard SPS. The synthesized oligomers were used in 
the total construction of tRNA via enzyme catalyzed ligation. The construction of tRNAIle with 
and without modification was achieved in a one-pot 3-fragment ligation using a T4 DNA ligase 
with a DNA-splint 99. The products were further investigated for the stability of the tertiary 
structure via UV melting curve analysis. The results of the melting curve analysis show that the 
unmodified tRNA was more stable compared to the fully modified tRNA.  
In the case of siRNA, synthesis and incorporation of modified nucleotides as phosphoramidites 
was achieved and the knock down of gene and the immunostimulation in cells were investigated. 
In a series of experiments, the antisense strand of the siRNA has been made to contain 1, 2 or 3 
rT, m1G, m2G and m22G modifications. The induction of interferon by the siRNA containing the 
m1G was a higher as compared to the others. The knock down of GFP by the siRNA with the 
various modifications was measured by the amount of fluorescence emitted by the cells. The 
m1G, m2G and the rT modified siRNAs showed very high knock down efficiency whereas those 
with m22G were less efficient.  
Future work should include the chemical synthesis of the phosphoramidites of s2U, mnm5U, 
cmo5U, mnm5s2U, m5C, m6A and t6A just to mention a few. This may throw light on the mystery 
surrounding these modifications by their selective incorporation into full-length tRNA. The 
inclusion of hypermodified nucleotides for siRNA studies and its effect on knock-down and 
immunostimulation may open the door to gene silencing therapy. 
 
4.2 Specific recognition of modification in RNA 
 
The recognition of the modifications in RNA and in particular the chemical recognition of 
pseudouridine by 4-bromomethyl-coumarin was also investigated. The specific reaction between 
pseudouridine and 4-bromomethyl coumarin at optimal conditions in the presence of the four 
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main canonical nucleosides has been optimized in the Helm group {unpublished results}. The 
reaction mixture of bromomethyl coumarin, pseudouridine and the other nucleosides at optimal 
temperature and pH results in a coupled product with the pseudouridine nucleoside. The scheme 
of the extension of the concept to full-length tRNA containing pseudouridine with bromomethyl 
coumarin is shown in Figure 73. 
 
 
Figure 73 Concept of pseudouridine detection by bromomethyl coumarin 
 
The synthesis of 7-azido-4-bromomethyl-coumarin 61 was executed, which can be used to 
investigate the click chemistry of the product of the bromomethyl coumarin and pseudouridine 
containing modified nucleotide. In a 5-step synthesis, 61 was obtained with a yield of 44 %. The 
results of preliminary investigation of the reaction of 61 with pseudouridine containing 
nucleosides shows the formation of the product which has been confirmed from the 
fragmentation pattern of the LC-MS/MS {unpublished results}.  
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Figure 74 Perspective of immobilzing of Ψ containinig RNA by ‘click’ chemistry. 
 
The reaction of an aryl-azido moiety with a terminal alkynyl group in the presence of Cu+ ions 
has been known and studied for some time now 111-117. The use of a solid support which is 
functionalized with an alkyne can be made to react with an azido functionality of the product of 
the reaction between pseudouridine and an azido-4-bromomethyl coumarin. Further studies may 
be conducted to illucidate if this method illustrated in Figure 74 can be used as a means of 
immobilizing pseudouridine containing RNAs onto a solid support. 
A 6-step synthesis of the biotinylated 4-bromomethyl-coumarin spaced with jeffamine-148 was 
also carried out. The difficulty in this work was in the final attachment of the coumarin moiety to 
the biotin via the succinyl-jeffamine moiety with a yield of 29 %. The overall yield of the 6 step 
synthesis was 17 %. This product 67, which is water soluble, may allow both the detection as 
well as the separation of product of the tagging of pseudouridine with bromomethyl coumarin 
taking advantage of the affinity between strepavidin and biotin 118. Future work should be 
focused on the improvement of the yield in the final step of the synthesis. In this direction, the 
use of cocktail mixtures of the peptide coupling reagents could be adopted for the ester bond 
formation reaction. The other possibility would be to use a more reactive nucleophile e.g. 7-
amino-4-bromomethylcoumarin whose amino group could be made to react with the carboxylic 
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acid functionality of the biotin directly or via a spacer to form an amide. These would ultimately 
lead to the identification of modifications in RNA by sequencing 
 
4.3 Rhodols, Rhodamines and their Derivatives 
 
A mild and bio-compatible condition for the syntheses of rhodols and rhodamines was 
discovered. This invention, a serendipitous one, occurred in our bid to extend the conjugation of 
the double bonds connected to the coumarin moiety in order to increase the extinction coefficient 
of the tagging molecule which will eventually lead to an increase in sensitivity. The conversion 
of fluorescein into the mesylated product at the 3-position only (69) or both 3 and 6 –position(s) 
(68) as shown in Figure 75, and the subsequent displacement of the mesylate with a nucleophile 
gave rise to rhodols or rhodamines respectively. 
 
 
Figure 75 3-Mono- and 3,6-di-mesyl-fluorescein 
 
The mild reaction conditions compared with traditional methods of synthesis 119 and even with 
the recent one via microwave assisted reactions 120 could allow for biomolecular labeling. The 
synthesis of rhodols with variation in the type of amine functionality could give rise to several 
derivatives with particular attention of it being either primary, secondary (e.g. amine functionality 
is jeffamine-148 or mono-alkylamine derivative) or tertiary (e.g. amine functionality is piperidine 
or di-alkylamine derivative) as shown Figure 76. With these variations the pH dependency of the 
rhodols fluorescence can be fine-tuned. 
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Figure 76 Variation of amine functionality leading to pH dependent fluorescence 
 
The synthesis of 3,6-bis-dimethylaminofluorescein, 3,6-dipiperidinylfluorescein and 3,6-
dijeffaminylfluorescein were all achieved at rt within a couple of hours. On the contrary, these 
rhodamine derivatives are not accessible at rt using 3-aminophenol functionalized at the 3-
position, reacting with phthalic anhydride. The mild conditions of this discovery prompted us to 
further investigate the tagging of polypeptides.The tagged tri and pentapeptide whose mass were 
confirmed by MALDI-TOF-MS, suggest that the condition could be adopted for several 
applications. The tagging of molecules containing an accessible amino functionality could be 
investigated. The use of other nucleophiles such as the thiol is currently being investigated. The 
use of carbon nucleophiles such as the alkyl metal halides found in the Grignard reaction 121-123, 
the Blaise reaction 124, the Reformatsky reaction 125, 126, and the Barbier reaction 127, 128 could be 
investigated in the presence of the mesylfluorescein shown in Figure 77. 
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M = Mg, X= Br: Grignard
M = Zn°, X= Br:
Blaise, Reformatsky, Barbier
depending on nature of R
 
Figure 77 Alkylmetal halides as nucleophile reacting with mesylfluorescein. 
 
 Also very interesting could be the investigation of the reaction between organolithium reagents 
of terminal alkynes with the dimesylfluorescein. This could lead to the extension of the 
conjugation of the double bonds of the xanthene as well as providing an alkynyl moiety for 
further extension of the side chain as shown in Figure 78. 
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Figure 78 Perspective of conjugation extention on the xanthene moiety. 
 
The extension of conjugation of the xanthene may lead to novel compounds with characteristic 
absorption and excitation spectra. The alkyne moiety which is formed could be used as a reacting 
partner in an alkyne-azide huisgen cycloaddition reaction. There may be the need to use Cu+ and 
also slightly higher temperature for the non-terminal nature of the alkyne. 
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5 Experimental Section 
 
Reagents and solvents of highest purity were purchased from various commercial suppliers 
and used without further purification. TOM-Cl and the 2'-O-TOM-protected ribonucleoside 
and the corresponding phosphoramidites were prepared according to Pitsch et al. 129. The 
reactions conducted at -20 °C were attained by mixing MeOH and dry ice (solid CO2) and the 
one at -78 °C was obtained using liquefied nitrogen. 
Workup implies distribution of the reaction mixture between DCM and satd. aq. NaHCO3 
solution, drying of the organic layer by MgSO4 or Na2SO4, and evaporation of solvent under 
reduced pressure using a rotary evaporator.  
Thin layer chromatography (TLC): Precoated silica gel plates from Merck. Staining was 
achieved by (i) dipping into a soln. of Blue Shift, constituents of which are anisaldehyde (10 
mL), H2SO4 (10 mL), and AcOH (2 mL) in EtOH (180 mL) and subsequently warming with a 
heat-gun until color/stain appears (ii) other methods of staining.  
Column chromatography (CC): Silica gel 60 (230–400 mesh) from Fluka.  
NMR-spectroscopy: Varian 300 MHz (1H: 300 MHz, 13C: 75 MHz, 31P: 121.5 MHz) and 
Bruker 500 MHz (1H: 500 MHz, 13C: 125 MHz, 31P: 202.5 MHz). Chemical shift δ in ppm, 
relative to external standards (1H- and 13C:, 31P: 85 % aq. H3PO4) and Me4Si as internal 
standard; coupling constants J in Hz; multiplicities (13C) according to DEPT-spectra.  
ESI-MS (positive mode): SSQ 710 (Finnegan), measurements in MeCN/H2O/AcOH 50:50:1.  
EI-MS: The GC analysis was performed with a WCOT Fused silica column (30m) coupled to 
a Varian Saturn 2200 mass spectrometer (Varian) for the GC-MS analysis (CP3800).  
MALDI-MS (positive mode): Axima CFR Plus (Kratos/Shimadzu), matrix: 2,4,6-
trihydroxyacetophenone, (NH4)2-citrate.  
ESI-MS (negative mode): Q-Tof-Ultima (Micromass/Waters) coupled to Cap-LC (Waters), 
injection: 2 μL aq. sample (c (RNA) = 2.5 μM, c (EDTA) = 1 mM); chromatography on 
Xterra 186  
RP-C18 column (Waters, 5 μm, 0.32 x 50 mm; flow 8 μL/min, eluent A: 25 mM aq. 
Me2NBu.H2CO3 (pH 8.4); eluent B: MeCN, elution at 60 °C, sheath-flow 25 μL/min 
(MeCN)); gradient A → A/B 1:1 (15 min.); deconvolution by MaxEnt1-software.  
Standard desalting  
The purified sequences were desalted by treating with 1M aq. Et3N.AcOH (pH 7, 5 mL) and 
applied to Sephadex column-cartridges (GE): after elution of the salts with 0.1 M aq. 
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Et3N.AcOH (pH 7, 10 mL), followed by H2O (20 mL), the Et3NH+-salt of the sequences were 
eluted with MeCN/H2O 1:1 (5 mL) and the solvent evaporated to dryness.  
Other measurements include the following on the Varian spectrophotometer and the Cary 100 
UV 
5.1 Instruments and Special Materials 
 
Analytical balance     AX 204 and B3001-S Mettler Toledo 
Centrifuges   Eppendorf 5804 R and Mikro 120 Hettich 
Electrophoresis chamber    GIBCO BRL Sequencing System LIFE  
Eppendorf and PCR tubes, silanized  Biozym 
Exposure cassettes     For 35 × 43 cm Kodak imaging screens 
Freeze dryer      BenchTop K Series, VirTis Ismatec 
Gel Documentation equipment   AlphaImagerTM 2200 Alpha Innotech 
Greiner tubes      CellStar 
HPLC       Agilent 1100 Series 
HPLC Columns: 
- Luna C18, 5 μm, 4.6 250 mm and 15.0 × 
250 mm      Phenomenex® 
- Chiralcel OJ-H, 4.6 × 250 mm   Daicel 
Mass Spectrometer: 
- MALDI-TOF     Bruker BIFLEX III 
- FAB and EI      JEOL JMS-700 
- ESI       Finnigan MAT TSQ 700 
- ESI FT-ICR      Bruker APEX IV 
Minicentrifuges     Kiesker 
NAP columns, Sephadex G-25   GE Healthcare (Amersham Biosciences) 
NMR Spectrometer     Mercury Plus 300, Varian VNMR S 500, 
Bruker AC-300, DRX-300 
pH-Meter      MP 220 Mettler Toledo 
Phosphorimager     Typhoon 9400 Amersham Biosciences 
Pipettes      Abimed P2, P20, P200, P1000 
Scintillation counter     Beckman LS 6500 
Silica gel 40 μm     J.T. Baker 
Silica gel plates Polygram® Sil G/UV254 
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40 × 80 mm     Macherey-Nagel 
Speed vac      Univapo 100 ECH 
Spin filters      Nanosep® MF Centrifugal devices, 0.2 
μm PALL, Life Sciences 
DNA/RNA Syntheziser    Applied Biosystems ExpediteTM 8909 
Syringe filters     PTFE, 13 mm, 0.2 μm, Carl Roth 
Thermomixer      Eppendorf, Thermomixer 5436 
Ultrapure Water Purification System  Milli-Q, Millipore 
UV Cuvettes      Quarzglas SUPRASIL, HELLMA 
UV-Lamp 254 nm     Benda NU-8 KL 
UV-Transilluminator     254 nm, 300 × 200 mm Carl Roth 
UV/VIS Spectrophotometer 
- Ultrospac 2100 pro     Amersham Pharmacia Biotech 
- NanoDrop ND-1000    Peqlab Biotechnologie 
- Cary 100 Bio     Varian 
5.2 Chemical Synthesis of m5U phosphoramidite 
 
This section describes the synthesis of the m5U phosphoramidite starting from the 
commercially available 5-methylribothymidine. 
 
5.2.1 Synthesis of 5'-O-DMT-5-methyluridine (7) 
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Chemical Formula: C31H32N2O8
Molecular Weight: 560,59
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DMT-Cl
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To a stirred solution of 5-methyluridine (6) (1.0 g, 4.1 mmol, 1.0 equiv) in 30 mL of 
anhydrous pyr was added DMT-Cl (1.53 g, 2.4 mmol, 1.2 equiv) in pyr (3 mL) portion-wise 
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over 2h at rt. The reaction mixture was stirred at rt and monitored by TLC. The reaction was 
complete after 5 h after which it was quenched with water. The mixture was then evaporated 
to dryness under reduced pressure. The resulting solid was redissolved in 5 mL of DCM and 
purified by fCC on silica gel with a gradient eluent system of DCM:MeOH, 60:1 to 40:1 to 
yield 7 (0.72 g, 85 %). 
TLC (silica gel, DCM:MeOH, 25:1): Rf = 0.38. 1H NMR (300 MHz, CDCl3, 25 °C): δ = 1.86 
(s, 3H, H5), 3.25 (m, 1H, H5'), 3.62 (m, 2H, H5'), 3.66 (s, 6H, 2x CH3O-trityl), 4.11 (m, 1H, 
H3'), 4.18 (m, 1H, H2'), 4.38 (t, 1H, H4'), 5.90 (s, 1H, H1'), 6.70 (d, 4H, trityl), 7.13 (d, 4H, 
trityl), 7.16 (d, 2H, trityl), 7.24 (d, 2H, trityl), 7.52 (s, 1H, H6) ppm. FAB-MS: 561.60 
[M+H]+, 303.1 (32, [(MeO)2Tr]+). 
 
5.2.2 Synthesis of 5'-O-DMT-2'-O-TBDMS-5-methyluridine (8) 
 
 
 
To a stirred solution of 5'-O-DMT-5-methyluridine (7) (60 mg, 0.12 mmol, 1.0 equiv) in 10 
mL of anhydrous pyr was added imidazole (30 mg, 0.48 mmol, 4.0 equiv) in 5 mL pyr at rt. 
The mixture was stirred for 15 min after which TBDMS-Cl (18 mg, 0.12 mmol, 1.1 equiv) 
was added portion-wise and stirring was continued overnight at rt to ensure completion of 
reaction (TLC) followed by quenching with MeOH. The reaction mixture was then 
evaporated to dryness under reduced pressure to give a yellow gum. The resulting solid was 
redissolved in 5 mL of DCM and purified by fCC on silica gel with a gradient eluent system 
of DCM:MeOH, 60:1 to 40:1 to yield 8.(0.38 mg, 50 %) and the 3'-O- isomer (0.32 mg, 48 
%). 
TLC (silica gel, DCM:MeOH, 25:1): Rf = 0.35. 1H NMR (300 MHz, CDCl3, 25°C): δ = 0.00 
(s, 3H, CH3,TBDMS), 0.01 (s, 3H, CH3,TBDMS), 0.79 (s, 9H, TBDMS), 1.86 (s, 3H, 5-CH3), 
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2.62 (m, 1H, H1), 3.25 (m, 2H, H5), 3.66 (s, 6H, 2x CH3O-trityl), 4.11 (m, 1H, H3'), 4.18 (m, 
1H, H2'), 4.38 (t, 1H, H4'), 5.90 (s, 1H, H1'), 6.70 (d, 4H, trityl), 7.13 (d, 4H, trityl), 7.16 (d, 
2H, trityl), 7.24 (d, 2H, trityl), 7.52 (s, 1H, H6) ppm. 13C NMR (75 MHz, CDCl3, 25°C): δ=-
1.8 (2C, 2 x SiCH3-) 12.9 (C-C5) 26.6 (C, 3CH3-tertBu) 58.82 (C, 4C-CH3O-trityl), 64.48 (C, 
CH2O-C5), 71.99 (C, C2), 73.94 (C, C3), 76.90 (C, C1), 81.45 (C, C4), 85.96 (C, C-
(MeOPh)2PhC), 110.23, 113.17 (C, 4C-MeOPh), 126.76 (C, C-phenyl), 127.72 (C, 2C-
phenyl), 127.86 (C, 2C-phenyl), 128.41, 130.32 (C, 4C-MeOPh), 136.44, 136.48, 139.27, 
145.72, 151.27, 158.85, 163.59. MALDI-TOF-MS: 675.83 [M+H]+, 303.14 (100, 
[(MeO)2Tr]+). 
With TOM-Cl, Light yellow foam. TLC (Hex/AcOEt 1:1): Rf 0.47. 1H-NMR (400 MHz, 
CDCl3): 1.04 – 1.16 (m, iPr3Si); 1.38 (s, Me-C(5)); 3.13 (br. s, OH_C(3')); 3.40 (dd, J=1.5, 
11.4, H-C(5')); 3.53 (dd, J=1.9, 11.5, H-C(5')); 3.81 (s, 2 MeO); 4.19 (br. s, H-C(4')); 4.38 (t, 
J=5.1, H-C(2')); 4.48 (br. s, H-C(3')); 5.03 (d, J=4.5, 1 H, OCH2O); 5.24 (d, J=4.5, 1 H, 
OCH2O); 6.14 (d, J=8.3, H-C(1')); 6.84 – 6.86 (m, 4 arom. H); 7.26 – 7.43 (m, 9 arom. H); 
7.66 (br. s, H-C(6)); 8.47 (br. s, H-N(3)). 13C-NMR (75 MHz, CDCl3): 12.1 (d, Me2CH); 12.3 
(q, Me-C(5)); 18.2 (q, Me2CH); 55.7 (q, MeO); 63.5 (t, C(5')); 70.8 (d, C(2')); 82.9 (d, C(3')); 
84.3 (d, C(4')); 86.2 (s, arom. C); 87.4 (d, C(1')); 91.2 (t, OCH2O); 111.7 (s, C(5)); 113.6 (d, 
arom. C); 127.6, 128.2, 128.5, 130.6 (4d, arom. C); 135.6, 135.8 (2s, arom. C); 144.7 (s, 
C(6)); 150.7 (s, C(2)); 159.2 (s, arom. C); 163.9 (s, C(4)). ESI-MS: 373.29 (100, [M+H]2+).  
 
5.2.3 Synthesis of 5'-O-DMT-2'-O-TBDMS-3'-O-CEP-5-methyluridine (9) 
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In a 2-neck rb flask equipped with a stirrer at rt was added 5'-ODMT-2'-OTBDMS-5-
methyluridine (8) (189 mg, 0.21 mmol) and DCM (5 mL). The reaction mixture was treated 
consecutively with DIEA (160 mg, 2.2 mmol, 1.01 equiv) and CEP-Cl (79 mg, 0.33 mmol, 
1.5 equiv). The reaction was stirred at rt for 2 h (TLC). The mixture was then evaporated to 
dryness under reduced pressure to give a yellow foam. The resulting solid was redissolved in 
Hex: EtOAc (2 mL, 10:1) and purified by fCC on silica gel with a gradient eluent system of 
Hex: EtOAc, 60:1 to 40:1. The yield of the reaction was 86 %. 
TLC (silica gel, Hex/EtOAc, 25:1): Rf = 0.44. 1H NMR (300 MHz, CDCl3/DMSO-d6, 25°C): 
δ = 0.01 (s, 3H, CH3,TBDMS), 0.02 (s, 3H, CH3,TBDMS), 0.78 (s, 9H, TBDMS), 1.09 (d, 
12H-4xCH3-N-isopropyl), 1.86 (s, 3H, 5-CH3), 2.61 (m, 2H-NCCH2-CEP), 2.63 (m, 1H, H1), 
2.98 (m, 2H- N-isopropyl), 3.25 (m, 2H, H5), 3.66 (s, 6H, 2x CH3O-trityl), 3.92 (m, 2H-
CH2OCEP), 4.11 (m, 1H, 3'), 4.18 (m, 1H, H2'), 4.38 (t, 1H, H4'), 5.91 (s, 1H, H1'), 6.70 (d, 
4H, trityl), 7.13 (d, 4H, trityl), 7.16 (d, 2H, trityl), 7.23 (d, 2H, trityl), 7.53 (d, 1H) ppm. 13C 
NMR (75 MHz, CDCl3, 25°C): δ=-1.2 (2C, 2 x SiCH3-) 12.9 (C-C5) 26.6 (C, 3CH3-tertBu), 
21.2, 24.8, 24.9 52.3, 56.74, 58.82 (C, 4C-CH3O-trityl), 64.48 (C, CH2O-C5), 71.99 (C, C2), 
73.94 (C, C3), 76.90 (C, C1), 81.45 (C, C4), 85.96 (C, C-(MeOPh)2PhC), 110.23, 113.17 (C, 
4C-MeOPh), 119.12, 126.76 (C, C-phenyl), 127.72 (C, 2C-phenyl), 127.86 (C, 2C-phenyl), 
128.41, 130.32 (C, 4C-MeOPh), 136.44, 136.48, 139.27, 145.72, 151.27, 158.85, 163.59. 
MALDI-TOF-MS: 876.83 [M+H]+, 303.14 (100, [(MeO)2Tr]+). 
 
5.3 Chemical Synthesis of Uridine Phosphoramidite 
 
5.3.1 Synthesis of 5'-O-DMT-Uridine (24) 
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To a stirred solution of uridine (23) (1.0 g, 4.1 mmol, 1.0 equiv) in 30 mL of anhydrous pyr 
was added DMT-Cl (1.53 g, 2.4 mmol, 1.2 equiv) in pyr (3 mL) portion-wise over 2h at rt. 
The reaction mixture was stirred at rt and monitored by TLC. The reaction was complete after 
5 h after which it was quenched with water. The mixture was then evaporated to dryness 
under reduced pressure. The resulting solid was redissolved in 5 mL of DCM and purified by 
fCC on silica gel with a gradient eluent system of DCM:MeOH, 60:1 to 40:1 to yield 24 (0.74 
g, 86 %).  
TLC (silica gel, DCM:MeOH, 25:1): Rf = 0.25. 1H NMR (300 MHz, CDCl3, 25°C): δ = 3.40 
(dd, 1H, J=3.4, 10.9 Hz), 3.50 (dd, 1H, J=2.9, 10.9 Hz), 3.79 (s, 2 OCH3), 4.28 (m, 1H-C4'), 
4.34 - 4.38 (m, 2H, H3' & H2'), 5.56 (d, 1H, J = 8.2 Hz, H5), 5.80 (d, 1H, J = 3.6 Hz, H1'), 
6.83 (m, 4H, trityl-H), 7.23-7.36 (m, 9H, trityl-H) ppm 13C NMR (125MHz, CDCl3, 25°C): 
δ= 55.16 (2 CH3O), 62.52 (C5), 71.25 (C3), 76.49 (C2), 84.92 (C4), 87.01, 92.06 (C1), 
101.37 (C5'), 113.20, 127.06, 127.89, 127.95, 127.97 (trityl C), 135.06, 135.15, 137.30 (C6'), 
144.15, 152.12, 158.66, 162.53 ppm. MALDI-TOF-MS: 569.60 [M+Na]+. 
 
5.3.2 Synthesis of 5'-O-DMT-2'-O-TBDMS-Uridine (25) 
 
 
 
To a stirred solution of 5'-O-DMT-uridine 24 (60 mg, 0.12 mmol, 1.0 equiv) in 10 mL of 
anhydrous pyr was added imidazole (30 mg, 0.43 mmol, 4.0 equiv) in pyr 5 mL at rt. The 
mixture was stirred at rt for 15 min after which TBDMS-Cl (18 mg, 0.12 mmol, 1.1 equiv) 
was added portion-wise and stirring was continued. The reaction was monitored by TLC. The 
reaction was complete usually overnight, and then quenched with water. The mixture was 
then evaporated to dryness under reduced pressure to give a yellow gum. The resulting solid 
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was redissolved in 5 mL of DCM and purified by fCC on silica gel with a gradient eluent 
system of DCM:MeOH, 60:1 to 40:1 to yield 25 (0.42 mg, 48%). 
TLC (silica gel, DCM:MeOH, 40:1): Rf = 0.31. 1H NMR (300 MHz, CDCl3, 25°C): δ = 0.28 
(s, 6H, 2xCH3Si), 1.02 (s, 9H, CH3-tertBu), 3.40 (dd, 1H, J=3.4, 10.9 Hz, H5'), 3.50 (dd, 1H, 
J=2.9, 10.9 Hz, H5'), 3.79 (s, 2 OCH3), 4.28 (m, 1H, H4'), 4.33 – 4.38 (m, 2H, H3' & H2'), 
5.56 (d, 1H, J = 8.2 Hz, H-C5), 5.80 (d, 1H, J = 3.6 Hz, H1'), 6.83 (m, 4H, trityl-H), 7.23-7.36 
(m, 9H, trityl-H) ppm 13C NMR (125 MHz, CDCl3, 25 °C): δ= 27.12 (CH3-tertBu), 30.23 
(tertBu), 55.21 (2 CH3O), 62.52 (C5), 71.25 (C3), 76.49 (C2), 84.92 (C4), 87.01, 92.06 (C1), 
101.37 (C5'), 113.20, 127.06, 127.89, 127.95, 127.97 (trityl C), 135.06, 135.15, 137.30 (C6'), 
144.15, 152.12, 158.66, 162.53 ppm. MALDI-TOF-MS: 661.81 [M+H]+. 
 
5.3.3 Synthesis of 5'-ODMT-2'-OTBDMS-3'-OCEP-Uridine (26) 
 
 
 
In a 2-neck rb flask equipped with a stirrer at rt was added 5'-O-DMT-2'-O-TBDMS-Uridine 
(25) (189 mg, 0.21 mmol, 1 equiv) and DCM (5 mL). The reaction mixture was treated 
consecutively with DIEA (160 mg, 2.2 mmol) and CEP-Cl (79 mg, 0.33 mmol, 1.5 equiv). 
The reaction was monitored by TLC and was usually complete after 2 h. The mixture was 
then evaporated to dryness under reduced pressure resulting into a yellow foamy solid. The 
resulting solid was redissolved in Hex: EtOAc (2 mL, 10:1) and purified by fCC on silica gel 
with a gradient eluent system of Hex: EtOAc, 60:1 to 30:1 to yield 26 (0.42 g, 55 %).  
TLC (silica gel, Hex:EtOAc, 20:1): Rf = 0.37. 1H NMR (300 MHz, CDCl3, 25 °C): δ = 0.28 
(s, 6H, 2xCH3Si), 1.02 (s, 9H, CH3-tertBu), 1.09 (d, 12H-4xCH3-N-isopropyl), 2.62 (m, 2H-
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NCCH2-CEP), 2.98 (m, 2H- N-isopropyl), 3.40 (dd, 1H, J=3.4, 10.9 Hz), 3.50 (dd, 1H, J=2.9, 
10.9 Hz), 3.78 (s, 6H-3xCH3O-), 3.92 (m, 2H-CH2OCEP), 4.28 (m, 1H-C4'), 4.32 -4.38 (m, 
2H, H3' & H-C2')), 5.56 (d, 1H, J = 8.2 Hz, H5), 5.80 (d, 1H, J = 3.6 Hz, H1'), 6.83 (m, 4H-
trityl), 7.22 (m, 1H-phenyl), 7.30 (m, 2H-phenyl), 7.36 (m, 4H-trityl), 7.52 (m, 2H-pheny), 
7.54 (s, 1H-C6'). 13C NMR (75 MHz, CDCl3, 25°C): δ = 27.12 (CH3-tertBu), 30.23 (tertBu), 
58.82 (C, 4C-CH3O-trityl), 64.06 (C, CH2O-C5), 71.25 (C, C2), 73.94 (C, C3), 76.69 (C, C1), 
81.45 (C, C4), 85.96 (C, C-(MeOPh)2PhC), 110.23, 113.17 (C, 4 C-MeOPh), 126.81 (C, C-
phenyl), 127.91 (C, 2C-phenyl), 128.36 (C, 2C-phenyl), 130.29 (C, 4 C-MeOPh), 136.29, 
136.40, 138.37, 144.15, 152.12, 158.66, 163.54 ppm. FAB-MS: 862.10 [M+H]+, 303.1 (34, 
[(MeO)2Tr]+). 
 
5.4 Chemical Synthesis of Pseudouridine 
 
5.4.1 Synthesis of 6-((2-methoxypropan-2-yloxy)methyl)-2,2-
dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)one (28) 
 
27 28
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Chemical Formula: C12H20O6
Molecular Weight: 260,28
2, 2-dimethoxypropane
PPTS, Na2SO4
 
 
To a stirred solution of ribonic acid (27) (1.50 g, 7.5 mmol) in 2, 2-dimethoxypropane (15 
mL), at rt, was added anhydrous Na2SO4 (3.0 g), and PPTS (0.2 g), and the resulting mixture 
was refluxed for 8 h (TLC). The reaction mixture was concentrated under reduced pressure to 
dryness and purified by fCC on silica gel with a gradient eluent system of EtOAc:Hex, 20:1 to 
10:1. The silica gel was pre-treated in MeOH overnight. The afforded protected lactone 28 
was a colorless liquid, with a yield of 95 %. 
TLC (silica gel, EtOAc:Hex=1:5): Rf=0.42; 1H NMR (300 MHz, CDCl3, 25°C) δ= 1.29 (s, 
3H-CH3), 1.31 (s, 3H-CH3), 1.38 (s, 3H-CH3), 1.47 (s, 3H-CH3), 3.14 (s, 3H-CH3), 3.52 (d, 
1H, J=9.0 Hz), 3.75 (d, 1H, J=8.44 Hz), 4.7 (m, 3H). 13C NMR (75 MHz, CD3OD) δ 24.1 
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2(C8), 25.0 2(C7), 26.0(C10 & C11), 28.0(C-Me), 62.2, 78.5, 80.4, 83.9, 103.7, 114.8, 172.2, 
173.4; FAB-MS: 261.15 [M+H]+. 
 
5.4.2 Synthesis of 5-bromo-2,4-dichloropyrimidine (30) 
 
 
 
In a rb flask equipped with 5-bromouracil (29) (2.3 g, 12.1 mmol) was added DMF (25 mL) 
and phosphorous oxychloride(4.08 g, 26.6 mmol, 2.2 equiv). The mixture was then refluxed 
for 3 h (TLC). The DMF was then evaporated and the resulting solid purified by fCC on silica 
gel with a gradient eluent system of Hex: EtOAc 100:1, 100:2. The pure product 30 was 
recrystallized, after removal of solvent in vacuo, in Hex. The yield for this reaction was 98 %. 
TLC (silica gel, CHCl3:MeOH=2:1), Rf = 0.42; 1H NMR (DMSO-d6): δ = 8.67 (s, 1H), FAB-
MS: 225.59, 227.06 and 229.34 [M+H]+. 
 
5.4.3 Synthesis of 5-bromo-2, 4-di-tert-butoxypyrimidine (31) 
 
 
 
In a rb flask was added potassium tert-butyloxide (KOtBu) (0.99 g, 8.85 mmol), Hex (50 mL) 
and  refluxed for 1 h under argon after which 2,4-dichloro-5-bromopyrimidine (30) (1.0 g, 
4.42 mmol) was slowly added during 10 min. The mixture was reflux for further 2 h. The 
solution was allowed to cool afterwards and the solvent evaporated under reduced pressure. 
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The resulting mixture was dissolved in water and quickly extracted with diethyl ether (5x50 
mL). The organic extract was then washed with brine (sat. NaCl solution), and subsequently 
dried with Mg2SO4. The ether was then evaporated and the resulting solid purified by fCC on 
silica gel with a gradient eluent system of Hex: EtOAc: 100:1, 100:2. Pure product 31 
crystallized after removal of solvent. The yield was 87 %.  
TLC (silica gel, Hex:EtOAc=10:1), Rf=0.40; 1H NMR (DMSO-d6): δ = 1.48 (s, 9H), 1.52 (s, 
9H), 8.22 (s, 1H), 13C NMR (75 MHz, CD3OD): δ  = 28.48 (C-CH3(tertBu)), 28.52 (C- 
CH3(tertBu)), 80.94 (C- (tertBu)), 83.42 (C- (tertBu), 99.74 (C- CBr), 159.15 (C- CH), 
163.14 (C- COtertBu), 165.87 (C- CO tertBu) ppm. MALDI-MS: 304.2.[M+H]+. 
 
5.4.4 Synthesis of 4-(2,4-di-tert-butoxypyrimidin-5-yl)-6-((2-methoxypropan-2-
yloxy)methyl)-2,2 dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol (32) 
 
 
 
In an rb flask containing 2,4-di-tertbutoxy-5-bromopyrimidine 31 (0.200 g, 0.66 mmol) and 
n-butyl-lithium (0.73 mmol, 1.1 equiv.) in dry oxygen free THF (10 mL) at -78 °C, stirred for 
25 min, was added during 20 min the pre-cooled protected lactone 28 (700 mg, 2.7 mmol, 1 
equiv.) in 40 mL of THF at -78 °C. After 4 h at -78 °C the solution was allowed o warm to rt 
and left overnight. The THF was removed under reduced pressure after TLC shows no 
starting material. The crude product was purified by fCC on silica gel with a gradient eluent 
system of DCM: MeOH, 19:1, 10:1. 
TLC (silica gel, CHCl3:MeOH=10:1), Rf = 0.35. 1H NMR (CDCl3): δ = 1.26 (s, 3H CH3-
cyclic aceta), 1.28 (s, 3H-CH3-cyclic acetal), 1.40 (s, 6H-2xCH3-open acetal), 1.61 (s, 9H-
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3xCH3tertBu), 1.65 (s, 9H-3xCH3tertBu), 3.24 (s, 3H-CH3O), 3.64 (d, J = 6.3 Hz, 2H-C5), 
4.42 (m, 1H), 4.68 (s, 1H-OH), 4.87 (m, 1H-H2), 4.91 (m, 1H-H4), 8.46 (s, 1H-H6'). 13C 
NMR (125MHz, CDCl3, 25°C): δ=24.60 (C-CH3-cyclic acetal), 24.66 (C-CH3-cyclic acetal), 
25.54 (C-CH3-open acetal), 28.22 (C-CH3-open acetal), 28.65 (C-3xCH3tertBu), 28.75 (C-
3xCH3tertBu), 48.94 (C-CH3O), 62.88 (C-C5), 66.46 (C-C1), 69.13 (C-C4), 77.68 (C-C2), 
79.84 (C-C3), 80.34 (C- tertBu ), 82.19 (C- tertBu ), 100.64 (C-C5'), 108.85 (C-cyclic acetal), 
115.36 (C-open acetal), 157.90 (C-C6'), 163.70 (C-C2'), 168.04 (C-C4').484.6 [M+H]+. 
 
5.4.5 Synthesis of 1-(5-((2,4-di-tert-butoxypyrimidin-5-yl)(hydroxy)methyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-2-(2-methoxypropan-2-yloxy)ethanol (33) 
 
 
 
To 32 (340 mg , 0.70 mmol) in dry DCM (30 mL) at -78 °C was added ZnCl2 ( 0.95 mL, 0.95 
mmol, 1 M in Et2O) and the mixture was then stirred for 30 min. RedAl (2.38 mL, 2.38 mmol, 
1 M in THF) was then added dropwise and portion-wise over a period of 30 min at -78 °C. 
The mixture was then slowly brought to rt and stirred overnight. It was then quenched with 
EtOH (0.40 mL), H2O (0.09 mL), NaOH 6 M (0.35 mL) and H2O2 (30 % v/v, 0.35 mL). It 
was then stirred for 30 min and diluted with EtOAc (40 mL) and H2O (40 mL). Standard 
workup gave colorless oil which was purified by fCC on silica gel with a gradient eluent 
system of Hex: EtOAc (1:1, 2:1) giving the product as a white foamy solid 33 with yield of.  
TLC (silica gel, CHCl3:MeOH=10:1), Rf = 0.33. 1H NMR (CDCl3): δ = 1.26 (s, 3H CH3-
cyclic acetal), 1.28 (s, 3H-CH3-cyclic acetal), 1.40 (s, 6H-2xCH3-open acetal), 1.61 (s, 9H-
3xCH3tertBu), 1.65 (s, 9H-3xCH3tertBu), 3.24 (s, 3H-CH3O), 3.64 (d, J = 6.3 Hz, 2H-H5'), 
411 (m, 1H), 4.42 (m, 1H), 4.67 (s, 1H-OH), 4.87 (m, 1H-H2'), 4.91 (m, 1H-H4'), 8.46 (s, 1H-
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H6). 13C NMR (125MHz, CDCl3, 25°C): δ=24.60 (C-CH3-cyclic acetal), 24.66 (C-CH3-cyclic 
acetal), 25.54 (C-CH3-open acetal), 28.22 (C-CH3-open acetal), 28.65 (C-3xCH3tertBu), 
28.75 (C-3xCH3tertBu), 48.94 (C-CH3O), 62.88 (C-C5), 66.48 (C-C1), 69.03 (C-C4), 77.67 
(C-C2), 79.81 (C-C3), 80.34 (C- tertBu ), 82.19 (C- tertBu ), 100.64 (C-C5'), 108.85 (C-
cyclic acetal), 115.36 (C-open acetal), 157.90 (C-C6'), 163.70 (C-C2'), 168.04 (C-C4'). 
MALDI-TOF-Ms: 487.61 [M+H]+ 
 
5.4.6 Synthesis of 2,4-di-tert-butoxy-5-(6-((2-methoxypropan-2-yloxy)methyl)-2,2-
dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine (34) 
 
 
 
To a solution of (33) (3 g, 7.5 mmol) in THF (0.3 L) was added Ph3P (4 g, 15.1 mmol) at 0 °C 
under argon atmosphere. DIAD (12 mL, 59.4 mmol) was added, and the mixture was stirred 
overnight and concentrated. The residue was purified by fCC on silica gel with a gradient 
eluent system of Hex:EtOAc: (10:1, 2:1) to afford the bis-acetal as a white foamy solid 34. 
(2.5 g, 26.4 mmol, 86%). 
TLC (silica gel, CHCl3:MeOH=10:1), Rf = 0.38 1H NMR (300 MHz, CDCl3, 25°C): δ = 1.28 
(s, 6H-2xCH3-open acetal), 1.32 (s, 3H-CH3-cyclic acetal),- 1.40 (s, 3H-CH3-cyclic acetal), 
1.52 (s, 9H-3xCH3tertBu), 1.62 (s, 9H-3xCH3tertBu), 3.14 (s, 3H-CH3O), 3.49-3.52 (m, 2H-
H5'), 4.04 (m, 1H), 4.54 - 4.60 (m, 1H-H3'), 4.86 (m, 1H-H2'), 5.14 (m, 1H-H4'), 8.24 (s, 1H-
H6) ppm. 13C NMR (125MHz, CDCl3, 25°C): δ = 24.60 & 24.62 (C-CH3-cyclic acetal), 24.66 
& 24.72 (C-CH3-cyclic acetal), 25.54 & 25.62 (C-CH3-open acetal), 28.22 & 28.24 (C-CH3-
open acetal), 28.65 & 28.72 (C-3xCH3tertBu), 28.75 & 28.83 (C-3xCH3tertBu), 48.94 (C-
CH3O), 61.52 - 62.88 (C-C5), 67.48 (C-C1), 71.03 (C-C4), 77.67 & 77.72 (C-C2), 79.71 & 
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79.82 (C-C3), 80.32 & 80.36 (C- tertBu ), 82.19 & 82.23 (C- tertBu ), 100.64 (C-C5'), 111.65 
& 112.49 (C-cyclic acetal), 113.97 & 114.40 (C-open acetal), 157.04 & 157.70 (C-C6'), 
163.70 & 163.91 (C-C2'), 166.51 & 167.47 (C-C4') ppm. FAB-MS: 470.01 [M+H]+. The 
reported chemical shifts are for the mixed α and β anomers and not respective values for the 
α and β forms. 
 
5.4.7 Synthesis of 5-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl) 
pyrimidine-2,4(1H,3H)-dione (35) 
 
´ 
 
To β -5'-ODMT-Pseudouridine (37) (300 mg , 0.70 mmol) in Dry DCM (30 mL) at rt was 
added a 20 % solution of trifluoroacetic acid in DCM. The mixture was then slowly stirred 
and monitored by TLC every 5 min. The reaction was usually finished after 15 min after 
which it was quenched by the neutralization of the acid using sodium bicarbonate. Standard 
workup gave a solid which was purified by fCC on silica gel with a gradient eluent system of 
Hex: EtOAc (1:1, 1:2) to afford β-pseudouridine 35 as a white powder in70 % yield. 
TLC (silica gel, Hexane: EtOAc (1:2)), Rf = 0.18 as a white solid. 1H NMR (300 MHz, 
DMSO-d6, 25 °C): δ = 3.68 (dd, 1H, J=12.0, 4.4 Hz), 3.82 (dd, 1H, J=12.4, 3.2 Hz), 3.97 (m, 
1H), 4.10 (t, 1H, J= 5.6 Hz), 4.23 (t, 1H, J = 5.4 Hz), 4.67 (d, 1H, J = 5.6 Hz), 7.61(s, 1H) 
ppm. 13C NMR (125MHz, CDCl3, 25°C): δ=61.51, 70.80, 73.46, 79.81, 83.16, 110.06, 
139.34, 153.16, 164.74 ppm. MALDI-TOF- MS: 245.19 [M+H]+. 
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5.5 Chemical Synthesis of Pseudouridine Phosphoramidite 
 
5.5.1 Synthesis of 5'-O-DMT-Pseudouridine (37) 
 
 
 
To a stirring mixture of α and β-Pseudouridine 36 (1.0 g, 4.1 mmol, 1.0 equiv) dissolved in 
30 mL of anhydrous pyr was added DMT-Cl (1.53 g, 2.4 mmol, 1.2 equiv) in pyr (3 mL) 
portion-wise over 2 h at rt. The reaction mixture was stirred at rt and monitored by TLC. The 
reaction was complete after 5 h after which it was quenched with water. The mixture was then 
evaporated to dryness under reduced pressure. The resulting solid was dissolved in 5 mL of 
DCM and purified by fCC on silica gel with a gradient eluent system of DCM:MeOH, (60:1 
to 30:1) resulting in 37 (0.72 g, 85 %).  
Alpha-product. TLC (silica gel, DCM:MeOH, 40:1), Rf = 0.24. 1H NMR (300 MHz, Acetone-
d6, 25 °C): δ = 3.21 (m, 1H), 3.30 (m, 1H), 3.78 (s, 6H-3xCH3O), 4.09 (m, 1H), 4.14 (m, 1H), 
5.21(m, 1H), 5.62 (s, 1H), 6.89 (m, 4H-trityl), 7.22 (m, 1H-phenyl), 7.30 (m, 2H-phenyl), 
7.36 (m, 4H-trityl), 7.52 (m, 2H-pheny), 7.54 (s,1H-C6') ppm. 13C NMR (75 MHz, CDCl3, 
25°C): δ= 58.82 (C, 4C-CH3O-trityl), 64.48 (C, CH2O-C5), 71.99 (C, C2), 73.94 (C, C3), 
76.90 (C, C1), 81.45 (C, C4), 85.96 (C, C-(MeOPh)2PhC), 110.23, 113.17 (C, 4C-MeOPh), 
126.76 (C, C-phenyl), 127.72 (C, 2C-phenyl), 127.86 (C, 2C-phenyl), 128.41, 130.32 (C, 4C-
MeOPh), 136.44, 136.48, 139.27, 145.72, 151.27, 158.85, 163.59 ppm. MALDI-TOF-MS: 
547.61 [M+H]+, 303.14 (100, [(MeO)2Tr]+). 
Beta-product. TLC (silica gel, DCM:MeOH, 40:1): Rf = 0.22. 1H NMR (300 MHz, Acetone-
d6, 25°C): δ = 3.21 (m, 1H), 3.30 (m, 1H), 3.78 (s, 6H-3xCH3O), 4.09 (m, 1H), 4.14 (m, 1H), 
4.71(m, 1H), 5.62 (s, 1H), 6.89 (m, 4H-trityl), 7.22 (m, 1H-phenyl), 7.30 (m, 2H-phenyl), 
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7.36 (m, 4H-trityl), 7.52 (m, 2H-pheny), 7.54 (s,1H-C6') ppm. 13C NMR (75 MHz, CDCl3, 
25°C): δ= 58.82 (C, 4C-CH3O-trityl), 64.06 (C, CH2O-C5), 72.00 (C, C2), 73.94 (C, C3), 
76.90 (C, C1), 81.45 (C, C4), 85.96 (C, C-(MeOPh)2PhC), 110.23, 113.17 (C, 4C-MeOPh), 
126.81(C, C-phenyl), 127.91(C, 2C-phenyl), 128.36 (C, 2C-phenyl), 130.29 (C, 4C-MeOPh), 
136.29, 136.40, 138.37, 145.55, 151.27, 158.89, 163.59 ppm. MALDI-TOF-MS: 547.60 
[M+H]+, 303.14 (100, [(MeO)2Tr]+). 
 
5.5.2 Synthesis of 5'-O-DMT-2’-O-TOM- Pseudouridine (38) 
 
 
 
To a stirred solution of 5'-O-DMT- Pseudouridine (37) (60 mg, 0.12 mmol, 1.0 equiv) in 
anhydrous pyr (10 mL) was added imidazole (30 mg, 0.43 mmol, 4.0 equiv) in pyr (5 mL) at 
rt. The mixture was stirred at rt for 10 min after which TOM-Cl (18 mg, 0.12 mmol, 1.1 
equiv) was added portion-wise and stirring was continued. The reaction was complete usually 
overnight (TLC), and then quenched with water. The mixture was then evaporated to dryness 
under reduced pressure to give a yellow gum. The resulting solid was dissolved in 2 mL of 
DCM and purified by fCC on silica gel with a gradient eluent system of DCM:MeOH, (80:1 
to 40:1) to afford 38 (0.42 mg, 55 %) 
TLC (silica gel, DCM:MeOH, 40:1): Rf = 0.25. 1H NMR (300 MHz, Acetone-d6, 25 °C): δ = 
1.02 (s, 18H-6xCH3-isopropyl), 1.81 (m, 3H-isopropyl), 3.21 (m, 1H), 3.30 (m, 1H), 3.78 (s, 
6H-3xCH3O), 4.09 (m, 1H), 4.14 (m, 1H), 4.71 (m, 1H), 5.62 (s, 1H), 5.86 (s, 2H-OCH2O-
TOM), 6.89 (m, 4H-trityl), 7.22 (m, 1H-phenyl), 7.30 (m, 2H-phenyl), 7.36 (m, 4H-trityl), 
7.52 (m, 2H-pheny), 7.54 (s,1H-C6'). 13C NMR (75 MHz, CDCl3, 25°C): δ= 18.2 (C, 4C-
4xCH3-isopropyl), 23.12 (C, 3C-isopropyl), 58.82 (C, 4C-CH3O-trityl), 64.06 (C, CH2O-C5), 
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72.00 (C, C2), 73.94 (C, C3), 76.90 (C, C1), 81.45 (C, C4), 85.96 (C, C-(MeOPh)2PhC), 
110.23, 113.17 (C, 4C-MeOPh), 126.81 (C, C-phenyl), 127.91 (C, 2C-phenyl), 128.36 (C, 
2C-phenyl), 130.29 (C, 4C-MeOPh), 136.29, 136.40, 138.37, 145.55, 151.27, 158.89, 163.59. 
MALDI-TOF-MS: 733.92 [M+H]+, 303.14 (100, [(MeO)2Tr]+). 
 
5.5.3 Synthesis of 5'-O-DMT-2'-O-TOM-3'-O-CEP-pseudouridine (39) 
 
39
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In a 2-neck rb flask equipped with a stirrer at rt was added 5'-O-DMT-2'-O-TOM-
pseudouridine (38) (189 mg, 0.21 mmol, 1.0 equiv) in 5 mL dry DCM was added DIEA (160 
mg, 2.2 mmol) and CEP-Cl (79 mg, 0.33 mmol, 1.5 equiv) at rt. The reaction was stirred at rt 
for 2 h (TLC). The mixture was then evaporated to dryness under reduced pressure to giving 
yellow foam. The resulting solid was dissolved in Hex: EtOAc (2 mL, 10:1) and purified by 
fCC on silica gel with a gradient eluent system of (Hex: EtOAc, 60:1 to 40:1) resulting in the 
product 39 (0.42 g) as a diastereomeric mixture in 75 %. 
TLC (silica gel, Hex:EtOAc, 25:1): Rf = 0.32. 1H NMR (300 MHz, CDCl3, 25 °C): δ = 1.02 
(s, 18H-6xCH3-isopropyl), 1.09 (d, 12H-4xCH3-N-isopropyl), 1.81 (m, 3H-isopropyl), 2.62 
(m, 2H-NCCH2-CEP), 2.98 (m, 2H- N-isopropyl), 3.21 (m, 1H), 3.30 (m, 1H), 3.78 (s, 6H-
3xCH3O), 3.92 (m, 2H-CH2OCEP), 4.09 (m, 1H), 4.14 (m, 1H), 4.71(m, 1H), 5.62 (s, 1H), 
5.86 (s, 2H-OCH2O-TOM), 6.89 (m, 4H-trityl), 7.22 (m, 1H-phenyl), 7.30 (m, 2H-phenyl), 
7.36 (m, 4H-trityl), 7.52 (m, 2H-pheny), 7.54 (s,1H-C6') ppm. 13C NMR (75 MHz, CDCl3, 
25°C): δ= 18.2 (C, 4C-4xCH3-isopropyl), 23.12 (C, 3C-isopropyl), 58.82 (C, 4C-CH3O-trityl), 
64.06 (C, CH2O-C5), 72.00 (C, C2), 73.94 (C, C3), 76.90 (C, C1), 81.45 (C, C4), 85.96 (C, C-
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(MeOPh)2PhC), 110.23, 113.17 (C, 4C-MeOPh), 126.81(C, C-phenyl), 127.91(C, 2C-phenyl), 
128.36 (C, 2C-phenyl), 130.29 (C, 4C-MeOPh), 136.29, 136.40, 138.37, 145.55, 151.27, 
158.89, 163.59 ppm. MALDI-TOF-MS: 956.12 [M+Na]+, 303.14 (100, [(MeO)2Tr]+). 
 
5.6 Chemical Synthesis of m1G Phosphoramidite 
 
5.6.1 Synthesis of 2',3',5',N2-tetraacetyl-N1-methylguanosine (41) 
 
 
 
NaH (254mg, 10.6mmol, 1.0 equiv) was added to a stirred solution of guanosine (40) (3 g, 
10.6mmol, 1.0 equiv) in 20 mL of anhydrous DMSO at rt. The reaction mixture was stirred 
until evolution of hydrogen gas ceased followed by the addition of MeI (1.5 g, 10.6mmol, 1.0 
equiv) in 1 mL of DMSO was added dropwise and stirred for 5 h at rt. The mixture was 
evaporated to dryness under reduced pressure at 80°C and re-dissolved in a mixture of 
pyr/DMF/acetic anhydride (50 mL each) and heated to 140 °C for 10 h. Thin Layer 
Chromatography (TLC) showed no starting material after which reaction mixture was 
evaporated under reduced pressure. The resulting solid was dissolved in 200 mL of MeOH 
and 70 g of silica gel was added. The MeOH was evaporated, the silica gel coated by the 
crude product was dried under vaccum and purified by fCC on silica gel with a gradient 
eluent system of (silica gel, DCM:MeOH, 40:1 to 25:1) resulting in 41 (4.2 g, 85%).  
TLC (silica gel, DCM:MeOH = 40:1): Rf = 0.25; 1H NMR (500MHz, CDCl3, 25 °C): δ = 2.07, 
2.08, 2.13, 2.33 (4s, COCH3), 3.60 (s, 1-CH3), 4.40–4.46 (m, H1–C(5'), H–C(4')), 4.53 (dd, 
J=5.2, 11.0 Hz, H2– C(5')), 5.67 (t, H–C(3')), 5.91 (t, H–C(2')), 5.99 (d, J=5.2Hz, H–C(1')), 
7.80 (s, H–C(8)), 8.76 (br s, NH) ppm. 13C NMR (125MHz, CDCl3, 25°C): δ =20.37, 20.54, 
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20.79, 23.78 (COCH3), 31.90 (1-CH3), 63.19 (C(5')), 70.72 (C(3')), 72.95 (C(2')), 80.23 
(C(4')), 87.00 (C(1')), 122.90, 138.80 (C(8)), 145.73, 146.90, 157.29, 169.34, 169.62, 170.10, 
171.04 ppm. MALDI-TOF-MS: 466.45[M+H]+ and 488.5 [M+Na]+. 
 
5.6.2 Synthesis of N2-acetyl-N1-methylguanosine (42) 
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To a vigorously stirred solution of 41 (2.0 g, 4.3 mmol) in 24 mL of a mixture of 
THF/MeOH/H2O (5/4/2) aqueous NaOH (2 mL, 10 M) was added at rt. The reaction was 
monitored by TLC (CHCl3: MeOH, 1:1) and was completed typically after 15 min. The 
mixture was quenched with ~2 mL of acetic acid to give a final pH of 6.5. The product 42 
(1.18 g, 81 %) precipitated as a pale yellow solid after overnight storage at 4 °C and was 
collected by filtration and washed twice with 10 mL of cold THF/MeOH/H2O (-20 °C) and 
dried under vacuum for 3 days. Yield of the reaction was 72 %.  
TLC (silica gel, CHCl3:MeOH = 2:1): Rf = 0.4; 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.13 (s, COCH3), 3.41 (s, 1-CH3), 3.63 (dd, J=3.9, 11.9Hz, H1–C(5')), 3.53 (dd, J=4.0, 11.9 
Hz, H2–C(5')), 3.91 (q, H–C(4')), 4.12 (t, H–C(3')), 4.45 (t, H–C(2')), 4.99 (br s, HO–C(5')), 
5.15, 5.44 (2br s, HO–C(2'), HO–C(3')), 5.79 (d, J=5.8Hz, H–C(1')), 8.31 (s, H–C(8)) ppm; 
13C NMR (75MHz, d6-DMSO, 25°C): δ=23.8 (COCH3), 31.9 (1-CH3), 62.1 (C(5')), 71.2 
(C(3')), 74.9 (C(2')), 86.5 (C(4')), 87.8 (C(1')), 139.8 (C(8)), 122.0, 147.3, 148.0, 157.7, 171.0 
ppm; ESI MS: 340.1 [M+H]+. 
 
5.6.3 Synthesis of 5'-O-DMT-N2-acetyl-N1-methylguanosine (43) 
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To a stirred solution of N2-acetyl-N1-methylguanosine (42) (0.5 g, 1.5 mmol, 1.0 equiv) in 6 
mL of anhydrous pyr and 3 mL of anhydrous DMF at rt was added DMT-Cl (585 mg, 1.73 
mmol, 1.2 equiv) in 10 mL pyr. The reaction mixture was stirred and monitored by TLC. The 
reaction was complete after 8 h. The mixture was then evaporated to dryness under reduced 
pressure at 40 °C. The resulting solid was dissolved in 20 mL of DCM/MeOH (10:1) and 
purified by fCC on silica gel with a gradient eluent system of (DCM:MeOH, 40:1 to 25:1) 
resulting in 43 with yield (4.2 g, 85 %).  
TLC (silica gel, DCM:MeOH=10:1): Rf = 0.4; 1H NMR (500 MHz, CDCl3, 25 °C): δ = 1.84 
(COCH3), 3.22 - 3.42 (m, 2H–C5'), 3.45 (1-CH3), 3.71 (s, -OCH3), 3.72 (s, -OCH3), 4.29 (t, 
H–C4'), 4.42 (t, H–C3'), 4.88 (t, H–C2'), 5.86 (d, J=6.1Hz, H–C1'), 6.25 (br q, NH), 6.72–6.80 
(m, 4H, trityl-H), 7.10–7.42 (m, 9H, trityl-H), 7.85 (s, H–C(8)) ppm; 13C NMR (125 MHz, 
CDCl3, 25 °C): δ=23.62 (COCH3), 31.30 (1-CH3), 55.20 (2 CH3O), 63.68 (C5'), 71.91 (C(3')), 
74.88 (C2'), 85.27 (C4'), 86.40, 89.58 (C1'), 113.19 (trityl-C), 121.2, 126.96, 127.90, 128.03, 
129.99, 130.05 (trityl-C), 135.55, 135.63, 138.93 (C(8)), 144.66, 146.05, 146.43, 157.35, 
158.54, 170.25 ppm. FAB-MS: m/z=642.2 (100, [M+H]+), 303.1 (39, [(MeO)2Tr]+). 
 
5.6.4 Synthesis of 5'-ODMT-2'-OTOM-N2-acetyl-N1-methylguanosine (44) 
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In a rb flask equipped with a stirrer under argon was added 5'-ODMT-N2-acetyl-N1-
methylguanosine (43) (400 mg, 0.56 mmol, 1.0 equiv), DCE (4 mL), DIEA (285 mg, 2.25 
mmol, 4.0 equiv), and di-tert-butyltindichloride (200 mg, 0.65 mmol, 1.2 equiv). The mixture 
was heated to 70 °C and stirred for 15 min and then allowed to cool to rt again, and treated 
with TOM-Cl (145 mg, 0.6 mmol, 1.2 equiv). The mixture was further stirred for additional 1 
h followed by the addition of MeOH (0.3 mL) after which TLC showed no starting material. 
The mixture was evaporated to dryness after which it was subjected to fCC (silica gel, 
DCM:MeOH, 60:1 to 40:1) to afford the fluffy white solid 44 (204 mg, 46 %) and the 5'-O-
DMT-3'-OTOM-N2-acetyl-N1-methylguanosine (154 mg, 36 %). 
TLC (silica gel, DCM:MeOH = 25:1): Rf = 0.37; 1H NMR (500 MHz, CDCl3, 25 °C): δ=0.98–
1.07 (m, iPr3Si), 1.42 (s, COCH3), 3.00 (d, J=1.5Hz, HO–C3'), 3.17 (dd, J=3.2, 10.5 Hz, H1–
C5'), 3.52 (s, 1-CH3), 3.55 (dd, J=1.8, 10.5Hz, H2–C5'), 3.78, 3.79 (2s, 2 OCH3), 4.25 (m, H–
C4'), 4.52 (m, H–C3'), 4.94 (q, H–C2'), 4.90, 5.11 (2d, J=4.7Hz, OCH2O), 5.93 (d, J=7.3Hz, 
H–C1'), 6.80 (m, 4H, trityl-H), 6.98 (br s, NH), 7.17–7.54 (m, 9H, trityl-H), 7.83 (s, H–C8) 
ppm; 13C NMR (125 MHz, CDCl3, 25 °C): δ = 11.80 ((CH3)2CH), 17.75 ((CH3)2CH), 22.89 
(COCH3), 31.79 (1-CH3), 55.28 (2 CH3O), 63.78 (C5'), 70.90 (C3'), 81.96 (C2'), 84.37 (C4'), 
86.37 (C1'), 86.50, 91.07 (OCH2O), 113.26, 113.32 (trityl-C), 123.05, 127.16, 128.01, 128.08, 
129.97, 130.12 (trityl-C), 135.68, 135.89, 139.58 (C(8)), 145.12, 146.24, 157.30, 158.72, 
169.68 ppm; FAB-MS: m/z=829.2 (83, [M+H]+), 303.1 (100, [(MeO)2Tr]+). 
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5.6.5 Synthesis of 5'-O-DMT-2'-O-TOM-3'-O-CEP-N2-acetyl-N1-methylguanosine 
(45) 
 
 
 
In a 2-neck rb flask equipped with a stirrer at rt was added 44 (189 mg, 0.21 mmol, 1 equiv) 
and DCM (5 mL). The reaction mixture was treated consecutively with DIEA (160 mg, 2.2 
mmol) and CEP-Cl (79 mg, 0.33 mmol, 1.5 equiv). The reaction mixture was monitored by 
TLC, stirred for 3 h and quenched with MeOH (0.3 mL) , evaporated under vacuum to 
dryness. Workup and purified by fCC on silica gel with a gradient eluent system of 
DCM:MeOH (80:1, 40:1), containing 2 % Et3N afforded 45 (192 mg, 85 % as 
diastereoisomeric mixture). 
TLC (silica gel, DCM:MeOH=25:1): Rf = 0.5; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 0.86 – 
1.19 (m, 30H, iPr3Si (18H), ((CH3)2CH)2N (12H)), 1.44, 1.66 (br s, 6H, COCH3), 2.27, 2.69 
(2m, 4H, CH2CN), 3.21 (m, 2H, H1– C(5')), 3.50–3.55 (m, 4H, ((CH3)2CH)2N), 3.51, 3.52 
(2s, 6H, 1-CH3), 3.53, 3.59 (m, 2H, POCH2), 3.51, 3.62 (m, 2H, H2–C(5')), 3.77, 3.78 (2s, 
12H, OCH3), 3.90, 3.97 (2m, 2H, POCH2-), 4.27, 4.34 (2q, 2H, H–C(4')), 4.52, 4.57 (2m, 2H, 
H–C(3')), 4.89–4.96 (4d, 4H, J=5.2Hz, OCH2O), 5.00, 5.06 (t, q, 2H, H–C(2')), 5.89, 5.99 (2d, 
2H, J=7.1Hz, H–C(1')), 6.76–6.82, 7.20–7.31, 7.35–7.53 (m, 26H, trityl-H), 7.82, 7.84 (2s, 
2H, H–C(8)) ppm; 31P NMR (200MHz, CDCl3, 25°C): δ= 149.98, 150.50 ppm; FAB-MS: 
m/z=1028.5 (44, [M+H]+), 821.5 (100), 303.1 (35, [(MeO)2Tr]+). 
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5.7 Synthesis of Precursor for m2G and m22G Phosphoramidite 
 
5.7.1 Synthesis of 2',3',5'-tri-O-acetylguanosine (46) 
 
 
 
A rb flask equipped with a stirring bar containing a mixture of guanosine (40) (14.2 g, 50 
mmol, 1 equiv) acetic anhydride (30 mL), pyr (15 mL), and DMF (40 mL) was heated whilst 
stirring at 75 °C for 4 h. The resulting clear solution was filtered hot, cooled to rt and 
evaporated in vacuo to afford a heavy crystalline suspension. A portion of hot isopropanol (50 
mL) was added and the mixture cooled to 4 °C and the suspension filtered and rewashed with 
isopropanol and dried under vacuum overnightto afford crystalline sample 46, with a yield of 
(19.03 g, 46.6 mmol) 93 %. 
TLC (silica gel, CHCl3:MeOH=20:1): Rf = 0.24; 1H NMR (300 MHz, DMSO-d6, 25 °C): 
δ=2.03 (s, 3H-COCH3), 2.05 (s, 3H-COCH3), 2.11 (s, 3H-COCH3), 4.27 (3H, m, H-C4' & 
2H-C5'), 5.49 (1H, t, H-C3'), 5.79 (1H, t, H-C2'), 5.99 (1H, d, H-C1'), 6.53 (2H, s, H-NH2), 
7.93 (1H, s, H-C2'), 10.72 (1H, s,H-C5') ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ= 20.63 
(CH3-CO), 20.82 (CH3-CO), 20.97 (CH3-CO), 63.51 (C5), 70.75 (C4), 72.49 (C3), 79.99 
(C2), 84.85 (C1), 117.27 (C8'), 151.54 (C2'), 154.31 (C6' & 9'), 157.06 (C4'), 169.69 (C10'), 
169.86 (C11'), 170.51(C12') ppm MS-FAB 410.13 [M+H]+. 
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5.7.2 Synthesis of 2',3',5'-tri-O-acetyl-O6-nitrophenylethylguanosine (47) 
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Chemical Formula: C24H26N6O10
Molecular Weight: 558.50
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A suspension of 2',3',5'-O-triacetylguanosine (46) (340 mg, 24.6 mmol, 1.0 equiv) in dry 
dioxane (150 mL) and triphenylphosphine (PPh3) (440 mg, 37.5 mmol, 1.5 equiv) and 2-(4-
nitrophenyl)ethanol (54.8 mg, 56 mmol, 2.0 equiv) was stirred at 80 °C for 45 min. DEAD 
(45 mg, 37.5 mmol, 1.5 equiv) was added during which a clear solution was formed. The 
mixture was stirred at 60 °C for 1 h after which it was cooled to rt and evaporated under 
vacuo. The residual oil was purified by fCC on silica gel with a gradient eluent system of 
Et2O/DCM, 9:1 (200 mL), Et2O/DCM, 4:1 (200 mL), Et2O/DCM; 1:1 (200 mL), DCM (300 
mL), DCM/MeOH; 49:1 (300 mL), and finally DCM/MeOH; 19:1. The product 47 was 
obtained as a semi-solid with a yield of 58 %.  
TLC (silica gel, CHCl3:MeOH=20:1): Rf = 0.28. 1H NMR (300 MHz, CDCl3, 25 °C): δ = 2.08 
(s, 3H-COCH3), 2.10 (s, 3H-COCH3), 2.12 (s, 3H-COCH3), 3.26 (2H, t, H-C14'), 4.27 (3H, 
m, H-C4 & 2H-C5), 4.73 (2H, t, H-C13'), 5.75 (1H, t, H-C3), 5. 93 (1H, t, H-C2), 5.99 (1H, d, 
H-C1), 7.45 (2H, s, H-NH2), 7.48 (2H, m, H-C16'), 7.66 (2H, m, H-C17'), 8.14 (1H, s, H-C2') 
ppm. 13C NMR (75 MHz, CDCl3, 25°C): δ = 20.63 (CH3-CO), 20.82 (CH3-CO), 20.97 (CH3-
CO), 63.51 (C5), 70.75 (C4), 72.49 (C3), 79.99 (C2), 84.85 (C1), 117.27 (C8'), 151.54 (C2'), 
154.31 (C6' & C9'), 157.06 (C4'), 169.69 (C10'), 169.86 (C11'), 170.51(C12') ppm, MS-FAB 
559.63 [M+H]+.  
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5.8 Chemical Synthesis of m2G Phosphoramidite 
 
5.8.1 Synthesis of N2-methyl-O6-nitrophenylethylguanosine (48) 
 
 
 
A suspension of 2',3',5'-tri-O-acetyl-O6-nitrophenylethylguanosine 47 (5.3 g, 9.4 mmol) in 
40 mL of acetone was cooled to -20 °C and treated with 100 mL of 50 % HBF4 (1.0 mol in 
water). Under vigorous stirring NaNO2 (1.84 g, 23.5 mmol) in 22 mL of water were added 
dropwise. The reaction mixture was allowed to warm to room temperature, stirred for 4 h, and 
neutralized with 50 % NaOH. The reaction mixture was extracted two times with DCM, the 
organic layers were dried with Na2SO4 and evaporated to dryness. The crude material was 
dissolved in 8 M CH3NH2 in ethanol and stirred overnight. The reaction mixture was 
evaporated to dryness. Column chromatography (silica gel, DCM/MeOH; 15:1) afforded 48 
(2.46 g, 5.51 mmol, 51 %). 
TLC (silica gel, CHCl3:MeOH=20:1): Rf = 0.24; 1H NMR (300 MHz, DMSO-d6, 25 °C): 
δ=2.82 (d, J=4.8Hz, 3H-N2-CH3), 3.26 (t, J=6.8Hz, 2H-CH2–C6H4–NO2), 3.55 - 3.63 (2m, 
2H–C5'), 3.90 (q, 1H–C4'), 4.14 (q, 1H–C3'), 4.57 (q, 1H–C2'), 4.71 (t, J=6.8Hz, 2H-O6–
CH2), 4.84 (t, HO–C5'), 4.99 (d, J=4.9Hz, HO–C3'), 5.23 (d, J=6.1Hz, H-HO–C2'), 5.79 (d, 
J=5.9Hz, H–C1'), 6.75 (br q, NH), 7.61 (d, J=8.5Hz, 4-nitrophenyl H–C(2)/H–C(6)), 8.02 (s, 
1H–C8), 8.16 (d, J=8.5Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 13C NMR (75 MHz, d6-
DMSO, 25 °C): δ=28.65 (N2–CH3), 34.82 (CH2–C6H4–NO2), 62.05 (C(5')), 65.79 (O6–CH2), 
70.96 (C(3')), 73.56 (C(2')), 85.74 (C(4')), 87.49 (C(1')), 123.78 (4-nitrophenyl C(3)/C(5)), 
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114.33, 130.63 (4-nitrophenyl C(2)/C(6)), 138.73, 138.79 (C(8)), 146.74, 147.08, 154.67, 
159.76, 160.34 ppm, FAB-MS, 447.52 [M+H]+. 
 
5.8.2 Synthesis of 5'-O-DMT-N2-methyl-O6-nitrophenylethylguanosine (49) 
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In a rb flask equipped with compound (48) (2.1 g, 4.72 mmol) and a magnetic stirring bar was 
coevaporated three times with anhydrous pyr and finally dissolved in 20 mL of pyr. Then, 
DMT-Cl (1.76 g, 4.85 mmol) was added portion-wise over a period of 4 h. DMAP (0.21 g, 
1.67 mmol) was added and stirring was continued overnight. The reaction mixture was 
quenched with MeOH, evaporated to dryness, workup, and purified by fCC on silica gel with 
a gradient eluent system of DCM:MeOH; (50:1, 20:1) to yield 49 (2.45 g, 3.20 mmol) as a 
pale yellow foam (70 %).  
TLC (silica gel, DCM:MeOH=10:1): Rf = 0.4; 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.73 (d, J=4.8Hz, N2-CH3), 3.22 (d, J=4.7Hz, 2H–C(5')), 3.25 (t, J=6.7Hz, 2H-CH2–C6H4–
NO2), 3.71(s, 3H-OCH3), 3.72 (s, 3H-OCH3), 4.01 (q, 1H–C4'), 4.32 (q, 1H–C3'), 4.64 (q, 
1H–C2'), 4.71 (t, J=6.7Hz, 2H-O6–CH2), 4.97 (d, J=5.8Hz, 1H-HO–C3'), 5.28 (d, J=5.0Hz, 
1H-HO–C2'), 5.82 (d, J=4.6Hz, H–C1'), 6.65 (br q, NH), 6.81 (m, 4H, trityl-H), 7.17–7.27, 
7.33–7.37 (m, 9H, trityl-H), 7.60 (d, J=8.7Hz, 4- nitrophenyl H–C(2)/H–C(6)), 7.90 (s, H–
C(8)), 8.15 (d, J=8.7Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 13C NMR (125 MHz, DMSO-
d6, 25 °C): δ = 28.54 (N2-CH3), 34.78 (CH2–C6H4–NO2), 55.45 (2 CH3O), 64.46 (C(5')), 65.81 
(O6–CH2), 70.98 (C(3')), 73.26 (C(2')), 83.46 (C(4')), 85.98, 88.25 (C(1')), 113.56 (trityl-C), 
114.49, 123.73 (4-nitrophenyl C(3)/C(5)), 126.98, 128.05, 128.17 (trityl-C), 130.03, 130.08, 
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130.58 (trityl-C, 4-nitrophenyl C(2)/C(6)), 136.08, 138.71 (C(8)), 145.22, 146.83, 147.06, 
158.52, 158.55, 159.80, 160.40 ppm, FAB-MS, 748.81 [M+H]+, 303.01 [(MeO)2Tr]+). 
 
5.8.3 Synthesis of 5'-O-DMT-2'-O-TOM-N2-methyl-O6-nitrophenylethylguanosine 
(50) 
 
 
 
A stirred solution of of (49) (1.63 g, 1.76 mmol) and DIEA (2.26 g, 17.42 mmol) in 40 mL of 
anhydrous DCE, di-tert-butyltindichloride (1.60 g, 2.61mmol) was added. The mixture was 
heated to 70 °C for 15 min, allowed to cool to rt again and treated with TOM-Cl (0.53 g, 2.40 
mmol). Stirring was continued for further 3 h, followed by addition of 0.5 mL of MeOH, 
evaporation to dryness and workup. Purified by fCC on silica gel with a gradient eluent 
system of Hex:EtOAc=3:1 to 1:1 afforded of 50 (0.70 g, 0.6 mmol) as white solid foamwith 
yield of 55 %.  
TLC (silica gel, DCM:MeOH=10:1): Rf = 0.4; 1H NMR (350 MHz, DMSO-d6, 25 °C): δ = 
2.73 (d, J=4.8Hz, 3H-N2-CH3), 3.22 (d, J=4.7Hz, 2H–C(5')), 3.25 (t, J=6.7Hz, 2H-CH2–C6H4–
NO2), 3.71 s, 2H-OCH3), 3.72 (s, 3H-OCH3), 4.01 (q, 1H–C(4')), 4.32 (q, 1H–C(3')), 4.64 (q, 
1H–C(2')), 4.71 (t, J=6.7Hz, 2H-O6–CH2), 4.97 (d, J=5.8Hz, 1H-HO–C(3')), 5.28 (d, J=5.0Hz, 
HO–C(2')), 5.82 (d, J=4.6Hz, 1H–C(1')), 6.65 (br q, NH), 6.81 (m, 4H, trityl-H), 7.17–7.27, 
7.33–7.37 (m, 9H, trityl-H), 7.60 (d, J=8.7Hz, 4- nitrophenyl H–C(2)/H–C(6)), 7.90 (s, H–
C(8)), 8.15 (d, J=8.7Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 13C NMR (125MHz, DMSO-d6, 
25 °C): δ  = 28.54 (N2-CH3), 34.78 (CH2–C6H4–NO2), 55.45 (2 CH3O), 64.46 (C(5')), 65.81 
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(O6–CH2), 70.98 (C(3')), 73.26 (C(2')), 83.46 (C(4')), 85.98, 88.25 (C(1')), 113.56 (trityl-C), 
114.49, 123.73 (4-nitrophenyl C(3)=C(5)), 126.98, 128.05, 128.17 (trityl-C), 130.03, 130.08, 
130.58 (trityl-C, 4-nitrophenyl C(2)=C(6)), 136.08, 138.71 (C(8)), 145.22, 146.83, 147.06, 
158.52, 158.55, 159.80, 160.40 ppm. FAB-MS, 936.27 [M+H]+ 303.01 [(MeO)2Tr]+. 
 
5.8.4 Synthesis of 5'-O-DMT-2'-O-TOM-3'-O-CEP-N2-methyl-O6-
nitrophenylethylguanosine (51) 
 
 
 
A stirred solution of of (50) (1.63 g, 1.76 mmol) in 40 mL of anhydrous DCE was added 
DIEA (2.26 g, 17.42 mmol). The mixture was stirred for 15 min at 0 °C, allowed to warm to rt 
again and was added CEP-Cl (0.53 g, 2.40 mmol). Stirring was continued for 3 h, followed by 
addition of 0.5 mL of MeOH, evaporation to dryness and workup. Purified by fCC on silica 
gel with a gradient eluent system of (silica gel, Hex:EtOAc=3:1 to 1:1) to afford 51 (0.70 g, 
0.6 mmol) as white solid foam with a yield of 34 %.  
TLC (silica gel, Hex:EtOAc=1:1): Rf = 0.4; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 0.98–
1.10 (m, iPr3Si), 2.86 (d, J=5.1Hz, 3H-N2-CH3), 2.98 (d, J=4.1Hz, 1H-HO–C(3')), 3.28 (t, 
J=6.9Hz, 2H-CH2–C6H4–NO2), 3.36 (dd, J=4.5, 10.5 Hz, 1H–C(5')), 3.46 (dd, J=3.9, 10.5Hz, 
2H–C(5')), 3.78 (s, 3H-OCH3), 3.79 (s, 3H-OCH3), 4.22 (q, 1H–C(4')), 4.58 (q, 1H–C(3')), 
4.67 (br s, NH), 4.73 (t, J=6.9Hz, O6–CH2), 4.95 (t, 1H–C(2')), 4.98, 5.13 (2d, J=4.8Hz, 2H-
OCH2O), 6.03 (d, J=5.4Hz, 1H–C(1')), 6.79 (m, 4H, trityl-H), 7.19–7.32, 7.42– 7.43 (m, 9H, 
trityl-H), 7.47 (d, J=8.7Hz, 4-nitrophenyl H–C(2)/H–C(6)), 7.71 (s, H–C(8)), 8.16 (d, 
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J=8.7Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 13C NMR (75 MHz, CDCl3, 25 °C): δ = 11.85 
((CH3)2CH), 17.74 ((CH3)2CH), 28.59 (N2-CH3), 35.24 (CH2–C6H4–NO2), 55.16 (2 CH3O), 
63.55 (C(5')), 65.83 (O6–CH2), 70.99 (C(3')), 81.22 (C(2')), 83.74 (C(4')), 86.42, 86.70 
(C(1')), 90.79 (OCH2O), 113.13 (trityl-C), 115.33, 123.68 (4-nitrophenyl C(3)/C(5)), 126.81, 
127.79, 128.20 (trityl- C), 129.88, 130.08 (trityl-C, 4-nitrophenyl C(2)/C(6)), 135.77, 135.83, 
138.02 (C(8)), 144.64, 146.11, 146.84, 154.10, 158.52, 159.64, 160.51 ppm; MALDI-MS: 
m/z=1158.41 (5, [M+Na]+), 303.1 (100, [(MeO)2Tr]+) 
 
5.9 Chemical Synthesis of m22G Phosphoramidite 
 
5.9.1 Synthesis of (2R,3R,4S,5R)-2-(2-(dimethylamino)-6-(4-nitrophenethoxy)-9H-
purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (52) 
 
 
 
In rb flask containing a suspension of 2',3',5'-tri-O-acetylguanosine (47) (3.0 g, 5.3 mmol) in 
20 mL of acetone was cooled to -20 °C and treated with 50 mL of 50 % HBF4 (0.55 mol). 
Under vigorous stirring 0.92 g of NaNO2 (13.4 mmol) in 13 mL of water was added dropwise. 
The reaction mixture was allowed to warm to rt, stirred for 3 h, and neutralized with 50 % 
NaOH. The reaction mixture was extracted twice with DCM, the organic layers dried with 
Na2SO4 and evaporated to dryness. The crude material was dissolved in a stirred solution of 
33 % (CH3)2NH in 20 mL of ethanol. After 1 h, a solution of 40 % (CH3)2NH in 20 mL of 
water was added and stirring was continued for another 3 h. The reaction mixture was 
evaporated to dryness and co-evaporated three times with MeOH/toluene/DCM and purified 
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by fCC on silica gel with a gradient eluent system of (DCM: MeOH=40:1, 15:1) to afford 52 
(1.24 g, 2.7 mmol) with a yield of 50 %. 
TLC (silica gel, CHCl3:MeOH=10:1): Rf=0.5; 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
3.12 (s, N2-(CH3)2), 3.27 (t, J=6.7Hz, CH2–C6H4–NO2), 3.50, 3.61 (2m, H2–C(5')), 3.87 (q, 
H– C(4')), 4.14 (q, H–C(3')), 4.59 (q, H–C(2')), 4.73 (t, J=6.7Hz, O6–CH2), 4.90 (t, J=5.6Hz, 
HO– C(5')), 5.15 (d, J=4.9Hz, HO–C(3')), 5.35 (d, J=6.2Hz, HO–C(2'), 5.80 (d, J=5.9Hz, H–
C(1')), 7.60 (d, J=8.7Hz, 4-nitrophenyl H–C(2)=H–C(6)), 8.08 (s, H–C(8)), 8.16 (d, J=8.7Hz, 
4-nitrophenyl H–C(3)=H–C(5)) ppm; 13C NMR (125 MHz, DMSO-d6, 25 °C): δ=34.77 
(CH2–C6H4–NO2), 37.53 (N2-(CH3)2), 61.99 (C(5')), 65.81 (O6–CH2), 70.89 (C(3')), 73.41 
(C(2')), 85.58 (C(4')), 87.40 (C(1')), 113.69, 123.85 (4-nitrophenyl C(3)/C(5)), 130.64 (4-
nitrophenyl C(2)/C(6)), 139.29, 139.31 (C(8)), 146.68, 147.12, 154.71, 158.87, 159.86 ppm. 
FAB MS:461.12 [M+H]+. 
 
5.9.2 Synthesis of (2R,3S,4R,5R)-2-((bis(4-
methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(dimethylamino)-6-(4-
nitrophenethoxy)-9H-purin-9-yl)tetrahydrofuran-3,4-diol (53) 
 
 
 
In rb flask containing compound 52 (0.5 g, 1.09 mmol) was co-evaporated three times with 
anhydrous pyr was dissolved in 4 mL of the same solvent. Then, 0.41 g of DMT-Cl (1.21 
mmol) was added in three portions over a period of 1 h. DMAP (10 mg, 0.08 mmol) was 
added and stirring was continued overnight. Quenching by the addition of MeOH, evaporation 
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to dryness, workup, and purified by fCC on silica gel with a gradient eluent system of DCM: 
MeOH; (50:1, 35:1) yielded 690 mg of the product 53 as pale yellow foam (70 %). 
TLC (silica gel, DCM:MeOH=20:1): Rf = 0.37; 1H NMR (300 MHz, CDCl3, 25 °C): δ=3.04 
(s, HO–C(3')), 3.18 (s, N2-(CH3)2), 3.24 (dd, J=3.5, 10.4 Hz, 1H–C(5')), 3.31 (t, J=6.8Hz, 
CH2–C6H4–NO2), 3.41 (dd, J=3.8, 10.4 Hz, 2H–C(5')), 3.76 (s, 3H-OCH3), 3.77 (s, 3H-
OCH3), 4.39 (d, 1H–C(3')), 4.44 (t, 1H–C(4')), 4.68 (t, 1H–C(2')), 4.78 (t, J=6.8Hz, 2H-O6–
CH2), 5.83 (d, J=6.6Hz, 1H–C(1')), 6.73–6.79 (m, 4H, trityl-H), 7.16–7.22, 7.26–7.30 (m, 9H, 
trityl-H), 7.49 (d, J=8.9Hz, 4-nitrophenyl H–C(2)/H–C(6)), 7.84 (s, H–C(8)), 8.16 (d, 
J=8.9Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 13C NMR (75 MHz, CDCl3, 25 °C): δ = 35.16 
(CH2–C6H4–NO2), 37.78 (N2-(CH3)2), 55.10 (2 CH3O), 63.73 (C(5')), 65.89 (O6–CH2), 72.84 
(C(3')), 76.21 (C(2')), 86.34 (C(4'), 86.38, 90.41 (C(1')), 113.06 (trityl-C), 114.10, 123.70 (4-
nitrophenyl C(2)=C(6)), 126.77, 127.76, 127.97 (trityl-C), 129.82, 129.83, 129.89, 129.93 
(trityl-C and 4-nitrophenyl C(3)/C(5)), 135.38, 135.55, 136.83 (C(8)), 144.27, 145.90, 146.81, 
153.22, 158.45, 160.10 ppm; MALDI- MS: m/z=785.55 ([M+Na]+), 303.1 (100, 
[(MeO)2Tr]+). 
 
5.9.3 Synthesis of (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy) 
methyl)-5-(2-(dimethylamino)-6-(4-nitrophenethoxy)-9H-purin-9-yl)-4-
((triisopropylsilyloxy) methoxy)tetrahydrofuran-3-ol (54) 
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In rb flask containing a stirring solution of 53 (500 mg, 0.70 mmol) and DIEA (366 mg, 2.84 
mmol) in 6 mL of anhydrous DCE, di-tert-butyltindichloride (258 mg, 0.85 mmol) was 
added. The mixture was heated to 70 °C for 15 min, allowed to cool to rt again and treated 
with [(triisopropylsilyl)oxy]methylchloride (173 mg, 0.8mmol). Stirring was continued for 4 
h, quenched by addition of 0.5 mL of MeOH, evaporation to dryness and workup and purified 
by fCC on silica gel with a gradient eluent system of Hex:EtOAc = 3:1 to 1:1 to afford 54 
(222 mg, 0.23 mmol) as a white solid foam with a yield of 33 %. The regioselectivity of 2'-O-
alkylated over 3'-O- alkylated product was approximately 5:3 as judged from the isolated 
products from the fCC. 
TLC (silica gel, Hex: EtOAc=1:1): Rf = 0.4; 1H NMR (300MHz, CDCl3, 25 °C): δ = 1.02–
1.12 (m, iPr3Si), 2.99 (d, J=4.7, HO–C(3')), 3.10 (s, 3H-N2-(CH3)2), 3.30 (t, J=6.9Hz, 2H-
CH2–C6H4–NO2), 3.46 (d, H2–C(5')), 3.76 (s, 3H-OCH3), 3.78 (s, 3H-OCH3), 4.20 (q, 1H–
C(4')), 4.57 (q, 1H–C(3')), 4.76 (t, J=6.9Hz, 2H-O6–CH2), 4.92 (t, 1H–C(2')), 4.99, 5.14 (2d, 
J=4.8Hz, 2H-OCH2O), 6.05 (d, J=4.9Hz, 1H–C(1')), 6.78 (m, 4H, trityl-H), 7.19–7.33, 7.38–
7.42 (m, 9H, trityl-H), 7.48 (d, J=8.4Hz, 4-nitrophenyl C(2)/C(6)), 7.71 (s, H–C(8)), 8.17 (d, 
J=8.4Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 13C NMR (75 MHz, CDCl3, 25 °C): δ = 11.78 
((CH3)2CH), 17.66 ((CH3)2CH), 35.23 (CH2–C6H4–NO2), 37.33 (N2-(CH3)2), 55.08 (2 CH3O), 
63.59 (C(5')), 65.57 (O6–CH2), 70.80 (C(3')), 81.27 (C(2')), 83.49 (C(4')), 86.34, 86.75 
(C(1')), 90.72 (OCH2O), 113.06 (trityl-C), 114.16, 123.65 (4-nitrophenyl C(3)/C(5)), 126.71, 
127.71, 128.11 (trityl-C), 129.81, 129.99 (trityl-C, 4-nitrophenyl C(2)/C(6)), 135.70, 135.79, 
137.74 (C(8)), 144.56, 146.11, 146.79, 154.13, 158.43, 159.04, 159.86 ppm; MALDI-MS: 
m/z=950.2 (45, [M+H]+), 303.1 (100, [(MeO)2Tr]+). 
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5.9.4 Synthesis of (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy) 
methyl)-5-(2-(dimethylamino)-6-(4-nitrophenethoxy)-9H-purin-9-yl)-4 
((triisopropylsilyloxy)methoxy) tetrahydrofuran-3-yl 2-cyanoethyl 
diisopropylphosphoramidite (55) 
 
 
In rb flask containing a stirring solution of 54 (444 mg, 0.47 mmol) in 4 mL of anhydrous 
DCM was treated consecutively with ethyldimethylamine (343 mg, 4.7 mmol) and CEP-Cl 
(116 mg, 0.49 mmol). The mixture was stirred for 3 h, quenched with 0.15 mL of MeOH, and 
evaporated to dryness. Workup and purified by fCC on silica gel with a gradient eluent 
system of Hex:EtOAc= 5:1, 3:1 (+2 % Et3N)) afforded the product 55 (469 mg, 0.41 mmol) 
as a white solid foam with yield of 70 %. (1:1 mixture of diastereoisomers).  
TLC (silica gel, Hex:EtOAc=1:1): Rf = 0.63; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 0.86–
1.28 (m, 42H, iPr3Si, 24H, ((CH3)2CH)2N), 2.32, 2.64 (2m, 4H, CH2CN), 3.06, 3.07 (2s, 12H, 
N2-(CH3)2), 3.29 (t, 4H, J=6.4Hz, CH2–C6H4–NO2), 3.35–3.47 (m, 4H, 2H–C(5')), 3.48–3.65 
(m, 4H, ((CH3)2CH)2N, 2H, POCH2), 3.77, 3.78 (2s, 12H, OCH3), 3.84–3.96 (2m, 2H, 
POCH2), 4.30, 4.33 (2q, 2H, H–C(4')), 4.62 (m, 2H, H–C(3')), 4.75 (t, J=6.4Hz, O6–CH2), 
4.88–4.97 (q, 4H, J=6Hz, OCH2O), 5.06 (m, 2H, H–C(2')), 6.05, 6.09 (2d, 2H, J=5.9Hz, H–
C(1')), 6.75–6.79, 7.20–7.40 (m, 26H, trityl-H), 7.48 (2d, J=8Hz, 4-nitrophenyl H–C(2)/H–
C(6)), 7.70 (s, 2H, H–C(8)), 8.16 (d, J=8Hz, 4-nitrophenyl H–C(3)/H–C(5)) ppm; 31P NMR 
(f00MHz, CDCl3, 25°C): δ=150.22, 150.59 ppm; MALDI-MS: m/z= 1171.53 (5, [M+Na]+), 
303.12 (100, [(MeO)2Tr]+). 
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5.10 Chemical Syntheses of Coumarins and Related Derivatives 
 
5.10.1 Synthesis of 4-(bromomethyl)-7-hydroxy-2H-chromen-2-one (56) 
 
 
 
In a rb flask equipped with a stirrer was added 1,3-dihydroxybenzene 15 (2 g, 18.2 mmol, 1 
equiv) and ethyl 4-bromo-3-oxobutanoate (3.8 g, 18.2 mmol, 1.0 equiv) and the mixture was 
homogenized by carefully mixing after which the mixture was cooled to 0 °C and then 
sulfuric acid 70 % ( 1 mL) was added in drops. The reaction mixture was stirred until the 
disappearance of the purple coloration. Cooled water and ice (0 °C) (20 mL) was added and 
the resulting granular solid was carefully triturated into fine particles and filtered afterwards, 
followed by washing with cold water. The solid was dried under vacuo to give a final off 
white product 56 (3.7 g, 14.50 mmol) 79 %.  
TLC (silica gel, Hex:EtOAc=10:1): Rf=0.24, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ =, 
4.61 (s, 2H, -CH2-Br, H9),6.45 (s, 1H, Ar H3), 7.42 (m, 1H, Ar H5), 7.56 (s, 1H, Ar H8), 7.75 
(m, 1H, Ar H6), 8.05 (s br, 1H, Ar-OH),13C NMR (75 MHz, DMSO-d6, 25 °C): δ= 28.56, 
105.56 (C(4)), 112.66, 114.44 (C(6)), 115.50, 127.27 (C(5)), 143.87 (C(7)), 153.99 (C(3)), 
160.61 (C(2)) ppm.  FAB-MS: 253.2, 255.2[M+H]+ 
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5.10.2 Synthesis of 4-(bromomethyl)-2-oxo-2H-chromen-7-yl acetate (57) 
 
56
57
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3
45
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O O
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O
Chemical Formula: C12H9BrO4
Molecular Weight: 297.10
O
10
11
Acetic anhydride
Iodine, reflux, 1 h
 
 
In an rb flask containing 4-(bromomethyl)-7-hydroxy-2H-chromen-2-one 56 (3 g, 11.7 
mmol) was added acetic anhydride (5 mL). The reaction mixture was heated to 40 °C and 
iodine (20 mg; as catalyst) was added and heating was continued for further 1 h. The reaction 
was usually finished after 1 h. EtOAc (5 mL) was added and cooled to 4 °C overnight for 
precipitation. The precipitate was filtered and washed several times with cold EtOAc (50 mL) 
and dried under vacuum. The yield of the product 57 (2.99 g, 10.06 mmol) was 86 %. 
TLC (silica gel, Hex:EtOAc=10:1): Rf = 0.34, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.32 t, 3H-H11), 4.62 (s, 2H, -CH2-Br, H9), 6.45 (s, 1H, Ar H3), 7.42 (m, 1H, Ar H5), 7.58 (s, 
1H, Ar H8), 7.65 (m, 1H, Ar H6), 8.05 (br, 1H, Ar-OH),13C NMR (75 MHz, DMSO-d6, 25 
°C): δ= 22.32 (C(11)), 28.54, 105.54 (C(4)), 112.67, 114.44 (C(6)), 115.50, 127.27 (C(5)), 
144.87 (C(7)), 154.98 (C(3)), 160.61 (C(2)),  169.61 (C(10)) ppm.  FAB-MS: 295.1, 
297.1[M+H]+ 
 
5.10.3 Synthesis of ethyl 3-hydroxyphenylcarbamate (12) 
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This reaction was performed based on the reported protocol from Maly et al. 100In an rb flask 
containing 3-aminophenol (10) (15 g, 137.4 mmol, 1.0 equiv) was added EtOAc (50 mL) and 
the mixture was refluxed for 30 min. To the refluxing mixture was added ethyl chloroformate 
(9 mL, 94.1 mmol, 0.7 equiv) in drops over 30 min. The reaction mixture was further refluxed 
for 1 h. The mixture was filtered whilst hot and the hot filtrate cooled to rt and then 
evaporated to dryness. To the off-white residue was added hot isopropanol and the dissolved 
mixture kept at 4 °C overnight after which the precipitate 12 was filtered and dried under 
vacuum with total yield of 95.6 % (23.4 g, 129 mmol).  
TLC (silica gel, DCM:MeOH=40:1): Rf=0.47, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
1.20 (t, J = 9.3 Hz, 3H (CH3)), 4.07 (q, J = 9.3 Hz, 2H (CH2-)), 6.38 (m, 1H, ar H6), 6.85 (m, 
1H, ar H7), 6.92-7.08 (m, 2H, ar-H5 and ar-H9), 9.43 (s, 1H, NH, H10), 13C NMR (300 MHz, 
CDCl3, 25°C): δ = 15.79 (C(1)), 60.66 (C(2)), 106.61 (C(9)), 109.52 (C(7)), 110.54 (C(5)), 
130.82 (C(6)), 140.95 (C(4)), 154.09 (C(3)), 158.35 (C(8)) ppm.  FAB-MS: 182.09 [M+H]+ 
 
5.10.4 Synthesis of ethyl 4-(bromomethyl)-2-oxo-2H-chromen-7-ylcarbamate (58) 
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Ethyl 3-hydroxyphenylcarbamate (12) (3.3 g,18.2 mmol, 1 equiv), ethyl 4-bromo-3-
oxobutanoate (3.8 g, 18.2 mmol, 1.0 equiv) in a rb flask was homogenized by carefully 
mixing after which the mixture was cooled to 0 °C and then pre-cooled sulfuric acid 70 % (5 
mL) at 0 °C was added portion-wise. The reaction mixture was stirred at 0 °C for 4 h and was 
allowed to slowly warm up to rt overnight. The reaction mixture was diluted with water (10 
mL) and extracted with EtOAc (4 times). The product 58 (5.2 g, 16.02 mmol) was obtained 
after drying under vacuum overnight with 88 % yield. 
TLC (silica gel, DCM:MeOH=40:1): Rf= 0.47, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
1.25 (t, 3H, -CH3 H1), 4.15 (q, 2H, -CH2- H2), 4.81 (s, 2H, -CH2-Br, H10),6.54 (s, 1H, Ar 
H8), 7.42 (m, 1H, Ar H6), 7.56 (s, 1H, Ar H13), 7.75 (m, 1H, Ar H5), 10.17 ((s, 1H, NH); 13C 
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NMR (300 MHz, DMSO-d6, 25 °C): δ=15.78 (C(1)), 28.56, 61.45 (C(2)), 105.56 (C(7)), 
112.66, 114.44 (C(5)), 115.50, 127.27 (C(6)), 143.87 (C(4)), 151.81 (C(3)), 153.99, 155.11, 
161.62 (C(8)) ppm. FAB-MS: 326.1, 328.1 [M+H]+ 
 
5.10.5 Synthesis of ethyl 2-(7-(ethoxycarbonylamino)-2-oxo-2H-chromen-4-
yl)acetate (14) 
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In a rb flask equipped with a stirrer was placed ethyl 3-hydroxyphenylcarbamate (12) (1.1 g, 
6.1 mmol, 1.0 equiv) and diethyl-1,3-acetone dicarboxylate (1.23 g, 6.1 mmol, 1.0 equiv) and 
the mixture was homogenized. Concentrated sulfuric acid (H2SO4) (3 drops) was added and 
the stirring was continued overnight. TLC shows no starting material. NMR reveals product in 
> 90 % yield. This was used in the next reaction without further purification. 
TLC (silica gel, DCM:MeOH=25:1): Rf= 0.38 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
1.25 (t, 3H, -CH3-H1), 1.27 (t, 3H, -CH3-H17),3.21 (s, 2H, -CH2-, H10), 4.14-4.17 (m, 4H-H2 
& H16), 6.54 (s, 1H, Ar H8), 7.42 (m, 1H, Ar H6), 7.56 (s, 1H, Ar H13), 7.75 (m, 1H, Ar 
H5), 10.17 ((s, 1H, NH); 13C NMR (300 MHz, DMSO-d6, 25 °C): δ =15.62, 15.78 (C(1)), 
35.56, 61.45 (C(2)), 61.65 (C(16)), 105.54 (C(7)), 112.65, 114.44 (C(5)), 115.50, 127.27 
(C(6)), 143.87 (C(4)), 151.81 (C(3)), 153.99(C(8)), 160.61 (C(9)), 170.61 (C(14)) ppm. FAB-
MS: 319.3, 320.3 [M+H]+ 
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5.10.6 Synthesis of 2-(7-amino-2-oxo-2H-chromen-4-yl)acetic acid (59) 
 
 
 
In a rb flask equipped with a stirrer was placed ethyl 2-(7-(ethoxycarbonylamino)-2-oxo-2H-
chromen-4-yl)acetate (14) (2.6 g, 8.1 mmol, 1.0 equiv) and aqueous sodium hydroxide (25 
mL, 4 M) and the mixture was refluxed overnight; approximately 16 h. After cooling to rt, the 
pH was adjusted to 2.0 by dropwise addition of concentrated H2SO4. The resultant yellow 
fluffy precipitate was collected by filtration and dried under vacuum. The filtrate was cooled 
to 4 °C overnight and the resulting precipitate was refiltered. The total yield after purification 
was 72 % (1.28 g, 5.83 mmol). This was used in the next reaction without further purification. 
TLC (silica gel, Hex:EtOAc=10:1): Rf = 0.12, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
3.20 (s, 2H, -CH2-COOH, H9), 6.50 (s, 1H, Ar H3), 7.52 (m, 1H, Ar H5), 7.25 (s, 1H, Ar H8), 
7.53 (m, 1H, Ar H6), 13C NMR (75 MHz, DMSO-d6, 25 °C): δ= 28.56, 105.56 (C(4)), 
101.66(C(8)), 114.44 (C(6)), 115.50, 128.27 (C(5)), 154.87 (C(7)), 153.99 (C(3)), 155.21, 
160.61 (C(2)),  172.01 (C(10)) ppm. FAB-MS: 242.2 [M+Na]+ 
 
5.10.7 Synthesis of 2-(7-azido-2-oxo-2H-chromen-4-yl)acetic acid (60) 
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In a rb flask equipped with a stirrer was placed 2-(7-amino-2-oxo-2H-chromen-4-yl)acetic 
acid 59 (650 mg, 2.97 mmol, 1.0 equiv), concentrated H2SO4 (20 mL), ice slurry (80 g), and 
the temperature was maintained at 0 °C. Sodium nitrite (NaNO2) (308 mg, 4.45 mmol, 1.5 
equiv) was added portion-wise as a solution in iced-water (20 mL). Stirring was continued for 
10 min after which sodium azide (1.2 g, 17.8 mmol, 6.0 equiv) was added in one-portion as a 
solution in icold water (20 mL). The reaction mixture was stirred overnight after which it was 
extracted with EtOAc (5x100 mL). The organic layer was washed with brine and then dried 
with anhydrous sodium sulfate. After filtration, the organic phase was concentrated under 
vacuum. The product 60 was pure enough and so was used in the next step without further 
purification. The part of the crude was purified by fCC and was used for analysis (yield was 
estimated as 86 % by proportion (625 mg, 2.55 mmol)).  
TLC (silica gel, Hex:EtOAc=10:1): Rf = 0.18, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
3.18 (s, 2H, -CH2-CO2H, H9), 6.51 (s, 1H, Ar H3), 7.42 (m, 1H, Ar H5), 7.55 (s, 1H, Ar H8), 
7.73 (m, 1H, Ar H6), 13C NMR (75 MHz, DMSO-d6, 25 °C): δ= 28.56, 105.56 (C(4)), 112.66, 
114.44 (C(6)), 115.50, 127.27 (C(5)), 143.87 (C(7)), 151.23, 154.00 (C(3)), 160.60 (C(2)),  
172.01 (C(10)) ppm. FAB-MS: 245.2 [M+H]+ 
 
5.10.8 Synthesis of 7-azido-4-(bromomethyl)-2H-chromen-2-one (61) 
 
 
 
In a rb flask equipped with a stirrer was placed 2-(7-azido-2-oxo-2H-chromen-4-yl)acetic 
acid (60) (350 mg, 1.43 mmol, 1.0 equiv) and AcOH (50 mL) and stirred for 10 min. Bromine 
(230 mg, 1.42 mmol, 1.0 equiv) was added as a solution in acetic acid (10 mL) and the 
reaction mixture was refluxed for 1 h, TLC reveals large amount of starting material. 
Additionally, Br2 (230 mg, 1.42 mmol, 1.0 equiv) was added and the refluxing was continued 
for further 1 h after which TCL shows still starting material. Br2 (230 mg, 1.42 mmol, 1.0 
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equiv) was then added again and the mixture refluxed overnight. The mixture was 
concentrated under reduced pressure and with the aid of a short fCC, the product was eluted 
with EtOAc. The total yield of the product formed 61 after purification was (330 mg, 1.18 
mmol) 83 %.  
TLC (silica gel, Hex:EtOAc=10:1): Rf = 0.28, 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
4.81 (s, 2H, -CH2-Br, H9),6.55 (s, 1H, Ar H3), 7.42 (m, 1H, Ar H5), 7.56 (s, 1H, Ar H8), 7.75 
(m, 1H, Ar H6), 13C NMR (75 MHz, DMSO-d6, 25 °C): δ= 28.56, 105.56 (C(4)), 112.66, 
114.44 (C(6)), 115.50, 127.27 (C(5)), 143.87 (C(7)), 153.99 (C(3)), 160.61 (C(2)) ppm. 
 FAB-MS: 278.1, 280.1 [M+H]+ 
 
5.10.9 Synthesis of 4-(bromomethyl)-7-hydroxy-2H-chromen-2-one (56) 
 
 
 
In an rb flask equipped with a stirrer, were added 7-acetyloxy-4-bromomethyl-coumarin (57) 
(1 g, 3.37 mmol, 1.0 equiv), and sodium perborate (403 mg, 4.04 mmol, 1.2 equiv). MeOH 
(17 mL) was added and stirred at rt. The reaction was monitored by TLC and was usually 
finished after 2.5 h. Filtration to remove sodium perborate, evaporation of solvent and then 
drying under vacuum to yield a yellow crystalline product 56 which was used for further 
reaction without any purification.  
TLC (silica gel, DCM:MeOH=25:1): Rf=0.37 FAB MS (3-NBA): [M+H]+ calculated 253.96, 
found 254.0; [M+H]+ calculated 254.97, found 255.0. 
 
 
 
 
 
 
5 Experimental Section  123 
 
5.10.10 Synthesis of N-(2,5-dioxopyrrolidin-1-yloxy)-5-((3aS,4S,6aR)-2-
oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide (28) 
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In a rb flask equipped with a stirrer was placed biotin(27) (5 g, 20.5 mmol, 3.0 equiv) and 
anhydrous DMF (20 mL) and N-hydroxysuccinimide ( 3.1 g, 26.6 mmol, 1.3 equiv) The 
mixture was stiired for 15 min after which dicyclohexylcarbodiimide (DCC) ( 5.5 g, 26.6 
mmol, 1.3 equiv) was added as a solution in DMF (20 mL). The mixture was stirred for 
additional 48 h after which TLC shows starting biotin. The mixture was stirred for further 14 
h after which it was filtered to remove the DCU. Water (120 mL) was added and the organic 
layer extracted with DCM /MeOH (9:1) (3 x 250 mL). The organic phase was dried with 
Na2SO4 and evaporated to dryness under vacuum. The crude precipitate was recrystallized 
using isopropanol 50 mL) to afford the final product in 92 % yield. 
TLC (silica gel, DCM:MeOH=40:1): Rf = 0.36 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
6.42, 6.36 (2 s, 2H, 2x NHCO), 4.31 (dd, 1H, H7), 4.29 (m, 1H, H9), 3.11 (m, 1H, H6), 2.85 
(dd, 1H, H10), 2.81 (s, 4H, 2x CH2 in NHS), 2.67 (t, 2H, 2x H2), 2.58 (d, 1H, H9'), 1.35-1.70 
(m, 6H, 2x H3, 2x H4, 2x H5); 13C-NMR (DMSO-d6): δ = 170.2 (2x (CO)NH in NHS), 168.8 
(C1), 162.6 (C8), 60.9 (C9), 59.1 (C7), 55.1 (C6), 39.8 (C10), 29.9 (C2), 27.7, 27.5, 25.4, 24.2 
(C3, C4, C5, 2x CH2 in NHS). FAB MS (3-NBA): [M+H]+ calculated 342.1, found 342.0. 
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5.10.11 Synthesis of 4-(2-(2-(2-aminoethoxy)ethoxy)ethylamino)-4-
oxobutanoic acid (26) 
 
65
64
H2N O
O
N
H
O
O
OH
Chemical Formula: C10H20N2O5
Molecular Weight: 248.28
1
2
3
45
67
89
10Succinic anhydride
THF, 60 °C, 3 h.
 
 
In a rb flask equipped with a stirrer was placed 2,2'-(ethane-1,2-diylbis(oxy))diethanamine 
(64) (27 g, 180 mmol, 3.0 equiv) and anhydrous THF (50 mL) and the mixture heated up to 
60 °C. Succinic anhydride (6.0 g, 60 mmol, 1.0 equiv) was added dropwise as a solution in 
THF (65 mL) using a dropping funnel over a period of 1 h. The mixture was then allowed to 
cool to rt whilst stirring and stirring was continued for additional 2 h after which it was cooled 
to 4 °C and maintained at this temperature overnight. The precipitate was filtered and dried 
under reduced pressure giving a sticky semi-solid. The total yield was quantitative (15 g, 60 
mmol). NMR reveals product in acceptable purity. This was used in the next reaction without 
further purification. 
TLC (silica gel, DCM:MeOH=40:1): Rf = 0.27 1H NMR (300 MHz, DMSO-d6, 25 °C):  δ = 
8.21 (t, 1H, NHCO), 3.60-3.49 (m, 6H, 2x H6, 2x H7, 2x H8), 3.40 (t, 2H, 2x H9), 3.18 (dd, 
2H, 2x H5), 2.87 (t, 2H, 2x H10), 2.25-2.23 (m, 4H, 2x H2, 2x H3); 13C-NMR (d6-DMSO): δ = 
176.1 (C1), 172.6 (C4), 69.7, 69.5, 69.2 (C6, C7, C8), 67.8 (C9), 38.8, 38.5 (C5, C10), 32.5, 32.1 
(C2, C3). FAB MS (3-NBA): [M+H]+ calculated 249.1, found 249.2. 
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5.10.12 Synthesis of N-(2-(2-(2-(4,4-dihydroxybutanamido )ethoxy)ethoxy) 
ethyl -5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-
yl)pentanamide (66) 
 
 
 
In a rb flask equipped with a stirrer was placed 4-(2-(2-(2-aminoethoxy)ethoxy)ethylamino)-
4-oxobutanoic acid (65) (2 g, 8.1 mmol, 1.1 equiv) as a solution in methanol (20 mL) and N-
(2,5-dioxopyrrolidin-1-yloxy)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-
4-yl)pentanamide 63 (2.5 g, 7.32 mmol, 1.0 equiv) in DCM (80 mL) as a suspension. The 
mixture was stirred until a clear solution was obtained. The reaction was usually finished after 
1 h as shown by TLC. Evaporation of the solvent under reduced pressure and the subsequent 
purification by fCC; (silica gel, (DCM, MeOH; 8:1 to 2:1)) gave the product 65(2.9 g, 6.1 
mmol) with a yield of 65 %. 
TLC (silica gel, DCM:MeOH=40:1): Rf=0.26 1H NMR (300 MHz, DMSO-d6, 25°C): δ = 
7.90, 7.83 (2 t, 2H, HA, HB), 6.42, 6.36 (2 s, 2H, HC, HD), 4.30 (dd, 1H, H17), 4.12 (m, 1H, 
H19), 3.50 (s, 4H, 2x H7, 2x H8), 3.39 (t, 4H, 2x H6, 2x H9), 3.18 (dd, 4H, 2x H5, 2x H10), 3.09 
(m, 1H, H16), 2.81 (dd, 1H, H20), 2.57 (d, 1H, H20'), 2.35 (m, 4H, 2x H2, 2x H3), 2.06 (t, 2H, 
2x H12), 1.70-1.20 (m, 6H, 2x H13, 2x H14, 2x H15); 13C-NMR δ = (d6-DMSO): 173.8 (C1), 
172.1 (C4), 171.0 (C11), 162.7 (C18), 69.5, 69.0 (C6, C7, C8, C9), 61.0 (C19), 59.1 (C17), 55.3 
(C16), 38.5, 38.4 (C5, C10, C20), 35.0 (C12), 29.9, 29.1, 28.1, 28.0, 25.2 (C2, C3, C13, C14, C15). 
MALDI-TOF MS (DHB): [M+H]+ calculated 475.2, found 475.4; [M+Na]+ calculated 497.2, 
found 497.4. 
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5.10.13 Synthesis of the compound (67) 
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Chemical Formula: C30H39BrN4O9S
Molecular Weight: 711.62
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In a rb flask equipped with a stirrer was placed (66) (960 mg, 2.02 mmol, 1.2 equiv) as a 
solution in DMF (15 mL), DCC (694 mg, 3.36 mmol, 2.0 equiv) and (HOBt) 454 mg, 3.36 
mmol, 2.0 equiv) and the solution stirred for 15 min under argon. 4-(bromomethyl)-7-
hydroxy-2H-chromen-2-one 56 (640 mg, 1.68 mmol, 1.0 equiv) was added as a solution in 
DMF (5 mL) and rinsed with additional DMF (5 mL). The mixture was stirred until a clear 
colorless solution was obtained. The reaction was usually finished after 48 h as shown by 
TLC. Evaporation of the solvent, and the subsequent purification by fCC; (silica gel, 
DCM/MeOH 5:1, 1:1).The yield for this reaction was 29 %. 
TLC (silica gel, DCM:MeOH=40:1): Rf = 0.21 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
7.90 (m, 1H-H5B), 7.83 (2 t, 2H, HA, HB),7.48 (m, 2H-H6B & H8B), 6.52 (s, 1H,-H3B), 6.42, 
6.36 (2 s, 2H, HC, HD), 4.62 (s, 2H,-CH2Br), 4.30 (dd, 1H, H17), 4.12 (m, 1H, H19), 3.50 (s, 
4H, 2x H7, 2x H8), 3.39 (t, 4H, 2x H6, 2x H9), 3.18 (dd, 4H, 2x H5, 2x H10), 3.09 (m, 1H, H16), 
2.81 (dd, 1H, H20), 2.57 (d, 1H, H20'), 2.35 (m, 4H, 2x H2, 2x H3), 2.06 (t, 2H, 2x H12), 1.70-
1.20 (m, 6H, 2x H13, 2x H14, 2x H15); 13C-NMR δ = (d6-DMSO): 173.8 (C1), 172.1 (C4), 171.0 
(C11), 163.6 (C2B), 162.7 (C18), 154.7, 117.8, 117.2 (C3B), 69.5, 69.0 (C6, C7, C8, C9), 61.0 
(C19), 59.1 (C17), 55.3 (C16), 42.16 (C-CH2Br), 38.5, 38.4 (C5, C10, C20), 35.0 (C12), 29.9, 29.1, 
28.1, 28.0, 25.2 (C2, C3, C13, C14, C15). ES-MS: [M+H]+ calculated 712.0, found 712.4; 
[M+H]+  
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5.11 Chemical Syntheses of Xanthene and Related Derivatives 
 
5.11.1 Synthesis of 3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl 
dimethanesulfonate (68) 
 
 
 
In a 2-neck-rb flask equipped with a stirrer and fluorescein (17) (2 g, 6.0 mmol, 1.0 equiv) 
dried overnight under reduced pressure was added pyr (40 mL) at rt. The mixture was then 
stirred for 30 min until the fluorescein was completely dissolved. Methanesulfonyl chloride 
(4.14 g, 2.80 mL, 6.0 equiv) was then slowly added as a solution in pyr during 1 h whilst the 
mixture was being stirred with cooling using ice. The reaction was monitored by TLC and 
was usually finished after 2 h. Purification of the product 68 involves removal of pyr under 
reduced pressure and then recrystallizing using DCM containing 2 %MeOH. The yield of the 
reaction was 80 %. 
TLC (silica gel, DCM:MeOH=80:1): Rf = 0.35; 1H NMR (300 MHz, CD3OD-d4, 25 °C): δ = 
3.47 (s, 6H, 2xCH3, Ms-C8' & C9'), 6.99 (d, J=9.6 Hz, 2H, C(1) & C(8)), 7.15 (dd, J=2.7, 9.6 
Hz, 2H, C(2) & C(7)), 7.40 (dt, J=8.0, 1.3 Hz, 1H–C(6')), 7.50 (d, J=2.7 Hz, 2H, C(4) & 
C(5)), 7.62 (td, J=8.0, 1.3 Hz, 1H, C(4')), 7.82 (td, J=8.0, 1.3 Hz, 1H1, C(5')), 8.07 (dt, J=8.0, 
1.3 Hz, 1H, C(3')) ppm, 13C NMR (75 MHz, CDCl3, 25 °C): δ = 38.32 (Ms- C8' & C9'), 81.08 
(1-CH0 bridge), 111.64 C(4')) and (C(5')), 118.38 (C(3')), 119.61 (C(2')), 124.84 (C(4')), 
125.86 (C(1')), 126.40 (C(4')), 130.60 (C(1')), 131.42 (C(8)), 136.81 (C(8)), 142.36 (C(8)), 
146.15 (C(8)), 150.92 (C(8)), 151.48 (C(1')), 168.98 (C(7')) ppm. MALDI-TOF-MS: 489.23 
[M+H]+. 
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5.11.2 Synthesis of 3'-hydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6'-yl 
methanesulfonate (69) 
 
69
17
pyr, rt, 2 h.
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Chemical Formula: C21H14O7S
Molecular Weight: 410,40
MeSO2Cl
7' 8'
9' 10'
 
 
In a 2-neck-rb flask (250 mL) equipped with a stirrer and fluorescein 17 (1 g, 3.0 mmol, 1.0 
equiv) dried overnight under reduced pressure was added pyr (20 mL) at rt. The mixture was 
then stirred for 10 min until the fluorescein was completely dissolved and cooled to 0 °C. 
Methanesulfonyl chloride (676 mg, 0.46 mL, 0.98 equiv) was then slowly added as a solution 
in pyr during 1 h whilst the mixture is being stirred maintaining 0 °C. The reaction mixture 
was stirred for further 30 min after which it was allowed to warm to rt. The reaction was 
monitored by TLC and was usually finished after 1 h. The removal of pyr was achieved under 
reduced pressure and the crude recrystallized using DCM containing 2 % MeOH to obtain the 
product 69 in 80 % yield. 
TLC (silica gel, DCM:MeOH=80:1): Rf = 0.25; 1H NMR (300 MHz, CD3OD-d4, 25 °C): δ = 
3.17 (s, 3H, CH3, Ms), 6.58 (dd, J=2.7, 9.6 Hz, 1H–C(2), 6.78 (m, 1H-C(4)), 6.74 (d, J=2.7 
Hz, 1H–C(5)), 6.80 (d, J=9.6 Hz, 1H–C(8)), 6.92(dd, J=2.7, 9.6 Hz, 1H–C(7)), 7.14 (m, 1H-
C(6')), 7.20 (d, J=9.6 Hz, 1H–C(1)),7.32(m, 1H-C(1')), 7.61 (m, 1H-C(4')), 7.67 (m, 1H-
C(5')), 8.00 (m, 1H-C(3')), 8.60 (s, br, 1H-OH) ppm, 13C NMR (75 MHz, CDCl3, 25 °C): δ = 
38.32 (SO2CH3), 81.08 (1-CH0 bridge), 111.64 C(4)) and (C(5)), 118.38 (C(9')), 119.61 
(C(10')), 124.84 (C(2)), 125.86 (C(7)), 126.40 (C(6')), 130.60 (C(4')), 131.42 (C(3')), 
136.81(C(2')), 142.36(C(1)), 146.15(C(8)), 150.92 (C(5)), 151.48 (C(6)), 152.71 (C(1')), 
156.32 (C(7')), 156.36 (C(8')),168.98 (C(3)), 172.45 (CO'))  ppm. MALDI-TOF-MS: 411.23 
[M+H]+. 
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5.11.3 Synthesis of 3'-hydroxy-6'-(piperidin-1-yl)-3H-spiro[isobenzofuran-1,9'-
xanthen]-3-one (70) 
 
 
 
In a 2-neck-rb flask (100 mL) equipped with a stirrer and fluorescein (17) (0.5 g, 1.50 mmol) 
dried overnight under reduced pressure was added pyr (10 mL) at rt. The mixture was then 
stirred for 10 min until the fluorescein was completely dissolved and cooled to 0 °C. 
Methanesulfonyl chloride (338 mg, 0.23 mL, 0.98 equiv) was then added as a solution in pyr 
during 1 h whilst the mixture was being stirred maintaining 0 °C. The reaction mixture was 
stirred for further 30 min after which it was allowed to warm to rt. The reaction was 
monitored by TLC and was usually finished after 1 h. To the above solution was added 
piperidine in excess (10 equiv) in one portion during cooling with ice and the stirring was 
continued for further 1h. The reaction mixture was evaporated after TLC showed no 
intermediate mesylated. The crude product was purified by fCC on silica gel with a gradient 
eluent system of DCM)/MeOH, 9:1, 5:1, 1:1. The produc 70 was obtained with a yield of 60 
%. 
TLC (silica gel, DCM:MeOH =10:1): Rf = 0.20; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 1.23 
(m, 4H-H8'), 1.55 (m, 2H-H9'), 3.27 (m, 4H-H7'), 5.30 (br, 1H-OH), 6.42-6.56 (m, 4H-H2, 
H4, H5, & H7), 6.62 (m, 2H-H1 & H8), 7.24 (m, H-H6'), 7.65-7.72 (m 2H-H4' & H5'), 7.98 
(m, 1H-H3') ppm. MALDI-TOF-MS: 400.59 [M+H]+. 
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5.11.4 Synthesis of 3'-(dimethylamino)-6'-hydroxy-3H-spiro[isobenzofuran-1,9'-
xanthen]-3-one (71) 
 
 
 
In a 2-neck-rb flask (100 mL) equipped with a stirrer and fluorescein (17) (0.025 g, 0.075.0 
mmol, 1 equiv) dried overnight under reduced pressure was added pyr (10 mL) at rt. The 
mixture was then stirred for 10 min until the fluorescein was completely dissolved and cooled 
to 0 °C. Methanesulfonyl chloride (17 mg, 0.012 mL, 0.98 equiv) was then added as a 
solution in pyr during 1 h whilst the mixture is being stirred maintaining 0 °C. The reaction 
mixture was stirred for further 30 min after which it was allowed to warm to rt. The reaction 
was monitored by TLC and was usually finished after 1 h. To above solution was added 
dimethylamine (as a solution in ethanol) in excess (10 equiv) in one portion during cooling 
with ice and allowed to warm to rt. The stirring was continued for 2days. The reaction 
mixture was evaporated after TLC showed no intermediate mesylated product.The product 71 
of this reaction purified by recrystalisation using DCM/MeOH with a yield of 50 %. 
TLC (silica gel, DCM: MeOH =10:1): Rf = 0.18; 1H NMR (300 MHz, CDCl3, 25 °C): δ = 3.42 
(s, 6H, -N(CH3)2), 5.30 (br, 1H-OH), 6.42-6.56 (m, 4H-H2, H4, H5, & H7), 6.62 (m, 2H-H1 
& H8), 7.24 (m, H-H6'), 7.65-7.72 (m 2H-H4' & H5'), 7.98 (m, 1H-H3') ppm. MALDI-TOF-
MS: 360.4 [M+H]+. 
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5.11.5 Synthesis of 3'-(2-(2-(2-aminoethoxy)ethoxy)ethylamino)-6'-hydroxy-3H-
spiro[isobenzofuran-1,9'-xanthen]-3-one (72) 
 
72
17
pyr, rt, 1.5 h.
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Chemical Formula: C26H26N2O6
Molecular Weight: 462.49
2. jeff.-148
 
 
To a stirring mixture of fluorescein (17) (0.025 g, 0.075.0 mmol) and pyr was added 
methanesulfonyl chloride (17 mg, 0.011 mL, 0.98 equiv) and the reaction mixture stirred at rt 
for 1.5 h. The unreacted methanesulfonyl chloride was evaporated after which Jeffamine-148 
(11.1 mg, 1.5 equiv) was then added in one portion during cooling with ice and the stirring 
continued for further 1h. The reaction mixture was evaporated after TLC showed no 
intermediate mesylated product. Flash column chromatography purification was achieved 
with (DCM/MeOH) (9:1, 5:1, 1:1, MeOH). The yield of the product 72 (after over week-end 
drying) was 50 %. 
TLC (silica gel, DCM: MeOH =2:1): Rf = 0.21; 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.67 (m, 4H), 3.37 (t, 4H), 3.57 (m, 4H), 5.75 (s, 1H-NH2), 6.40 (dd, J = 4.7 and 7.8 Hz, 2H-
H5 & H7,) 6.46 (d, J = 4.7 Hz, 1H), 6.58 (d, J = 7.8 Hz, 2H-H1 & H7), 7.20 (m, 1H-H6'), 
7.61-7.64 (m, 2H-H4' & H5'), 7.97 (m, 1H-H3') ppm. 13C NMR (75 MHz, DMSO-d6, 25 °C): 
δ =42.43 (C(15), 47.64 C(10)), 72.52 (C(11) 72.58 C(12)), 73.32 C(13)), 74.08 (C(14)), 81.09 
(1-CH0 bridge), 113.65 (C(7) 119.48, 120.62 (C(2)), 124.86 (C(6')), 125.80 (C(3')), 126.41 
(C(4')), 130.60 (C(2')), 131.44 (C(8)), 136.82 (C(1)), 142.33 (C(5')), 146.16 (C(6)), 150.94, 
151.49 (C(1')), 152.71 (C3)), 171.98 (C(CO.)) ppm. MALDI-TOF-MS: [M+H]+. 463.0, 
[M+Na]+ 485.0 
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5.11.6 Synthesis of 3',6'-di(piperidin-1-yl)-3H-spiro[isobenzofuran-1,9'-xanthen]-3-
one (73) 
 
73
17
pyr, rt, 1.5 h.
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In a 2-neck-rb flask (100 mL) equipped with a stirrer and fluorescein (17) (0.5 g, 1.5.0 mmol, 
1.0 equiv) dried overnight under reduced pressure was added pyr (10 mL) at rt. The mixture 
was then stirred for 10 min until the fluorescein was completely dissolved and cooled to 0 °C. 
methanesulfonyl chloride (1.4 g, 0.94 mL, 4.0 equiv) was then added as a solution in pyr 
during 1 h whilst the mixture is being stirred maintaining the reation at 0 °C. The reaction 
mixture was stirred for further 30 min after which it was allowed to warm to rt. The reaction 
was monitored by TLC and was usually finished after 2 h. To the above solution was added 
piperidine in excess (10.0 equiv) in one portion during cooling with ice and the stirring 
continued for further 1h. The reaction mixture was evaporated after TLC shows no 
intermediate mesylated product. Purification by fCC on silica gel with a gradient eluent 
system of DCM:MeOH (9:1, 5:1, 1:1). The product 73 was obtained with a yield of 60 %.  
TLC (silica gel, DCM: MeOH =10:1): Rf=0.24; 1H NMR (300MHz, CD3OD-d4, 25 °C): 
δ=1.28 (m, 2x4H-H11 & H14), 1.42 (m, 2x2H-H12 & H15), 3.37 (m, 2x4-2H-CH2-H10 & 
H13), 6.72 (d, J=9.6 Hz, 2xH– C(1) & C(8)), 6.55 (dd, J=2.7, 9.6 Hz, 2xH–C(2) & C(7)), 7.40 
(dt, J=8.0, 1.3 Hz, 1H–C(6')), 6.58 (d, J=2.7 Hz, 2xH– C(4) & C(5)), 7.61 (td, J=8.0, 1.3 Hz, 
1H–C(4')), 7.72 (td, J=8.0, 1.3 Hz, H1–C(5')), 8.02 (dt, J=7.8, 1.3 Hz, H1–C(3')) ppm, 13C 
NMR (75MHz, CDCl3, 25°C): δ =25.04 (C(12) &C(15)), 26.24 (C(11) &C(14)), 58.32 (C(10) 
&C(13)), 82.08 (1-CH0 bridge), 112.64 (C(4')), 113.64 (C(5')), 118.48 (C(3')), 119.62 (C(2')), 
124.84 (C(4')), 125.86 (C(1')), 126.40 (C(4')), 130.60 (C(1')), 131.42 (C(8)), 136.81 (C(8)), 
142.36 (C(8)), 146.15 (C(8)), 150.92 (C(8)), 151.48 (C(1')), 152.71 (C(1')), 168.98 (C(7')) 
ppm. MALDI-TOF-MS: calc. 466.56, found 467.5 [M+H]+. 
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5.11.7 Synthesis of 3',6'-bis(dimethylamino)-3H-spiro[isobenzofuran-1,9'-xanthen]-
3-one (74) 
 
 
 
To a stirring mixture of fluorescein (17) and was added methanesulfonyl chloride (4.0 equiv) 
and the reaction mixture was stirred at rt for 1.5 h. The excess methane sulfonyl chloride was 
then removed by evaporation under reduced pressure The reaction mixture was then cooled to 
0 °C during which excess dimethylamine in methanol was then added in one portion and 
stirring was continued for further 2 h. The reaction mixture was evaporated after TLC showed 
no intermediate mesylated product. The product 74 was purified by fCC on silica gel with a 
gradient eluent system of DCM:MeOH (9:1, 5:1, 1:2) with a yield of 40 %.  
TLC (silica gel, DCM: MeOH =10:1): Rf = 0.22; 1H NMR (300 MHz, CD3OD-d4, 25 °C): δ = 
3.32 (s, 12H, 4xCH3, -NMe2), 6.99 (d, J=9.6 Hz, 2xH– C(1) & C(8)), 7.14 (dd, J=2.7, 9.6 Hz, 
2xH–C(2) & C(7)), 7.41 (dt, J=8.0, 1.3 Hz, H–C(6')), 7.50 (d, J=2.7 Hz, 2xH– C(4) & C(5)), 
7.76-7.82 (m, 2xH–C(4')), 7.72 (td, J=8.0, 1.3 Hz, H–C(5')), 8.05-8.09 (m, H–C(3')) ppm. 13C 
NMR (75 MHz, CDCl3, 25 °C): δ = 25.04 (C(12) &C(15)), 26.24 (C(11) &C(14)), 58.32 
(C(10) &C(13)), 82.08 (1-CH0 bridge), 112.64 (C(4')), 113.64 (C(5')), 118.48 (C(3')), 119.62 
(C(2')), 124.84 (C(4')), 125.86 (C(1')), 126.40 (C(4')), 130.60 (C(1')), 131.42 (C(8)), 136.81 
(C(8)), 142.36 (C(8)), 146.15 (C(8)), 150.92 (C(8)), 151.48 (C(1')), 152.71 (C(1')), 168.98 
(C(7')) ppm. MALDI-TOF-MS: 387.5 [M+H]+. 
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5.11.8 Synthesis of 3',6'-bis(2-(2-(2-aminoethoxy)ethoxy)ethylamino)-3H-
spiro[isobenzofuran-1,9'-xanthen]-3-one (75) 
 
 
To a stirring mixture of fluorescein (17) and pyr was added methanesulfonyl chloride (4.0 
equiv) and the reaction mixture stirred at rt for 1.5 h. The unreacted methanesulfonyl chloride 
was evaporated after which jeffamine-148 (6.0 equiv) was added in one portion during 
cooling with ice and the stirring continued for further 1 h. TLC showed no complete 
conversion and so reaction was stirred overnight during which a slight green solution was 
formed. The reaction mixture was evaporated after TLC showed no intermediate mesylated 
product. Prep. TLC purification by fCC on silica gel with a gradient eluent system of 
DCM:MeOH (DCM, 9:1, 5:1, 1:1, MeOH). Product formation confirmed by MS and NMR 
but very unstable. 
TLC (silica gel, DCM: MeOH =2:1): Rf= 0.14; 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.65 (t, 4x2H-H10 & H15), 3.35 (t, 4x2H-H11 & H14), 3.46 (s, 4x2H-H12 & H13), 6.28 (m, 
2H), 6.32 (m, 2H), 6.58-6.60 (m, 2H), 7.13 (m, 1H), 7.54-7.58 (m, 2H), 7.94-7.98 (m, 2H) 
ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ =25.04 (C(12) &C(15)), 26.24 (C(11) &C(14)), 
58.32 (C(10) &C(13)), 82.08 (1-CH0 bridge), 112.64 (C(4')), 113.64 (C(5')), 118.48 (C(3')), 
119.62 (C(2')), 124.84 (C(4')), 125.86 ppm. MALDI-TOF-MS: calc. 593.7, found 593.6 
[M+H]+. 
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5.11.9 Synthesis of 2-(3'-(2-(2-(2-aminoethoxy)ethoxy)ethylamino)-3-oxo-3H-
spiro[isobenzofuran-1,9'-xanthene]-6'-ylamino)acetic acid (76) 
 
 
 
To a stirring solution of dried fluorescein (17) in pyr was added methanesulfonyl chloride (3.0 
equiv) and the reaction mixture was stirred until no colour could be detected by the unaided 
eye (TLC confirmed this). The excess methanesulfonyl chloride was evaporated together with 
the pyr. Glycine 1.0 equivalent was added and the reaction mixture was diluted with ethanol 
to ensure complete dissolution of the glycine. The reaction mixture was stirred overnight. A 
slight purple coloration results after which 2.5 equivalent jeffamine was added and reaction 
stirred for further for 2 h. TLC showed complete consumption of starting material. Work up 
involves evaporation of pyr and ethanol and purified by fCC on silica gel with a gradient 
eluent system of 
DCM/MeOH (100 % DCM, 100% MeOH). Product formation confirmed by mass 
Spectrometry, (but mainly di-jeffamine by comparing tlc). 
TLC (silica gel, DCM: MeOH =1:1): Rf = 0.18; 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.72 (m, 4H-H10 & H15), 3.40 (m, 4H-H11 & H14), 3.46 (s, 4H-H12 & H13), 5.44 (br, 2H-
NH2), 6.32-6.39 (m, 2H-H4 & H5), 6.42 (m, 2H-H2 & H8), 6.62 (m, 2H-H1 & H8) ppm. 13C 
NMR (75 MHz, CDCl3, 25 °C): δ =25.04 (C(12) &C(15)), 26.24 (C(11) &C(14)), 58.32 
(C(10) &C(13)), 82.08 (1-CH0 bridge), 112.64 (C(4')), 113.64 (C(5')), 118.48 (C(3')), 119.62 
(C(2')), 124.84 (C(4')), 125.86 ppm. MALDI-TOF-MS: calc. 520.6, found 520.5 [M+H]+. 
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5.11.10 Synthesis of (4S,7R,13R)-15-amino-7-(4-aminobutyl)-4-
(carboxymethyl)-1-(3'-(methylsulfonyloxy)-3-oxo-3H-
spiro[isobenzofuran-1,9'-xanthene]-6'-ylamino)-2,5,8,11,15-pentaoxo-
3,6,9,12-tetraazapentadecane-13-carboxylic acid (78) 
 
 
 
The penta-peptide 77 was synthesized according to standard SPPS (novabiochem 2008/9) on 
a Rink AM resin. After cleavage of the final fmoc from the amino functionality, 68 was added 
as a solid to which pyr was then aspirated and shaken overnight. The purplish-orange beads 
were then washed several times after which they were swirled with DCM and then dried 
under vacuum overnight. To the dried resin was added 95% TFA in DCM and filtered 3 times 
within 1 h. The combined filtrate was cooled and dried overnight by freeze drying. MS 
confirms product 78, estimated yield was 20 %.  
TLC (silica gel, DCM: MeOH =1:1): Rf=0.11; 1H NMR (300 MHz, DMSO-d6, 25 °C): 
MALDI-TOF-MS: calc. 881.9, found 882.8 [M+H]+. 
 
 
 
 
 
 
 
 
 
 
5 Experimental Section  137 
 
5.11.11 Synthesis of (2S)-4-amino-2-(2-((2S)-6-amino-2-(3'-
(methylsulfonyloxy)-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6'-
ylamino)hexanamido)acetamido)-4-oxobutanoic acid (80) 
 
 
 
The tripeptide 79 was synthesized according to standard SPPS (novabiochem 2008/9) on a 
Rink AM resin. After cleavage of the final fmoc, (68) was added as a solid to which pyr was 
then aspirated and shaken overnight. The purplish-orange beads was then washed several 
times after which was swirled with DCM and then dried under vacuum overnight. To the 
dried resin was added 95% TFA in DCM and filtered 3 times within 1 h. The combined 
filtrate was cooled and dried overnight by freeze drying. MS and NMR confirms product 80. 
TLC (silica gel, DCM:MeOH=40:1): Rf = 0.47 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
1.42 (s, 18H), 4.20 (s, 4H), 4.37 (q, J = 9.3 Hz, 1H), 4.50 (dt, J = 9.8 and 5.6 Hz, 1H), 4.72-
4.76 (m, 1H), 5.05 (t, J = 4.7 H. MALDI-TOF-MS: calc. 709.7, found 710.8 [M+H]+. 
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5.11.12 Synthesis of 3'-(2-(2-(2-amino-2-oxoethylamino)-2-oxoethylamino)-2-
oxoethylamino)-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6'-yl 
methanesulfonate (81) 
 
 
The tripeptide 81 was synthesized according to standard SPPS (novabiochem 2008/9) on a 
Rink AM resin. After cleavage of the final fmoc, 68 was added as a solid to which pyr was 
then aspirated and shaken overnight. The purplish beads were then washed several times after 
which they were swirled with DCM and then dried under vacuum overnight. To the dried 
resin was added 95% TFA in DCM and filtered 4 times within 1 h. Thecombined filtrate was 
cooled and dried overnight by freeze drying. MS confirms product 82. MALDI-TOF-MS: 
581.6 [M+H]+. 
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5.11.13 Synthesis of (3S)-4-((R)-2-(2-amino-2-oxoethylcarbamoyl)pyrrolidin-1-
yl)-3-(3'-(methylsulfonyloxy)-3-oxo-3H-spiro[isobenzofuran-1,9'-
xanthene]-6'-ylamino)-4-oxobutanoic acid (84) 
 
 
 
The tri-peptide (83) was synthesized as described previously. After cleavage of the final fmoc 
from the amino functionality, 68 was added as a solid to which pyr was then aspirated and 
shaken overnight. The purplish beads were then washed several times after which it was 
swirled with DCM, filtered and then dried under vacuum overnight. To the dried resin was 
added 95% TFA in DCM and filtered 4 times within 1 h. The combined filtrate was cooled 
and dried overnight by freeze drying. The crude was then purified by HPLC. The product 84 
is confirmed by MS and NMR  
TLC (silica gel, DCM:MeOH=2:1): Rf = 0.14 1H NMR (300 MHz, DMSO-d6, 25 °C): δ = 
2.22 (m, 4H-H5, H5', H6 & H6'), 3.02 (m, 2H-H12 & H12'), 3.14 (m, 2H-H7 & H7'), .3.89 
(m, 2H-H10 & H4 ), 4.12 (m, 2H-H1 & H1'), 6.58 (m, H1–C(2)-Ar), 6.78 (m, 1H-C(4)-Ar), 
6.74 (m, H1–C(5)-Ar), 6.80 (m, H1–C(8)-Ar), 6.92(m, H1–C(7)-Ar), 7.14 (m, 1H-C(6')-Ar), 
7.20 (d, H1– C(1)-Ar),7.32(m, 1H-C(1')-Ar), 7.61 (m, 1H-C(4')-Ar), 7.67 (m, 1H-C(5')-Ar), 
8.00 (m, 1H-C(3')-Ar) ppm. MALDI-TOF-MS: 701.6 [M+Na]+ 
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5.12 Synthesis of RNA Oligomers 
 
Step Function Mode Amount Time Description 
Deblocking 144/*Index Fract. Coll. 
0/*Default 
38/*Diverted Wsh A 
141/*Trityl Mon. On/Off 
16/*Dblk 
0/*Default 
16/*Dblk 
38/*Diverted Wsh A 
141/*Trityl Mon. On/Off 
38/*Diverted Wsh A 
144/*Index Fract. Coll 
NA 
WAIT 
PULSE 
NA 
PULSE 
WAIT 
PULSE 
PULSE 
NA 
PULSE 
NA 
1 
0 
15 
1 
20 
0 
40 
60 
0 
20 
2 
0 
15 
0 
1 
0 
20 
40 
0 
1 
0 
0 
‘Event out ON’ 
‘Wait’ 
‘Flush system with Wsh A’ 
‘START data collection’ 
‘Dblk to column’ 
‘Default’ 
‘Deblock’ 
‘Flush system with Wsh A’ 
‘STOP data collection’ 
‘Flush system with Wsh A’ 
‘Event out OFF’ 
Coupling 1/*Wsh 
2/*Act 
18/*A+Act 
18/*A+Act 
2/*Act 
18/*A+Act 
2/*Act 
0/*Default 
1/*Wsh 
1/*Wsh 
PULSE 
PULSE  
PULSE 
PULSE  
PULSE 
PULSE  
PULSE 
WAIT 
PULSE 
PULSE  
1 
0 
15 
1 
20 
0 
40 
60 
0 
20 
0 
15 
0 
1 
0 
20 
40 
0 
1 
0 
‘Flush system with Wsh A’ 
‘Flush system with Act’ 
‘Monomer + Act to Column’ 
‘Couple monomer’ 
‘Couple monomer’ 
‘Couple monomer’ 
‘Deblock’ 
‘Flush system with Wsh A’ 
‘STOP data collection’ 
‘Flush system with Wsh A’ 
Capping 12/*Act 
13/*Caps 
12/*Wsh 
12/*Wsh 
PULSE 
PULSE  
PULSE 
PULSE  
20 
0 
40 
60 
20 
0 
40 
60 
‘Event out ON’ 
‘Wait’ 
‘Flush system with Wsh A’ 
‘START data collection’ 
Oxidizing 15/*Act 
0/*Default 
12/*Wsh A 
PULSE 
WAIT  
PULSE 
20 
0 
40 
20 
0 
40 
‘Event out ON’ 
‘Wait’ 
‘Flush system with Wsh A’ 
Capping 13/* Caps 
12/* Wsh A 
PULSE 
PULSE 
  ‘Event out ON’ 
‘Wait’ 
[a] Deblocking reagent = dblk, acetonitrile = Wsh, and WshA, argon = Gas B, activator = act, capping reagents 
= Caps, oxidizer = Ox, [b] ! PULSE = 16 μL. 
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5.12.1 Synthesized RNA Oligomers 
 
Table 7 The RNA oligomeric units were synthesized using the 1 μmol synthetic protocol 
Sequence 
no. 
Sequencse (5’-3’) Av. coupling 
yield % 
Mass Meas. 
(MALDI) 
MH278 GAACUΨCAGGGUCAGCUUGCCG 42 7034.3 
MH279 GAACUΨCAGGGΨCAGCUUGCCG 38 7034.4 
MH280 GAACUΨCAGGGΨCAGCUΨGCCG 37 7034.4 
MH281 GAACUUCAGGGUCAGCUTGCCG 40 7048.5 
MH282 GAACUUCAGGGTCAGCUTGCCG 36 7071.2 
MH283 GAACUTCAGGGTCAGCUTGCCG 38 7072.4 
MH284 GAACUUCAGGGUCAGCUUm1GCCG 32 7047.7 
MH285 GAACUUCAGGm1GUCAGCUUm1GCCG 30 7061.3 
MH286 m1GAACUUCAGGm1GUCAGCUUm1GCCG 26 7075.4 
MH287 GAACUUCAGGGUCAGCUUm2GCCG 29 7047.2 
MH288 GAACUUCAGGm2GUCAGCUUm2GCCG 29 7061.3 
MH290 m2GAACUUCAGGm2GUCAGCUUm2GCCG 28 7075.2 
MH291 GAACUUCAGGGUCAGCUUm22GCCG 24 7061.2 
MH292 GAACUUCAGGm22GUCAGCUUm22GCCG 20 7089.3 
MH293 m22GAACUUCAGGm22GUCAGCUUm22GCCG 19 7117.1 
MH294 GCAAGCUGACCCUGAAGUUCAU 35 7002.3 
MH295 GCAAGCΨGACCCUGAAGUUCAU 32 7002.4 
MH296 GCAAGCUGACCCUGAAGUΨCAU 34 7003.3 
MH297 GCAAGCUGACCCΨGAAGUUCAU 34 7004.0 
MH298 GCAAGCUGACCCUGAAGΨΨCAU 24 7002.3 
MH299 GCAAGCΨGACCCΨGAAGUΨCAU 22 7002.4 
MH300 GAACUUCAGGGUCAGCUUGCCG 37 7034.3 
MH343 GAACUUCAGGGUCAGCUUm1GCCG 32 7049.1 
MH344 GAACUUCAGGGUCAm1GCUUm1GCCG 30 7063.2 
MH259 GAAAAAGUCAUGGAGGUCAUGGGGUUG 26 8817.5 
MH260 GAAAAAGUCAUGGAGGUCAUGGGGΨUG 22 8831.2 
MH261 GCUUGAAACCAGCUUUGGG 36 6078.7 
MH262 GGGUUCGAUUCCUUCAUUUUUUGCCA 38 8157.9 
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MH263 GGGTUCGAUUCCUUCAUUUUUUGCCA 34 8171.4 
MH264 CAGAGGUUCAAUUCCUCUUCUUAACACCA 30 9110.7 
MH265 CAGAGGUUCAATUCCUCUUCUUAACACCA 23 9125.2 
MH266 AAACUUAAAACUUUACUGU 41 5976.7 
MH267 AAACUUAAAACΨUUACUGU 24 5976.8 
MH268 CCCGGUAAUCGCAUA 34 4736.0 
MH269 CCCGGUAAUCGCAΨA 35 4737.1 
MH270 GUUAAGAUGGCAGAG 33 4880.06 
MH271 GUUAAGAUm1GGCAGAG 29 4895.7 
MH272 AGAAAUAUGUCUGAUAAA 32 5773.8 
MH273 AGAAAUAUm1GUCUGAUAAA 32 8000.3 
MH274 AGAGUUACUUUGAUAGAGUAAA 35 7076.4 
MH275 AGAm22GΨΨACUUUGAUAGAGUAAA 17 8015.2 
MH276 UAAUAGGAGCUUAAACCCCCUUAUUUCU
ACCA 
23 10075.2 
MH277 GGUACCCAAAAU 33 3803.4 
 
Synthesized Oligomers Code Mass 
Calc. 
Mass Meas. 
(MALDI) 
r(GAACUψCAGGGUCAGCUUGCCG) MH278 7034.29 7034.3 
r(GAACUψCAGGGψCAGCUUGCCG) MH279 7034.29 7034.4 
r(GAACUψCAGGGψCAGCUψGCCG) MH280 7034.29 7034.4 
r(GAACUUCAGGGUCAGCUTGCCG) MH281 7048.29 7048.5 
r(GAACUUCAGGGTCAGCUTGCCG) MH282 7062.29 7071.2 
r(GAACUTCAGGGTCAGCUTGCCG) MH283 7076.29 7077.4 
r(GAACUUCAGGGUCAGCUUm1GCCG) MH284 7048.29 7048.4 
r(GAACUUCAGGm1GUCAGCUUm1GCCG) MH285 7062.29 7063.3 
r(m1GAACUUCAGGm1GUCAGCUUm1GCCG) MH286 7076.29 7080.1 
r(GAACUUCAGGGUCAGCUUm2GCCG) MH287 7048.29 7049.0 
r(GAACUUCAGGm2GUCAGCUUm2GCCG) MH288 7062.29 7063.3 
r(m2GAACUUCAGGm2GUCAGCUUm2GCCG) MH290 7076.29 7078.2 
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5.12.2 Preparation of RNA Sequences  
 
Typical synthesis of oligomers by SPOS using the following as an example: RNA-sequence 
r(GAACUψCAGGGUCAGCUUGCCG) MH278, 
 
The sequence was assembled from 34 mg of solid support (loading 30 μmol/g) on an 
Expedite 8909 synthesizer using the standard conditions for the assembly of 2′-O-TOM-
protected ribonucleoside phosphoramidites, employing a combination of 2′-O-TOM and 
TBDMS protected phosphoramidite building block.. After the final coupling, the solid support 
was washed with (iPr)2NH/MeCN 1:9 for 20 min (flow-rate 2.5 mL/min). Cleavage from the 
solid support and deprotection was carried out with 12 M NH3 in MeOH (1 mL) for 14 h at 20 
°C. The supernatant was removed by centrifugation and evaporated to dryness; the residue 
was treated with a THF soln. (1 mL) of Bu4NF.3H2O (1 M) for 14 h at 20 °C, diluted with aq. 
Tris.HCl buffer (1 mL, 1 M, pH 7.4) and evaporated to a volume of 1 mL. After desalting on 
a NAP cartridge, the main peak of the crude product was isolated by semi-preparative HPLC 
and characterize by MALDI-TOF-MS analysis:  
 
These oligomers shown in Table 7 were syntheiszed by modification of the synthetic protocol 
in order to take into consideration the insoluble nature of the modified G. The modified G-
phosphoramidite was dissolved to make 0.2 M solution (usually 0.4 M for the other 
nucleosides). The dilution of the G was taken into consideration and hence the coupling times 
and the injection volume were all increased by a factore of two. 
 
5.12.3 Phosphorylation Reactions 
 
Table 8 The phosphorylation of the 5’ of the ligation fragments. 
Conc(µM) MH 
Oligo 
(μL) 5X KL
ATP 
100mM 
DTT 
0.1M H2O PNK 
Total 
Volume 
100 272 26 20 2 5 39.6 7.6 100 
100 273 28.6 20 2 5 37.0 7.6 100 
100 274 22.2 20 2 5 43.4 7.6 100 
100 275 27 20 2 5 38.6 8 100 
100 276 65.6 20 2 5 0.0 7.6 100 
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The Fragment components for the ligation experiment were phosphorylated at the 5`end 
before subjecting to the ligation condition. A typical phosphorylation reavtion scheme for a 
100µM scale synthesis is as shown in Table 8. The final mixture was incubated at 37°C for 1h 
at 300 rpm after which it was cooled to rt. The phosphorylated products were used without 
further purification. 
 
5.12.4 Ligation Experiments 
 
RNA-sequence r(GCUUGAAACCAGCUUUGGG) MH261, and that of MH 262 and 263).  
The 21mer MH262, 13mer MH2635 and 24mer template MH261 were mixed to a final 
concentration of 40 μM for the substrates and 40 μM for the template (1.0 eq). After the 
addition the master mix and water (~54 μl), the mixture was heated at 75° for 4 min and 
subsequently cooled down to r.t within 10min. After the addition of ligation buffer (40mM 
TrisHCl, 2mM MgCl2, 10mM DTT, 0.5mM ATP) and 8 units of ribonuclease inhibitor 
(Fermentas), the reaction was initiated by adding T4 DNA ligase and kept at 16 °C overnight 
stirring at 300 rpm. 
 
Table 9 The ligation scheme for the synthesis of tRNAIle. 
A typical ligation scheme for an 8 µM scale synthesis is shown below. 
 oligo1  oligo2  oligo3 Splint L-premix  ligase  H2O  T.vol   
MH  272  274  276  329  4x      
Conc  100  100  100  100      Ile1 
μL  20  20  20  20  62.5 40  67.5  250   
MH  273 275 276       
Conc  100  100  100  100      Ile4 
μL  20  20  20  20  62.5  40  67.5  250   
 
The scheme above shows the amount of substance used for the ligation experiment. The 
amount of oligomers (shown above), the DNA splint, the ligation premix and H20 were 
pipetted into an eppendorf tube. The reaction tube together with its content was then heated to 
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75 °C for 5 min after which it was allowed to cool to rt within 10 min. The ligase was then 
added and the mixture kept at 16 °C and shaken at 300 rpm overnight. 
NB: The ligation premix has the following constituent.80 µL of 5xKL, 10µL of H2O, 8µL of 
0.1M ATP and 2µL of 1M DTT.) 
 
For the ligation kinetic, 5µL aliquots was taken after which 12µL of the DNAse I was added 
to the remaining portion and stirred at 37°C for an hour. A 12 % analytical PAGE gel reveals 
formation of the full length ligated product and also the digestion of the DNA splint. The 
product of the ligation was purified finally on a 12% PAGE after which the bands were 
excised and eluted overnight in an ammonium acetate solution. 
Analytical gel Preparative gel
Product band Product band
Digest DNA
splint
Digest DNA
splint
 
Figure 79 PAGE chromatogram after DNase digestion. 
 
5.12.5 General Concentration of RNA by Alcohol Precipitation  
 
RNA can be purified for RNA sequencing or for ligation or restriction digestion by 
precipitation in an alcohol/water mixture in the presence of a high concentration of inorganic 
salt. RNA is recovered from the aqueous solution by addition of salt to final concentrations of 
0.8 M LiCl, 0.3-0.5 M NaCl, NaOAc, or 2.5 M NH4OAc and an appropriate volume of 
alcohol (30 %-50 % final percentage isopropanol; 60 %-80 % final percentage ethanol), 
storage for a brief period of time at –20 °C or –70 °C, followed by centrifugation. Subsequent 
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desalting of the RNA pellet involves rinsing in 70 % alcohol, recentrifugation and re-
suspension in appropriate buffer or water.  
About 1/2 as much isopropanol as ethanol is required to precipitate RNA, although higher 
concentrations may be helpful when the RNA is at low concentration. Since isopropanol is 
less volatile than ethanol, and since many salts are less soluble in isopropanol than in ethanol, 
a second 70% alcohol rinse of the pellet is recommended to more efficiently desalt the RNA 
pellet. NaCl is not as soluble as NH4OAc, NaOAc or LiCl in ethanol/water or isopropanol/ 
water; it can be replaced by the latter salts when feasible. Precipitations are commonly 
performed at –70 °C, -20 °C, 0 °C, or room temperature for periods of 5 min to overnight. For 
low RNA concentrations: higher final concentrations of alcohol, longer precipitations (1 h to 
overnight), lower temperatures (-20 °C to –70 °C) and longer centrifugation times (up to 30 
min) may be required for efficient recovery. At the lower temperatures, the viscosity of the 
alcohol is greatly increased and centrifugation for longer times may be required to effectively 
pellet the precipitated RNA. The efficiency of precipitation for small concentrations or 
amounts of RNA may be increased by incubation at –70 °C, but these reactions should be 
brought to 0 °C before centrifugation.  
When SDS is present, one must take care not to precipitate it along with the RNA. By adding 
NaCl to a final concentration of only 0.2 M or using LiCl (0.5 M) before adding the alcohol, 
the SDS will remain in the supernatant. Finally, one should take care to remove all NH4+ ions 
if subsequent enzymatic steps are to be utilized, as it inhibits many enzymes (especially T4 
polynucleotide kinase).  
 
5.12.6 Isopropanol Precipitation  
 
(1) Add to the RNA solution 1/2 vol. of 7.5 M NH4OAc and 2-2.5 vol. isopropanol (based on 
volume of RNA + salt solution) (1 vol. isopropanol is sufficient to precipitate RNA). 
(2) Incubate at room temperature for 10 minutes. 
(3) Spin for 10 minutes at highest speed and remove the supernatant solution. Wash with 70 
% ethanol. The volume of ethanol should be sufficient to at least cover the pellet and wet the 
sides of the tube when vortexed (there is no volume too large). Vortex the sample for 1 
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minute; the pellet should come loose from the tube and be broken up in the EtOH. Centrifuge 
the sample 10 minutes highest speed, to recollect the pellet. 
(4) Gently pour off ethanol being careful not to dislodge the pellet. Re-spin for 1 min and 
remove remaining ethanol using 100 μL pipette. 
(5) Air dry for 10 min. Resuspend in volume of water or TE buffer to achieve desired final 
concentration of RNA. 
General Notes: 
(1) Advantage of isopropanol over ethanol - less volume, fewer salts co-precipitated, done at 
room temperature, and may be more effective in separating primers (which is not precipitated) 
from PCR products than ethanol. 
(2) For improved recovery of RNA from dilute solutions (<10 ng/ml), overnight incubation 
and extended (30 min) centrifugation is recommended. 
(3) In general, the length of time of centrifugation is more important for precipitation DNA 
than chilling the solution in -20 or -70 °C freezer. 
(4) Addition of ammonium acetate to 2.5 M (without ethanol) has been shown to be effective 
in precipitating proteins while leaving the RNA in solution.  
(5) NaOAc precipitation can precipitate large amount of protein together with theRNA.  
 
5.12.7 Mass Spectrometry Analysis of Oligonucleotides 
 
Conditions for MALDI-TOF MS analysis. Oligonucleotides were dissolved in water to a final 
concentration of ~10 μM and desalted by using C18-ZipTips (Millipore Corporation, Bedford, 
MA, USA). The C18 resin was wetted using 50% aqueous acetonitrile solution (4 x 10 µL) 
and then equilibrated by washing with 0.1 M TEAA (4 x 10 µL). For binding of the 
oligonucleotide to the resin, the sample was aspirated and dispensed (approx. 5-8 times). The 
salts were removed by washing with 0.1 M TEAA. The desalted DNA was eluted by 
aspirating and dispensing about 3 times 10 µL 60% acteonitrile/water in another vial. The 
samples for analysis were prepared using the dried droplet method with the  
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following matrix solutions: 1) 6-aza-2-thiothymine/diammonium hydrogen citrate in 1:2 v/v 
water/acetonitrile (detection in negative mode); 2) 3-hydroxy-picolinic acid/diammonium 
hydrogen citrate in 1.2:1 v/v water/acetonitrile (detection in positive mode) The results of the 
Maldi is summarized in Table 7. 
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